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THE RETROVIRIDAE FAMILY OF RETROVIRUSES 
The human immunodeficiency virus type 1 is an enveloped virus, characterized by 
an icosahedral capsid, containing the viral genome, which consists of two copies of 
positive single strand RNA. HIV-1 is classified as retrovirus and, like all the 
retroviruses, belongs to the Retroviridae family (International Committee on 
Taxonomy of Viruses (6th) et al., 1995). The peculiarity of retroviruses, as 
suggested by the term “retro”, relies on the specific capability to perform the reverse 
transcription of their genome from RNA into DNA, which can then be integrated 
into the host cellular genome.  
The Retroviridae family is the only viral family possessing this feature, which 
characterizes the Group VI of viruses of Baltimore classification. This classification 
is based on the genetic system of the viruses and describes the obligatory 
relationship between the viral genome and its mRNA. By convention, mRNA is 
defined as positive strand, because it contains the immediately translatable 
information. In the Baltimore classification, a strand of DNA that is of equivalent 
polarity is also designated as positive strand. The RNA and DNA complements of 
positive strands are designated as negative strands. According to Baltimore 
classification, viruses are divided into the following seven classes: (I) dsDNA 
viruses, (II) ssDNA viruses, (III) 
dsRNA viruses, (IV) (+)-sense 
ssRNA viruses, (V) (-)-sense 
ssRNA viruses, (VI) RNA reverse 
transcribing viruses, and (VII) DNA 
reverse transcribing viruses. 
Retroviruses used to be 
taxonomically divided into three 
subfamilies: the Oncovirinae, which 
includes those with oncogenic 
potential; the Lentivirinae or slow Figure 1-1. The Baltimore classification. 
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viruses, including HIV; and the Spumavirinae or foamy viruses, which have not 
been shown to be pathogenic (Coffin et al., 1997). 
This taxonomic classification is no longer used and Retroviridae family has been 
reclassified into seven distinct genera largely on the basis of the sequence similarity 
within the pol gene (Coffin et al., 1997): mammalian C-type viruses (prototype 
MLV), avian C-type viruses (the ASLV, prototype RSV), B-type viruses (prototype 
MMTV), D-type viruses (prototype M-PMV), viruses of the HTLV/BLV group 
(prototype HTLV-1), lentiviruses (prototype HIV-1), and spumaviruses (prototype 
HFV) (Coffin et al., 1997; Zuckerman et al., 2004). 
  Genus Example Virion morphology 
1. Avian sarcoma and 
leukosis viral group 
Rous Sarcoma Virus central, spherical core “C 
particles” 




eccentric, spherical core “B 
particles” 
3. Murine leukemia-
related viral group 
Moloney Murine 
Leukemia Virus 
central, spherical core “C 
particles” 





central, spherical core 
5. D-type viral group Mason-Pfizer Monkey 
Virus 
cylindrical core “D particles” 




7. Spumaviruses Human Foamy Virus central, spherical core 
Table 1-1.  Classification of Retroviruses. (Coffin et al., 1997). 
HIV-1 STRUCTURE 
The HIV-1 virus is about 120 nm in diameter and roughly spherical. It is surrounded 
by an envelope composed by the plasma 
membrane of host-cell origin and the viral 
proteins gp120 and gp41. Immediately in the 
interior, matrix protein lines the inner surface of 
the viral particle. Deeper inside there is a cone-
shaped viral core, which contains two molecules 
of positive RNA, the viral proteins involved in the 
essential enzymatic functions (protease, integrase Figure 1-2. Schematic representation of HIV-1 structure. 
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and reverse transcriptase), and three of the viral accessory proteins (Vif, Vpr, and 
Nef) (Coffin et al., 1997; Frankel and Young, 1998). 
VIRAL GENOME 
Retroviral genomic RNA is a product of the host RNA synthesis machinery, and as 
such, the viral RNA genome has the structural features of a cellular messenger 
RNA, including a methylated cap ribonucleotide at the 5’ end and a polyadenylated 
3’ end. Two direct repeats, termed R for repeated sequences, lie at the 5’ and 3’ end 
of the genomic viral RNA flanking the 5’ cap and the 3’ Poly(A) tail, respectively. 
Immediately adjacent and internal to the R sequences, there are two unique 
sequences, known as U5 at the 5’ end and U3 at the 3’ end of the viral RNA 
genome. Following U5 there is the primer binding site (PBS), a region annealed by a 
tRNA, that functions as the primer for reverse transcriptase to initiate synthesis of 
the minus strand of DNA. Adjacent to PBS there is the Ψ sequence, which is 
involved in the packaging of the genomic RNA into the assembling virions. Next, 
there are genes encoding structural, functional and accessory proteins. Finally, just 
upstream of U3, there is the polypurine tract, a purine-rich sequence, which is 
cleaved during reverse transcription to produce the RNA primer for the synthesis of 
the plus strand of viral DNA.  
 
Figure 1-3. RNA viral genome. (Coffin et al., 1997). 
HIV-1 PROTEINS 
The retroviral genome is about 9-kb of RNA, and encodes nine open reading frames. 
Three of these encode the Gag, Pol, and Env polyproteins, which are subsequently 
proteolyzed into individual proteins common to all retroviruses. The four Gag 
INTRODUCTION  
 12 
proteins, matrix (MA or p17), capsid (CA or p24), nucleocapsid (NC or p7), and p6, 
and the two Env proteins, gp120 and gp41, are structural components that make up 
the core of the virion and outer membrane envelope, respectively. The three Pol 
proteins, protease (PR), reverse transcriptase (RT), and integrase (IN), provide 
essential enzymatic functions and are also encapsulated within the viral particle, as 
mentioned above. HIV-1 encodes six additional proteins, often called accessory 
proteins, three of which (Vif, Vpr, and Nef) are found in the viral particle (Coffin et 
al., 1997; Frankel and Young, 1998). 
Figure 1-4. Organization of the HIV-1 genome. The location of the long terminal repeats (LTRs) and 
the genes encoded by HIV-1 are indicated. Gag, Pol and Env proteins are  initially synthesized as 
polyprotein precursors. The Gag precursor is cleaved by the viral protease (PR) into the mature Gag 
proteins: matrix (MA), capsid (CA), nucleocapsid  (NC) and p6. The GagPol precursor undergoes PR-
mediated processing to generate the Gag proteins and the Pol enzymes: PR, reverse transcriptase (RT) 
and integrase (IN).  The Env glycoprotein precursor gp160 is cleaved by a cellular protease during 
transport to the cell surface to generate the mature surface glycoprotein gp120 and the trans-membrane 
glycoprotein gp41. The sizes of the genes and encoded proteins are not to scale. (Freed, 2004).  
The core and matrix proteins are encoded by Gag. The Gag proteins of the mature 
virus are p17, p24, p7 and p6, and are processed by cleavage of the p55 precursor 
protein by the viral protease (Coffin et al., 1997; Zuckerman et al., 2004). MA is the 
N-terminal component of the Gag polyprotein and is important for targeting Gag and 
Gag-Pol precursor polyproteins to the plasma membrane prior to viral assembly. 
Indeed, MA protein contains a bipartite membrane-binding signal: one is the 14-
carbon, saturated fatty acid myristate covalently linked to N-terminal glycine 
residue, the other is the largely basic sequence located a short distance downstream. 
The two signals mediate high-affinity binding of MA and of Gag polyprotein to the 
lipid bilayer by hydrophobic interactions with membrane lipids and ionic bonds with 
negatively charged head groups of membrane phospholipids, respectively (Flint et 
al., 2004). As a consequence of this interaction, MA lines the inner surface of the 
mature viral particle. In addition, this protein appears to help incorporate Env 
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glycoproteins into viral particles (Mammano et al., 1995). Furthermore, MA is part 
of the pre-integration complexes (PICs) (Bukrinsky et al., 1993b) and the two 
nuclear localization signals (NLS) (Haffar et al., 2000) may facilitate the nuclear 
import (Gallay et al., 1995).  
CA is the second component of the Gag polyprotein and forms the core shell of the 
HIV-1 viral particle with about 2000 molecules per virion (Scarlata and Carter, 
2003). This protein is often used in Enzyme-Linked ImmunoSorbent Assay (ELISA) 
for quantifying the amount of virus. The C-terminal domain functions primarily in 
assembly and is important for CA dimerization and Gag oligomerization. Capsid is 
important for infectivity, by participating in viral uncoating through its interaction 
with cyclophilin A (cypA) (Kootstra et al., 2003; Saphire et al., 2002; Towers et al., 
2002; Towers, 2007) and it is the major determinant of infection in growth-arrested 
cells (Yamashita and Emerman, 2004). Cyclophilin A is a cytosolic cellular protein 
that belongs to the peptidyl prolyl isomerases family and performs the cis-trans 
isomerization of proline peptide bonds in sensitive proteins (Towers, 2007). By 
interacting with Gag in infected cells, CypA is incorporated into nascent HIV-1 
virions (Franke et al., 1994; Thali et al., 1994). CypA performs cis-trans 
isomerization at CA Gly89-Pro90 on the outer surface of the capsid (Bosco et al., 
2002; Bosco and Kern, 2004) leading to an increased infectivity. The research group 
lead by Luban (Sayah et al., 2004) showed that cypA is an important cellular factor, 
since it is the target for the recently discovered old world monkey TRIM5α 
restriction factor (Song et al., 2005; Stremlau et al., 2004; Yap et al., 2004), which 
has been demonstrated to greatly decrease HIV-1 infectivity (Berthoux et al., 2005; 
Keckesova et al., 2006; Stremlau et al., 2006). 
Nucleocapsid protein is the third component of the Gag polyprotein and coats the 
genomic RNA inside the virion core. The primary function of NC is to bind 
specifically, through its two zinc finger domains, to the packaging signal (Ψ) and 
deliver full-length viral RNAs into the assembling virion. The packaging signal is 
composed of three RNA hairpins located around the major splice donor site, the first 
of which contains the kissing loop involved in RNA dimerization. NC is a basic 
protein that also binds single-stranded nucleic acids nonspecifically, leading to 
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coating of the genomic RNA that presumably protects it from nucleases and 
compacts it within the core (Frankel and Young, 1998). 
Protein p6 comprises the C-terminal 51 amino acids of Gag and is important for 
incorporation of Vpr during viral assembly (Cohen et al., 1990). In addition, p6 is 
required for efficient viral particle release (Demirov et al., 2002; Huang et al., 1995). 
The pol gene encodes the enzymes protease, reverse transcriptase and integrase. 
When the virus buds from the membrane surface, it is released as immature 
noninfectious particle. PR mediates the cleavage of Gag and Pol polyproteins 
(Coffin et al., 1997). 
RT protein catalyzes both RNA-dependent and DNA-dependent DNA 
polymerization reactions and contains an RNase H domain that cleaves the RNA 
portion of RNA-DNA hybrids generated during the reaction (Coffin et al., 1997). 
RT is a heterodimer containing a 560-residue subunit (p66) and a 440-residue 
subunit (p51), both derived from the Pol polyprotein (Flint et al., 2004), each of 
which contains a polymerase domain composed of four subdomains called fingers, 
palm, thumb and connection, and p66 contains an additional RNase H domain 
(Frankel and Young, 1998). Even though their amino acid sequences are identical, 
the polymerase subdomains are arranged differently in the two subdomains, with 
p66 forming a large active-site cleft and p51 forming an inactive closed structure. 
RT is characterized by an high error rate when transcribing RNA into DNA, since it 
lacks a proofreading function (Coffin et al., 1997). 
Following reverse transcription, IN catalyzes a series of reactions to integrate the 
viral genome into a host chromosome. IN together with other viral and cellular 
proteins forms the pre-integration complex (PIC) and binds specific sequences 
located at the ends of the viral cDNA (att sites) (Coffin et al., 1997). This protein 
will be described in more detail in the subsequent sections. 
The env gene encodes the gp41 and gp120 envelope glycoproteins, cleaved by 
cellular enzymes (furins) from the gp160 precursor (Zuckerman et al., 2004). The 
proteins gp120 and gp41 are located on the viral membrane surface and their 
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function is to bind the CD4 receptor of the target cells and mediate fusion between 
viral and cellular membranes, respectively (Frankel and Young, 1998).  
In addition to gag, pol and env, HIV-1 carries six regulatory and accessory genes. 
The tat gene encodes a small protein, which is essential for efficient transcription of 
viral genes and for viral replication (Kessler and Mathews, 1992; Marcello et al., 
2001), resulting in a remarkable increase of viral gene expression (Ratnasabapathy 
et al., 1990; Zhou and Sharp, 1995). Tat binds to a structured RNA element (TAR, 
transactivation-responsive region) present at the 5’-end of viral leader mRNA via 
cyclin T bridging between the activation domain of Tat and the TAR loop (Wei et 
al., 1998). Through this interaction, Tat recruits a series of transcriptional 
complexes, including histone acetyl transferases, which modify chromatin at the 
proviral integration site and make it more suitable to transcription, and P-TEFb 
(Positive Transcription Elongation Factor b), which stimulates RNA polymerase II 
phosphorylation by Cdk9, increasing the processivity of the enzyme complex 
(Bieniasz et al., 1998; Shilatifard et al., 2003; Wei et al., 1998).  
Rev is a sequence-specific RNA binding phosphoprotein that is expressed during the 
early stages of HIV-1 replication (Malim et al., 1989). Rev transports to the 
cytoplasm single-spliced and un-spliced viral mRNA that are required for expression 
of HIV structural proteins and production of genomic RNA. Eukaryotes have 
evolved a special mechanism to retain the incompletely spliced RNAs in the 
nucleus. Since HIV-1 only has one LTR promoter, it encodes a single genome-
length primary transcript. In order to express the various incompletely spliced viral 
transcripts, some HIV-1 transcripts must be transported out of the nucleus without 
splicing. Rev fulfill this function (Malim et al., 1989).  
Nef is a 27 KDa myristoylated protein that is abundantly produced during the early 
phase of viral replication cycle. It is highly conserved in all primate lentiviruses, 
suggesting that its function is essential for survival of these pathogens. Nef has 
different roles in HIV-1 replication and disease pathogenesis. It down-regulates CD4 
(Garcia and Miller, 1991), which limits the adhesion of a Nef-expressing T cell to 
the antigen-presenting cell, thus promoting the movement of HIV-infected cells into 
circulation and spread of the virus. Nef down-modulates MHC I (Schwartz et al., 
INTRODUCTION  
 16 
1996) cell surface expression, protecting HIV-infected cells from host CTL 
response. In addition, it interferes with cellular signal transduction pathways and it 
enhances virion infectivity and viral replication, since it induces actin remodeling 
and facilitates the movement of the viral core past a potentially obstructive cortical 
actin barrier (Campbell et al., 2004; Chowers et al., 1994).   
Vpr is a 96 aa small basic protein. Despite its small size, Vpr has been shown to 
have multiple activities during viral replication. Vpr appears to participate in the 
anchoring the PICs to the nuclear envelope and to be involved in the nuclear 
translocation of the viral DNA (Heinzinger et al., 1994). In addition, Vpr induces 
cell cycle G2 phase arrest (Bartz et al., 1996; Di Marzio et al., 1995). The biological 
significance of Vpr-induced arrest during viral infection is not well understood. 
However, HIV-1 LTR seems to be more active in the G2 phase, implying that Vpr-
induced G2 arrest may confer a favorable cellular environment for efficient 
transcription of HIV-1 (Goh et al., 1998).  
Vpu is a 9 KDa membrane protein that induces the degradation of the CD4 receptor. 
Vpu interacts with a membrane-proximal domain of the cytoplasmic tail of CD4 and 
links it to h-βTrCP (Margottin et al., 1998). The CD4-Vpu-h-βTrCP ternary 
complex then recruits SKP1, a member of the ubiquitination machinery (West, 
2003). As a result, CD4 is ubiquitylated and targeted to proteasomes for 
degradation. In addition, Vpu increases progeny virus secretion from infected cells. 
This function is related to the ability of Vpu to self-assemble into homooligomeric 
complexes that in vitro function as ion-conductive membrane pores (Bour and 
Strebel, 2003). The requirement of Vpu for efficient virus release is host cell-
dependent (Varthakavi et al., 2003), suggesting that Vpu may counteract an 
inhibitory cellular factor that, in the absence of Vpu, inhibits virus release. Recent 
report showed that this factor is TASK-1, an acid-sensitive K+ channel (Hsu et al., 
2004). TASK-1 is structurally homologous to Vpu, suggesting oligomerization as a 
possible mechanism of inactivation of ion channel activity of these proteins (Hsu et 
al., 2004). However, the mechanism by which TASK-1 inhibits virion release is still 
unclear (Li et al., 2005).  
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Vif is a 192 aa protein that is expressed at high levels in the cytoplasm of infected 
cells. Vif was thought to be important because it is essential for the replication of 
HIV-1 in the peripheral blood lymphocytes, macrophages, and certain cell lines 
known as “nonpermissive” cells (Strebel et al., 1987).  The molecular nature of the 
permissivity is related to a host cellular protein known as APOBEC3G 
(apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3G), a potent 
inhibitor of HIV infection in the nonpermissive cells (Harris et al., 2002; Jarmuz et 
al., 2002). APOBEC3G is a member of the cytidine deaminase family, which 
prevents viral cDNA synthesis via deaminating deoxycytidines in the minus-strand 
retroviral cDNA replication intermediate (Harris et al., 2003; Yu et al., 2004). As a 
result, it creates stop codons or G to A transitions in the newly synthesized viral 
cDNA, which is then subjected to elimination by host DNA repair machinery 
(Zhang et al., 2003). Thus, APOBEC3G represents an innate host defense 
mechanism against HIV infection. However, the virus has also developed an 
offensive strategy to suppress the antiviral effect of APOBEC3G through Vif. Vif 
binds directly to APOBEC3G and counteracts its anti-HIV activity by promoting its 
degradation (Li et al., 2005). In addition, Vif is specifically packaged into virions, 
where it is processed by protease (Khan et al., 2002). Vif also stabilizes viral 
nucleoprotein complex through direct interaction with 5’ region of HIV-1 genomic 
RNA (Simon and Malim, 1996).  
HIV-1 REPLICATION CYCLE 
Viral Entry 
The tropism of HIV-1 for the target cells is governed by the presence of both the 
cellular receptor CD4 and a coreceptor on the plasma membrane of target cells 
(Dalgleish et al., 1984). Two types of coreceptor were identified: the chemokine 
receptors CCR5 [chemokine (C-C motif) receptor 5] and CXCR4 [chemokine (CXC 
motif) receptor 4] (Choe et al., 1996; Deng et al., 1996). The distribution of these 
coreceptors permits infection not only of CD4+ T cells, but also macrophages and 
dendritic cells (DCs).  
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Figure 1-5.The HIV-1 replication cycle. 
(Pommier et al., 2005). 
In order to enter the target cell, HIV-1 gp120 
protein binds the CD4 receptor, inducing a 
conformational change and promoting the 
binding of the chemokine receptor CCR5 or 
CXCR4. It is noteworthy that individuals 
homozygous for a defective CCR5 allele are 
highly resistant to HIV-1 infection. The 
interaction between gp120, CD4 and the 
coreceptor induce a conformational change in 
gp41 that expose a hydrophobic glycine-rich 
“fusion” peptide, which initiate the fusion of the 
viral envelope with the plasma membrane in 
specific membrane microdomains rich in 
cholesterol, known as lipid rafts (Manes et al., 
2000). 
Retrotranscription 
Following entry, the viral RNA genome is in the 
cell cytoplasm as part of a nucleoprotein 
complex, which associates with microtubules 
before the loss of the capsid structure 
(McDonald et al., 2002). The function of the 
microtubule-based mobility is to transport the 
HIV-1 viral complex from the cell periphery to 
the nucleus. The next step of viral infection is 
the synthesis of a DNA copy of the RNA viral genome, through the viral enzyme 
RT, and this process has been shown to start in the intact capsid structure 
(McDonald et al., 2002).  
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Reverse transcription is an 
essential step in HIV-1 life cycle, 
since it is a process that converts 
the genomic RNA into DNA. It 
has been proposed that 
retroviruses copackage two copies 
of positive single-stranded RNA to 
increase the probability of 
successful DNA synthesis (Coffin, 
1979). During initiation of reverse 
transcription, a cellular tRNA 
primer (tRNALys) is placed onto a 
complementary sequence in the 
viral genome, called the primer 
binding site (PBS). The reverse 
transcriptase recognizes this RNA-
RNA complex and catalyzes the 
synthesis of minus-strand DNA 
starting from the 3’ end of the 
tRNA primer, with the viral RNA 
acting as template. The synthesis of minus-strand DNA (-sssDNA) extends up to the 
5’ cap of the genomic RNA template and the RNase domain of RT cleaves the RNA 
portion of RNA-DNA hybrid. Continued minus-strand DNA synthesis requires a 
strand-transfer reaction that allows the 3’end of the genomic RNA to serve as a 
template. Once the first jump has occurred, the 3’end of the minus strand is extended 
up to the PBS of the RNA viral genome. The site where DNA plus-strand is initiated 
is the polypurine tract, where RNase H domain of RT cleaves the RNA to generate 
an RNA primer. RT catalyzes the synthesis of the plus-strand DNA (+sssDNA) up 
to a portion of the tRNA. The 3’end of the +sssDNA is complementary to the PBS 
of the –sssDNA and it is required as complementary region for the second strand 
transfer. Once the second jump has occurred, elongation of the plus and minus 
Figure 1-6. Schematic representation of HIV-1 reverse 
transcription. (Coffin et al., 1997). 
INTRODUCTION  
 20 
strands can be completed. The final product is a blunt-ended linear duplex DNA 
(Coffin et al., 1997). 
Compared to other DNA polymerases, RT lacks a 3’ exonuclease activity capable to 
excise mispaired nucleotides, resulting in a more error-prone enzyme. This feature 
allows the HIV-1 to adapt to environment changes, helping it to escape immune 
system defensive mechanisms and even drugs treatment (Coffin et al., 1997). 
Nuclear translocation 
Once the reverse transcription process is completed, the newly synthesized viral 
DNA remains associated with a high molecular weight complex composed of both 
viral and cellular proteins, known as preintegration complex (PIC), that will be 
explained in more detail in the subsequent sections.  
Whereas most retroviruses need the nuclear membrane disassembly during mitosis 
to allow the retrotranscribed viral complexes to access the host genome, lentiviruses 
have evolved a mechanism whereby the PIC is actively transported across the 
nuclear envelope through the nuclear pores. Several viral determinants for nuclear 
import have been proposed, including MA (Bukrinsky et al., 1993a), Vpr 
(Heinzinger et al., 1994), the IN enzyme (Gallay et al., 1997) and an unusual triple-
stranded fragment of lentiviral DNA referred to as the DNA ‘flap’ (De Rijck and 
Debyser, 2006). Although a consensus has not emerged so far regarding the 
mechanism by which the PIC is imported to the nucleus, this unique property 
enables lentiviruses to infect non-dividing cells.  
Integration 
Once inside the nucleus, IN catalyzes the integration of the viral DNA into the host 
cell chromosome, which will be discussed in more detail in the subsequent sections. 
IN together with other viral and cellular proteins that forms the PICs bind specific 
sequences located at the end of the viral cDNA (att sites) (Coffin et al., 1997). So far 
no primary sequence in the cellular genome has been identified as the preferential 
binding site for IN and integration seems to occur at random on DNA molecules 
(Carteau et al., 1998; Stevens and Griffith, 1996). Only recently it has been showed 
that transcriptionally active genes are strongly favored as integration target sites 
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(Barr et al., 2006; Barr et al., 2005; Carteau et al., 1998; Ciuffi et al., 2005; Lewinski 
et al., 2005; Lewinski et al., 2006; Mitchell et al., 2004; Schroder et al., 2002; Wu et 
al., 2003). 
Alternatively, the viral DNA may follow three different fates, all of which do not 
lead to the formation of a functional provirus. The ends of viral DNA may join to 
form a 2-LTR ring or the viral genome may undergo homologous recombination 
producing a single LTR ring. Finally, the viral DNA may integrate into itself 
(autointegration) leading to the formation of a rearranged circular structure (Coffin 
et al., 1997). None of these circular forms serve as precursor to integrated provirus, 
and none appear to contribute significantly to viral replication. Rather, they all 
appear to be dead-end by-products of aborted infections (Coffin et al., 1997). 
 
Viral Transcription 
In the integrated provirus, the 5’ LTR acts as the viral promoter; it contains several 
positive transcription factor binding sites even if, in the absence of the viral Tat 
protein, the binding of these factors is not sufficient to activate the transcription of 
viral genes. However, the presence of these promoter elements results in the correct 
Figure 1-7. Unintegrated viral DNA structures. 
(A) The linear product of viral  DNA synthesis is 
the precursor to the integrated provirus. (B) 1-LTR 
circle. This structure is consistent with one that 
could be formed by  homologous recombination 
between the LTRs of the linear DNA molecule. (C) 
2-LTR circle. This structure is consistent with one 
that could be formed  by simply joining the ends of 
the linear DNA molecule, although there are  often 
bases inserted or deleted at the "circle junction". (D 
and E)  Autointegration products. These circular 
molecules are apparently formed by the suicidal 
integration of the viral DNA ends using the viral 
DNA itself as  the target, instead of cellular DNA. 
Their structures depend on the site of  integration 
(which determines the spacing between the two 
LTRs in the full-  length circular products or the 
sizes of the two subgenomic circular  products), and 
on the path of the DNA between the ends and the 
target site  (which determines whether the product 
is a single full-length circle [D] or  two smaller 
circles [E]). Dots indicate the sites of joining; 
arrows show  orientation of the DNA sequence 
relative to the RNA genome. (Coffin et al., 1997). 
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positioning of RNA polymerase II at the site of initiation of transcription and to the 
assembly of the pre-initiation complex. At this point transcription starts but the 
polymerase produces predominantly short, non-polyadenylated RNA that include a 
hairpin structure at the 5’ end of the nascent viral RNA, named trans-activation-
responsive region (TAR) (Peterlin and Trono, 2003). Tat acts as a very powerful 
transcriptional activator of the integrated provirus by interacting with TAR and 
promoting the production of polyadenylated full-length RNA viral genomes.  
  
Tat-activated transcription originates different transcripts derived by the splicing of 
the full-length viral genome. The first viral transcripts that appear after infection are 
completely spliced and are rapidly transported into the cytoplasm following the 
same pathway as cellular mRNA (Cullen, 1998).  
Figure 1-8. Mechanism of Tat transactivation. Activators that bind the promoter recruit RNA 
polymerase II (RNAPII) to the long terminal repeat (LTR). In the pre-initiation complex, the 
unphosphorylated carboxy-terminal domain (CTD) of RNAPII, which is shown as a yellow coil, binds 
mediators. Together with the general transcription factor TFIIH, which contains DNA-helicase and CTD-
kinase activities, RNAPII clears the promoter and starts copying the viral genome. Cyclin-dependent 
kinase 7 (CDK7) in TFIIH is shown as a grey changing to red ball, indicating its activation as a kinase. 
The partially phosphorylated RNAPII arrests at or near the transactivation response element (TAR), 
synthesizing TAR and/or an alternative paused hairpin. 5,6-dichloro-1-β-D-ribofuranosylbenzimidazole 
(DRB)-sensitivity-inducing factor (DSIF) and negative elongation factor (NELF) then ensure that 
RNAPII does not elongate. RD — so named for its many repeats of arginine and glutamate residues — in 
NELF contains an RNA-recognition motif that binds the stem in TAR. For formation of the tripartite 
complex with transcriptional transactivator (Tat) and TAR, positive transcription elongation factor b (P-
TEFb), which contains cyclin T1 (CYCT1) and CDK9, must be free of 7SK RNA, and CDK9 must be 
autophosphorylated. After its recruitment to TAR, P-TEFb phosphorylates suppressor of Ty 5 (SPT5) in 
DSIF and RD in NELF, and completes the phosphorylation of the CTD of RNAPII, thereby modifying 
RNAPII for efficient elongation. The phosphorylated CTD now binds elongators, which consist of 
capping enzymes, splicing apparatus and polyadenylation factors. Efficient elongation of transcription 
and viral replication ensue. The change in color of the CTD from yellow to red and its increased 




Incompletely spliced RNAs are blocked in the nucleus by the cellular machinery that 
control the integrity of the splicing process; the single spliced and unspliced 
transcripts persist in the nucleus due to defective donor and acceptor splice sites and 
to the inhibitory effect of Rev on splicing (Luo et al., 1994; Powell et al., 1997). The 
translocation of these transcripts into the cytoplasm depends on the expression of the 
Rev protein (Pomerantz et al., 1992). Rev is able to shuttle between the nucleus and 
the cytoplasm and binds the viral transcripts through the interaction with an RNA 
stem-loop structure named Rev responsive element (RRE), located in the env gene 
(Malim et al., 1990). 
Viral Assembly 
Once translated, all the viral proteins necessary for the virion assembly and RNA 
genomes are transported to the plasma membrane, in cholesterol-rich lipid domains 
known as lipid rafts, where the building of new virions begins. The gp120/gp41 
complex is transported via the Endoplasmic reticulum-Golgi pathway, whereas the 
Gag-Pol polyproteins are targeted to the plasma membrane after the myristoylation 
of Gag (Gottlinger et al., 1989). The resulting virions bud from the plasma 
membrane as immature virions. Their maturation is accomplished by viral protease 
activity that first cleaves Gag-Pol and then, starting from the Gag and Pol separated 
precursors, originates the single core proteins, matrix and the viral enzymes. The 
proteolytic activity ends when the virion is already detached from the host plasma 
membrane and results in the formation of mature infectious viruses (Coffin et al., 
1997).  
Figure 1-9. The HIV genome, transcripts 
and proteins. HIV transcripts. Integrated into 
the host chromosome, the 10-kb viral genome 
contains open reading frames for 16 proteins 
that are synthesized from at least ten 
transcripts. Black lines denote unspliced and 
spliced transcripts, above which coding 
sequences are given, with the start codons 
indicated. Of these transcripts, all singly 
spliced and unspliced transcripts shown above 
those encoding the transcriptional 
transactivator (Tat) require regulator of virion 
gene expression (Rev) for their export from 
the nucleus to the cytoplasm. The RNA target 
for Rev, the Rev response element (RRE), is 
contained in the gene encoding envelope 





The name of the key enzyme mediating retroviral integration has evolved through 
several stages in the past 25 years, reflecting incremental progress in our 
understanding of its role and activities. Indeed, this enzyme was initially identified 
by its apparent molecular weight, then labeled “endonuclease”, in recognition of the 
relatively non specific endonuclease activity observed in assays using unnatural 
DNA substrates, and finally “integrase” (IN), when it became clear that it was the 
enzyme that actually catalyzed the key chemical steps in integration (Coffin et al., 
1997). 
The integrase protein is encoded by sequences at the 3’end of the pol gene, 
immediately downstream from the sequences encoding reverse transcriptase. Once 
viral protease has cleaved the polyprotein, the stoichiometry of integrase protomers 
in the virion is 1:1 with reverse transcriptase protomers, or approximately 50-100 
protomers per viral particle (Coffin et al., 1997). 
Integrase catalyzes the integration of the viral DNA into the host cell genome, via a 
two-step process: the 3’-end processing and the 3’-end joining (Coffin et al., 1997). 
Integrase Structure 
HIV-1 integrase is a protein of 288 amino acids (about 32 kDa) and it shares similar 
structural domains with the other retroviral integrases. The domains consist of an N-
terminal domain of 50 amino acids, a central domain of 160 amino acids, and a less 
conserved C-terminal domain of 80 amino acids.  
Figure 1-10. Schematic of the domain structure of retroviral integrases. The three domains appear to 
be stably folded when prepared separately. The amino-terminal-most (HHCC) domain is characterized by 
pairs of histidine and cysteine residues that are universally conserved among retroviral integrases. The 
central domain contains the catalytic site. It is characterized by a triad of universally conserved and 
essential residues, an aspartate, followed at some distance by an aspartate and glutamic acid that are 
always separated by 35 amino acids. The carboxy-terminal domain is sometimes called the DNA-binding 
domain, a bit of a misnomer since the core domain also binds DNA, but nevertheless an accurate 




Within the N-terminal domain of IN is a putative zinc finger of the HHCC type. 
Using a zinc binding assay, Bushman et al. (Bushman et al., 1993) reported that 
wild-type HIV IN binds zinc. Recently, a solution structure of the N-terminal 
domain was determined and revealed a dimeric structure having an HHCC zinc 
binding motif that coordinates zinc. The folds of the N termini are similar to those of 
other DNA binding proteins in having a helix-turn-helix structural motif (Hindmarsh 
and Leis, 1999). The N terminus influences the catalytic activity of IN but does not 
contain its catalytic core and seems not to be involved in the multimerization 
(Hindmarsh and Leis, 1999).  
The central core domain comprises residues 50 to 212 and has been shown to 
coordinate divalent cations. The crystal structures of the catalytic core domains for 
HIV-1 have been solved. The central core is the catalytic domain of the enzyme. The 
core domain is characterized by the catalytic triad of three highly conserved 
residues, D,D(35)E. Substitutions of any of these residues abolish end-processing 
and/or joining reactions. Crystal structures of the catalytic core, coordinating a 
divalent cation, have been determined for HIV by using Mg++. The divalent cations 
were found to be coordinated by the two conserved aspartic acid residues of the 
catalytic triad (Hindmarsh and Leis, 1999). 
The C terminus of IN is required both for 3’end processing and integration activity 
(Coffin et al., 1997). An HIV-1 IN fragment representing residues 235 to 288 binds 
nonspecifically to DNA (Hindmarsh and Leis, 1999). Interpretation of the DNA 
binding activity of the carboxy-terminal region is complicated by the fact that 
integration involves two different DNA substrates, which have different structural 
requirements: the viral cDNA and the host genomic DNA. The isolated carboxy-
terminal region binds well to simple linear double-stranded DNA oligonucleotides 
(Engelman et al., 1994; Lutzke et al., 1994; Vink et al., 1993), suggesting that it may 
contribute to binding the viral cDNA ends (att sites) (Coffin et al., 1997). In 
addition, the C-terminus seems to be involved in the multimerization of IN 




Integration occurs in two well-characterized catalytic steps, referred to as end 
processing and end joining (Coffin et al., 1997; Hindmarsh and Leis, 1999).  
End processing involves removal of a dinucleotide, adjacent to a highly conserved 
CA dinucleotide, from the 3’ strand of the U3 and U5 viral DNA LTRs in a reaction 
involving a water molecule or other nucleophile (Engelman et al., 1991). This 
exposes a 3’ hydroxyl group, whose oxygen is used as an attacking nucleophile on 
the target DNA during the joining reaction, in which the viral DNA is inserted into 
the cellular DNA. It is believed that a Mg++ atom coordinated in the active site of IN 
facilitates the deprotonation of the water to activate it as a nucleophile. 
 
Figure 1-11. Schematic outline of the principal steps in retroviral DNA integration. (Coffin et al., 
1997). 
The DNA-joining step of integration, which involves the formation of new 
phosphodiester bonds joining the viral and host DNAs, proceeds without an extrinsic 
source of chemical energy. This suggests that the energy from the target DNA bonds 
that need to be broken in this step is used to form the new bonds that join the viral 
and target DNAs. This cleavage-ligation reaction proceed via a transesterification 
reaction and not via a covalent intermediate between IN and DNA (Engelman et al., 
1991), as it happens, for example, between topoisomerases and DNA (Champoux, 
1977). 
Integration is accompanied by duplication of a short sequence from the target site, 
which flanks the integrated provirus as a direct repeat of 4-6 bp (Coffin et al., 1997). 
INTRODUCTION  
 27 
The 5’ ends of the viral DNA and the 3’ ends of the host DNA remain unjoined. It is 
thought that repair of this integration intermediate is carried out by cellular enzymes, 
generating the integrated provirus (Coffin et al., 1997; Hindmarsh and Leis, 1999).  
NUCLEAR STRUCTURE 
The DNA of eukaryotic cells is sequestered from the cytoplasm in the nucleus and it 
is complexed with cellular proteins. The result is a very complex structure, with 
different levels of organization. Since retroviral integration takes place in the 
cellular genome, it is important to understand the organization of the host genome. 
The Nucleus 
The nuclear compartment is delimited from the cytoplasm by the nuclear envelope, 
constituted by two concentric lipid bilayer membranes. The inner membrane 
contacts the nuclear lamina, which forms a thin sheetlike meshwork giving 
 
Figure 1-12. A cross-sectional view of a typical cell nucleus. The nuclear envelope consists of two 
membranes, the outer one being continuous with the endoplasmic reticulum membrane. The space inside 
the endoplasmic reticulum (the ER lumen) is colored yellow; it is continuous with the space between the 
two nuclear membranes. The lipid bilayers of the inner and outer nuclear membranes are connected at 
each nuclear pore. Two networks of intermediate filaments (green) provide mechanical support for the 
nuclear envelope; the intermediate filaments inside the nucleus form a special supporting  structure called 
the nuclear lamina. (Alberts et al., 2002). 
mechanical support to the nuclear envelope. The nuclear lamina is a layer of 
intermediate filament proteins. The α-helical heptad repeats of lamins form coiled-
coil dimers, which associate head-to-tail in filaments that span from pore to pore 
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(Akhtar and Gasser, 2007). The outer membrane is directly connected to the 
endoplasmic reticulum of the cytosol. The space between these two membranes is 
continuous with the lumen of the endoplasmic reticulum (Alberts et al., 2002).  
In order to allow the trafficking of molecules between the nuclear compartment and 
the cytosol the two membranes come into contact at openings called nuclear pore 
complexes. There are more than 3,000 pore complexes on the nuclear envelope of an 
animal cell. Each complex is composed of more than 50 different proteins, the 
nucleoporins, which are arranged with a striking octagonal symmetry. The nuclear 
pores are used for both import of molecules, like proteins synthesized in the cytosol, 
and export, like mRNAs transcribed in the nucleus.  
 
Figure 1-13. The arrangement of nuclear pore complexes in the nuclear envelope. (A) A small region 
of the nuclear envelope. In cross section, a nuclear pore complex seems to have four structural building 
blocks; column subunits, which form the bulk of the pore wall; annular subunits, which extend "spokes" 
(not shown) toward the center of the pore; luminal subunits, which contain transmembrane proteins that 
anchor the complex to the nuclear membrane; and ring subunits, which form the cytosolic and nuclear 
faces of the complex. In addition, fibrils protrude from both the cytosolic and the nuclear sides of the 
complex. On the nuclear side, the fibrils converge to form basketlike structures. Localization studies 
using immunoelectron microscopy techniques showed that the proteins that make up the core of the 
nuclear pore complex are symmetrically distributed across the nuclear envelope so that the nuclear and 
cytosolic sides look identical. This is in contrast to proteins that make up the fibrils, which are different 
on each side of the cytosolic or the nuclear side. (B) A scanning electron micrograph of the nuclear side 
of the nuclear envelope of an oocyte. (C) The continuity of the inner and outer nuclear membrane at the 
pore is apparent in this thin section electron micrograph, showing a side view of two nuclear pore 
complexes (brackets). (D) This electron micrograph shows face-on views of negatively stained nuclear 





The DNA of human cells is made up of 
approximately 7x109 nucleotides, divided 
between a set of 46 chromosomes, 22 pairs 
common to both males and females, plus two 
so-called sex chromosomes (X and Y in 
males and two Xs in females). Stretched out 
end to end, the human DNA would extend 
for a total length of about 1.8 meters.  
Since the average diameter of a nucleus is 
around 6 µm, it comes out that the DNA 
must be tightly packaged to fit in it. This 
packaging is performed by proteins, which 
successively coil and fold the DNA into 
higher level of organization until the highest 
one that is the mitotic chromosome. The high 
overall packing ratio of the genetic material 
suggests that DNA cannot be directly 
packaged into the final structure of 
chromatin. Indeed there are hierarchies of 
organization.  
The proteins that bind the DNA to form the 
eukaryotic chromosome are divided into two 
classes: the histones and the nonhistone 
chromosomal proteins. The complex 
resulting from both classes of proteins and 
the nuclear DNA is called chromatin.  
The first and most basic level of chromatin 
organization is the nucleosome. At this level 
the double strand DNA is wrapped around a complex of eight histone proteins, 
called the histone core. This histone octamer consists of two copies each of H2A, 
Figure 1-14. Structural organization of the 
nucleosome. A nucleosome contains a protein 
core made of eight histone molecules. As 
indicated, the nucleosome core particle is 
released from chromatin by digestion of the 
linker DNA with a nuclease, an enzyme that 
breaks DNA. (The nuclease can degrade the 
exposed linker DNA but cannot attack the 
DNA wound tightly around the nucleosome 
core.) After dissociation of the isolated 
nucleosome into its protein core and DNA, the 
length of the DNA that was wound around the 
core can be determined. This length of 146 
nucleotide pairs is sufficient to wrap 1.65 




H2B, H3 and H4. The organization of DNA with proteins to form nucleosomes 
leads to a chromatin length that is one-third of the initial one. At this stage the 
chromatin is a continuous of nucleosomes and resembles a series of beads on a 
string. This structure, called 10 nm fiber, is not still clear whether exists in vivo or is 
only an artifact, as a consequence of unfolding during extraction in vitro.  
 
Figure 1-15. Nucleosomes as seen in the electron microscope. This electron micrograph shows a length 
of chromatin that has been experimentally unpacked, or decondensed, after isolation to show the  
nucleosomes (Alberts et al., 2002). 
The 10 nm fiber condenses into a more packed form, named 30 nm fiber. The 
presence of histone H1 is required to form the 30 nm fiber. Histone H1 condense the 
10 nm fiber through its interaction with nucleosomes, changing the path of the DNA 
and leading to a fiber resembling a solenoid (Schalch et al., 2005). It has about 6 
nucleosomes per turn, which correspond to a packing ratio of 40 (1 µm of this fiber 
contains 40 µm of DNA).  
These still extended structures present in the interphase chromosomes condense 
more and more during mitosis to form highly condensed structures called mitotic 
chromosomes. At this stage each chromosome consist of two daughter DNA 
molecules produced by DNA replication and they are folded separately to produce 
two sister chromosomes, called sister chromatids, held together at their centromers. 
Several mechanisms of chromatin condensation that lead to the formation of the 
highly condensed chromosome structure have been proposed (Belmont, 2002; 
Belmont and Bruce, 1994; Poirier and Marko, 2002; Strukov et al., 2003; Swedlow 
and Hirano, 2003), but the most known is the “radial loop model” (Coelho et al., 
2004; Maeshima and Laemmli, 2003; Swedlow and Hirano, 2003). In this model the 




Figure 1-16. Chromatin packing. This model shows some of the many levels of chromatin packing 
postulated to give rise to the highly condensed mitotic chromosome. (Alberts et al., 2002).  
Interphase chromatin 
Highly condensed chromosomes are present in the eukaryotic cell for a brief period, 
during the act of cell division. During most of the life cycle of the cell, however, its 
genetic material occupies an area of the nucleus in which individual chromosomes 
can’t be distinguished. The structure of interphase chromatin doesn’t change visibly 
between one division and the following. The characteristics of chromatin in 
interphase nuclei have been studied at light microscope since the 1930s, 
distinguishing two types of material: a highly condensed and a less condensed form, 
called heterochromatin and euchromatin, respectively. 
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Euchromatin is composed of the types 
of chromosomal structures such 30 nm 
fiber and looped domains. It has 
relatively dispersed appearance in the 
nucleus and occupies most of the 
nuclear region. Heterochromatin, in 
contrast, is characterized by regions 
very densely packed with fibers, 
displaying a condition comparable to 
that of the chromosome at mitosis. It 
includes additional proteins and 
although present in many locations 
along chromosomes, it is concentrated 
in specific regions, including the 
centromeres and the telomeres (Alberts 
et al., 2002; Lewin, 2004). The amount 
and distribution of condensed chromatin is similar in terminally differentiated cells 
of the same lineage, but it varies in the nuclei of different cell types, indicating that 
nuclear organization may be cell-type specific (Francastel et al., 2000). 
The same fibers run continuously between euchromatin and heterochromatin, which 
implies that these states represent different degrees of condensation of the genetic 
material. In the same way, euchromatic regions exist in different states of 
condensation during interphase and during mitosis. So the genetic material is 
organized in a manner that permits alternative states to be maintained side by side in 
chromatin, and allows cyclical changes to occur in the packaging of euchromatin 
between interphase and division (Lewin, 2004).  
The structural condition of the genetic material is correlated with its activity. Indeed, 
active genes are contained within euchromatin, but only a small minority of the 
sequences in the euchromatin is transcribed at any time. So location in euchromatin 
is necessary for gene expression, but is not sufficient for it. Heterochromatin is not 
transcribed and replicates late in the S phase of cell cycle (Lewin, 2004; Wu et al., 
Figure 1-17. Electron micrograph of a cell 
nucleus. A thin section through a nucleus stained 
with Feulgen shows heterochromatin (H) as 
compact regions clustered near the nucleolus (Nu) 
and the nuclear membrane. Euchromatin (E) appears 




2005). This suggests that condensation of the genetic material is associated with 
(perhaps is responsible for) its inactivity. Heterochromatin can be distinguished in 
facultative or constitutive heterochromatin. The former is the fraction of chromatin 
that is condensed and inactive in a given cell lineage, which may be decondensed 
and active in another. The latter is the fraction of heterochromatin that stays compact 
through the cell cycle. It is mainly composed of repetitive sequences (e.g. satellite 
DNA), and is concentrated as mentioned above in centromeres and telomeres 
(Francastel et al., 2000).  
Epigenetic 
Historically, the word “epigenetics” was used to describe events that could not be 
explained by genetic principles. Conrad Waddington, who is given credit for coining 
the term, defined epigenetics as “the 
branch of biology which studies the 
causal interactions between genes and 
their products, which bring the 
phenotype into being” (Goldberg et al., 
2007).  
Epigenetics, in a broad sense, is a bridge 
between genotype and phenotype; it’s a 
phenomenon that changes the final 
outcome of a locus or chromosome 
without changing the underlying DNA 
sequence. More specifically, epigenetics 
may be defined as the study of any potentially stable and, ideally, heritable change 
in gene expression or cellular phenotype that occurs without changes in Watson-
Crick base pairing of DNA. 
Much of today’s epigenetic research is converging on the study of covalent and 
noncovalent modifications of histone proteins and DNA and the mechanisms by 
which such modifications influence overall chromatin structure (Goldberg et al., 
2007). The efforts in studying these chromatin modifications have clearly showed 
that epigenetic contributes to regulate chromatin structure and DNA accessibility; 
Figure 1-18. Epigenetic. In 1957, Conrad 
Waddington proposed the concept of an epigenetic 
landscape to represent the process of cellular 
decision-making during development. At various 
points in this dynamic visual metaphor, the cell 
(represented by a ball) can take specific permitted 
trajectories, leading to different outcomes or cell 
fates. Figure reprinted from Waddington, 1957. 




nevertheless, it’s part of the core mechanism for regulating the transcriptional status 
of a genetic locus, whether a small element within an individual gene, a 
chromosomal domain, or even an entire chromosome (Bernstein et al., 2007). 
Among the epigenetic modifications there are mainly two categories: histone 
posttranslational modifications and DNA methylation. All these chromatin 
modifications influence how the genome is made manifest across a different array of 
developmental stages, tissue types and even disease states (Margueron et al., 2005).  
Histone Post-Translational Modifications 
The binding of a chemical group to one or more aminoacidic residue of histones is 
known as histone posttranslational modification (HPTM). There are a large number 
of HPTMs, and they divide into two groups (Allis et al., 2007): (1) small chemical 
groups, including acetylation, phosphorylation and methylation; (2) the much larger 
peptides, including ubiquitylation and sumoylation. 
The mechanism through which HPTMs may 
affect chromatin structure and/or gene 
transcription is still poorly understood. Three 
mechanisms are commonly considered (Allis 
et al., 2007). In the first one, the binding of 
chemical compounds may change the charge 
of the aminoacids, altering the organization of 
the chromatin, leading it to a more or less 
condensed structure. The other two 
mechanisms propose that a structural change 
of the aminoacids, as a consequence of the 
HPTMs, may favor or block the binding of 
specific proteins, such as chromatin 
remodeling proteins, chromatin modifying 
complexes, and transcriptional factors.  
Histones may be modified at many sites. To date, more than 60 different residues 
have been identified, either by specific antibodies or by mass spectrometry 
Figure 1-18. Models showing how histone 
posttranslational modifications affect the 
chromain template. Model 1 proposes that 
changes to chromatin structure are mediated 
by the cis effects of covalent histone 
modifications, such as histone acetylation or 
phosphorylation. Model 2 illustrates the 
inhibitory effect of an HPTM for the binding 
of a chromatin-associated factor (CF). In 
model 3, an HPTM may provide binding 
specificità for a chromatin-associated factor. 
(Allis et al., 2007). 
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(Kouzarides, 2007; Macek et al., 2006). This large number of histone 
posttranslational modifications and their various combinations have led to the idea 
that they regulate via combinatorial patterns, in temporal sequences, and can be 
established over short- and long-range distances. 
Acetylation 
Less condensed chromatin regions are transcriptionally active (Felsenfeld and 
Groudine, 2003; Weintraub and Groudine, 1976). Indeed, these regions are 
characterized by an “open” chromatin configuration, which is more accessible to 
enzymes involved in DNA regulatory processes, such as transcription (Allis et al., 
2007). In addition, these regions showed 
to be closely correlated with acetylated 
histones (Hebbes et al., 1994), revealing 
a role for acetylation in chromatin 
condensation and gene regulation. 
Acetylation is a histone posttranslational 
modification mediated by a family of 
proteins called histone acetyl 
transferases (HAT). These enzymes 
transfer an acetyl group from acetyl-
coenzyme A (acetyl-CoA) to the ε-
amino group of specific lysine residues within the histone basic N-terminal tail 
region (Roth et al., 2001). HAT proteins can acetylate lysine on all four core 
histones, but different enzymes possess distinct specificities in their substrate of 
choice.  
To date three families of HAT have been described. One major HAT family, GNAT 
(for GCN5 related acetyltransferase), targets histone H3 as its major substrate. A 
second family, the MYST, targets histone H4 as its main substrate. A third major 
family, CBP/p300, targets both H3 and H4, and is the most promiscuous. Each of 
these acetyltransferase families is also able to acetylate non-histone substrates (Allis 
et al., 2007; Glozak et al., 2005). 
Figure 1-19. Characterized sites of histone 
acetylation. Histones are mostly acetylated at 
lysine residues located in the amino termini of H3 
and H4, with the exeption of H3K5 localized in the 
globular domain. The proteins that express binding 
specificity to acetylated histones are shown. (Allis 
et al., 2007). 
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The acetylation of histones may regulate chromatin structure through different 
mechanisms. It neutralizes the positively charged lysines, reducing the strength of 
binding of the strongly basic histones or histone tails to negatively charged DNA, 
opening chromatin for gene activation (Vettese-Dadey et al., 1996). But another 
mechanism exploited is the involvement of a specialized protein domain called 
bromodomain that specifically binds to acetylated lysines. Bromodomain is 
commonly found in many HATs, such as GCN5 and CBP/p300, and other 
chromatin-associated proteins (Allis et al., 2007; Dhalluin et al., 1999). Proteins 
containing this motif bind to acetylated histones and, thus, associate with chromatin 


















Table 1-2. Role of different histone acetylated sites on transcription. 
Acetyl groups may be removed from acetylated histones through histone deacetylase 
enzyme (HDAC) (Kurdistani and Grunstein, 2003; Yang and Seto, 2003). There are 
numerous HDAC enzymes and they fall into three catalytic groups. Type I and type 
II have a related mechanism of deacetylation, which does not involve a cofactor, 
whereas type III (Sir-2 related enzymes) require the cofactor NAD. Many of 
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HDACs are found within large multisubunit complexes, components of which serve 
to target the enzymes to genes, leading to transcriptional repression (Kurdistani and 
Grunstein, 2003; Yang and Seto, 2003).  
Phosphorylation 
Phosphorylation is a histone posttranslational modification associated with active 
transcription. Indeed, when immediate-early genes are induced to become 
transcriptionally active a strong correlation is found with H3 phosphorylation (Allis 
et al., 2007; Mahadevan et al., 1991). The histone 3 serine 10 residue has turned out 
to be an important phosphorylation site for transcription (Nowak and Corces, 2004).  
The precise mechanistic role of histone phosphorylation is still not known, but the 
collective negative charges resulting from the phosphorylation of clusters of nearby 
residues affects the affinity of binding of histone H1 to DNA, positively increasing 
the transcriptional potential (Dou and Gorovsky, 2002). Otherwise, phosphorylated 
residues of histones may dislodge proteins bound to chromatin (Fischle et al., 2005; 
Hirota et al., 2005) or, alternatively, they are bound by phospho-binding protein 
(Macdonald et al., 2005) that modify chromatin structure or or regulate transcription 
activity (Allis et al., 2007).  
Methylation 
Methylation is another histone posttranslational modification. It occurs on either 
lysines or arginines. Furthermore, there can be multiple methylated states on each 
residue, resulting in a higher level of complexity with respect to the other HPTMs. 
Indeed, lysines can be mono- (me1), di- (2me) or tri- (3me) methylated, whereas 
arginines can be mono- or di- methylated. The consequence of methylation can be 
either positive or negative toward transcriptional expression, depending on the 
position of the residue within the histone. 
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Given that there are at least 24 identified 
sites of lysine and arginines methylation 
on H3, H4, H2A and H2B, the number of 
distinct nucleosomal methylated sites is 
enormous. Such combinatorial potential 
of methylated nucleosomes may be 
necessary, at lest partly, to allow the 
regulation of complex and dynamic 
processes such as transcription and 
replication, which requires sequential and 
precisely timed events (Allis et al., 2007; 
Dimitrova and Gilbert, 1999; Wu et al., 
2005). 
Histone lysine methyltransferases (HKMTs) have been identified and their sites of 
modification on histones are defined. All of these enzymes, except Dot 1, share the 
SET domain, which contain the catalytically active site and allows binding to the S-
adenosyl-L-methionine cofactor. Of the many known methylated sites, six have been 
well characterized do date: five on H3 (K4, K9, K27, K36 and K79) and one on H4 
(K20). The role of these modifications on transcription is reported in Table 1-3. 
Specific protein binders recognize each of the six characterized methylation sites 
and, in turn, regulate chromatin 
condensation and gene expression. 
These proteins have one of three 
distinct types of methyl lysine 
recognition domains: the chromo, 
tudor and PHD repeat domains. For 
example, the methylation of lysine 
9 of histone 3 by the 
methyltransferase SUV39H creates 
a binding site for HP1 (Nishigaki et 











Figure 1-20. Sites of histone methylation, their 
protein binders, and functional role in 
genomic processes. Methylation of histones  
occurs at lysine residues in histones H3 and H4. 
Ceratin methylated lysine residues are associated 
with activating transcription (green Me flag), 
whereas others are involved in repressive 
processes (red Me flag). Proteins that bind 
particular methylated lysine residues are 
indicated. (Allis et al., 2007). 





its chromodomain, it can spread onto adjacent nucleosomes, by its association with 
SUV39H, which further catalyzes neighboring histone methylation (Allis et al., 
2007; Nakayama et al., 2001). In addition, HP1 self-associates via the 
chromoshadow domain, facilitating the spreading of heterochromatin.  
Ubiquitylation and Sumoylation 
Ubiquitylation and sumoylation are different from the others HPTMs since ubiquitin 
and SUMO are large polypeptides, which increase the size of the histone by 
approximately two-third. 
Ubiquitylation can be either repressive or activating, depending on the specific sites. 
Indeed, H2B monoubiquitylation is activating to transcription (Kim et al., 2005; 
Wood et al., 2003; Zhu et al., 2005), while Ub1H2A119, is repressive (Wang et al., 
2004). The role of sumoylation may be generally negative-acting to prevent 
activating histone posttranslational modifications, such as acetylation (Shiio and 
Eisenman, 2003).  
Histone posttranslational modifications are dynamic and rapidly changing. 
Acetylation, methylation and phosphorylation can appear and disappear on 
chromatin within minutes of stimulus arriving at the cell surface. Thus examining 
bulk histones under one specific set of conditions (with either antibodies or mass 
spectrometry) will identify only a proportion of the possible modifications. There 
are also problems of detection that are specific for antibodies. Firstly, there are the 
obvious issues of specificity. These are difficult to avoid, as there are no true 
controls for modifications in mammalian cells (unlike yeast) where it is impossible 
to mutate the residue to make sure reactivity is lost. In addition, an adjacent 
modification may disrupt the binding of the antibody or a protein may occlude its 
recognition, both of which may give a misinterpretation. Similarly, there are 
Figure 1-21. Sites of histone 
ubiquitylation and their consequence 
for transcriptional regulation. 
Ubiquitylation of H2A at Lys-119 is 
correlated with transcriptional 
repression. H2BK123 ubiquitylation is 
conversely associated with 




problems of detection that are specific to mass spectrometry. Peptide coverage is not 
equivalent for all parts of the histone and this reduces the sensitivity of detection in 
these regions. These facts undoubtedly contribute to an underestimation of the extent 
of modifications present on histones (Kouzarides, 2007). 
 
Figure 1-22. This picture depicts those histone-modifying enzymes whose specificity has been 
determined. (Kouzarides, 2007). 
DNA Methylation 
The DNA of vertebrate animals is covalently modified by methylation of the 
cytosine base in the dinucleotide sequence 5’CpG3’. CpG is an abbreviation for 
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cytosine and guanine separated by a phosphate, which links the two nucleotides 
together in the DNA. In mammals, nearly all DNA methylation occurs on cytosine 
residues of CpG dinucleotides. 
Regions of the genome that have a high density of CpGs are referred to as CpG 
islands, and DNA methylation of these islands correlates with transcriptional 
repression (Goll and Bestor, 2005). Indeed, the methyl moiety of methyl cytosine 
resides in the major groove of the DNA helix, 
where many DNA-binding proteins make 
contact with DNA, and exerts its effect by 
attracting or repelling various DNA-binding 
proteins. A family of proteins that can bind to 
DNA containing methylated CpG dinucleotides, 
known as methyl-CpG-binding proteins, have 
been shown to recruit repressor complexes to 
methylated promoter regions and thereby 
contribute to transcriptional silencing. Certain transcription factors bind to CpG-
containing DNA sequences only when they are nonmethylated. In these cases CpG 
methylation can prevent protein binding and affect transcription (Allis et al., 2007).  
Spatial Organization of Genomes 
The most global level of cellular genome organization is the arrangement of genome 
regions within the whole 3D space of the cell nucleus (Meaburn and Misteli, 2007). 
The nonrandom nature of spatial genome organization is indicated by the above 
mentioned historical observation of segregation of transcriptionally active and 
inactive regions into physically separate domains of euchromatin and 
heterochromatin, respectively. New technologies and new methods, such as DamID 
(van Steensel et al., 2001), ChIP (Casolari et al., 2004), LacO/LacI tagging system 
(Taddei et al., 2006), have significantly extended this concept and have made it clear 
that chromosomes, genome regions, and single genes are nonrandomly arranged 
within the nucleus. Changes in positioning patterns occur during differentiation and 
development, which strongly suggests a link between positioning and genome 
function. 
Figure 1-23. Schematic representation 




A simple way to assess the position of a genome region within the nucleus is by 
determining its distance from the nuclear periphery (Misteli, 2007). A general 
correlation between transcriptional silencing and localization toward the nuclear 
edge has long been suggested based on the observation that early-replicating and 
presumably transcriptionally active regions are generally found toward the center of 
the nucleus, whereas late-replicating, inactive regions are often located toward the 
periphery. Indeed, the position of single genes relative to the nuclear periphery is 
nonrandom and has been linked to their functional status. For example, the CD4 
locus repositions from the periphery to the nuclear interior during T cell 
differentiation (Kim et al., 2004). Conversely, the radial position of a gene is 
generally not directly related to its activity, as indicated by the fact that in most cells 
the two alleles are positioned differently, even if their functional properties appear to 
be similar (Misteli, 2007). 
The potential role of the nuclear periphery in genome regulation has become of 
particular importance due to the emergence of several human diseases that are 
caused by mutations in the LMNA gene, which encodes lamin A and lamin C, the 
two major architectural proteins of the peripheral lamina (Gruenbaum et al., 2005). 
Although the nuclear lamina has traditionally been considered to have purely 
structural properties, recent observations allow for the possibility that it more 
directly contributes to gene regulation by tethering specific genome regions. 
Figure 1-23. Heterochromatin in 
mammalian and yeast cells is distinct from 
nuclear pores. (A) An electron micrograph of 
the mammalian liver nucleus (with an 
enlarged section shown in part B), showing 
dense-staining heterochromatin located 
around the nucleolus and against the nuclear 
envelope. Nuclear pores open onto 
lighterstaining open chromatin. (C) In budding 
yeast, heterochromatin binds the nuclear 
envelope through Esc1 (enhancer of silent 
chromatin 1; labelled green), which forms 
distinct foci alternating with nuclear pores 
(visualized in red through labelling of Nup49 
(nucleoporin 49)). (D) An electron micrograph 
showing Esc1 at non-pore sites along the yeast 
inner nuclear envelope. An arrow indicates the 
nuclear pore, and black dots represent the 
labelling of Myc-epitope-tagged Esc1 using 
fluoronanogold Alexa-488 anti-mouse 
antibody. (Akhtar and Gasser, 2007). 
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Peripheral localization of genome regions might occur directly via interactions 
between lamin A and core histones (Gruenbaum et al., 2005). 
The nuclear periphery, however, does not function exclusively as a repressive 
environment given that a large number of S. cerevisiae genes are repositioned to the 
periphery where they interact with nuclear pore components when they become 
activated (Gruenbaum et al., 2005; Taddei et al., 2006). In fact, by electron 
microscopy it has been possible to observe that in a differentiated nucleus of 
mammalian cell dense-staining, transcriptionally inactive heterochromatin is usually 
plastered against the inner face of the nuclear membrane. The heterochromatic 
patches are interrupted by nuclear pores, which contain the light-staining 
nucleoplasm of euchromatin (Akhtar and Gasser, 2007). This association with the 
periphery is not probably an absolute requirement for gene expression, but it might 
play a role in optimizing gene activity (Taddei et al., 2006). 
Recent studies (Abruzzi et al., 2006) show that gene association with the nuclear 
periphery does not require ongoing transcription and suggest that the 3’UTR may 
contribute to the tethering of the gene  gene-nuclear periphery tether. 
Taken together these results demonstrate that some promoters alone are sufficient to 
establish strong promoter-pore interactions, others need 3’UTR-linked factors 
interaction for anchoring to nuclear pores (Akhtar and Gasser, 2007). In conclusion, 
the studies so far performed suggest that the positioning of chromatin at the nuclear 
envelope can contribute to gene regulation in both a positive and negative manner, 
probably depending on the subnulcear positioning. 
RELATIONSHIPS BETWEEN VIRAL INTEGRATION AND 
CHROMATIN ORGANIZATION  
Integration is an essential step for retroviral replication. This process leads to the 
irreversible and permanent viral DNA insertion into the host cell genome, allowing 
the transcription of viral genes by the cellular machinery. This peculiarity of 
retroviruses raised the possibility to exploit HIV-1 in gene therapy, as a vector to 
stably integrate genes into the genome of the target cells, in order to restore the 
functionality of defective endogenous genes. 
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However, integration is a mutagenic event, which may alter a cellular function 
depending on the targeted genetic site. For example, retroviral vectors have been 
used to treat patients with severe immunodeficiency (X-linked severe combined 
immunodeficiency; X-SCID). During this trial three out of ten children developed 
leukaemia; in two of these cases, in the leukaemic cells, the therapeutic retroviral 
vector was found to have integrated in the 5’ region of the LMO2 oncogene, which 
probably contributed to the neoplastic transformation (Hacein-Bey-Abina et al., 
2003a; Hacein-Bey-Abina et al., 2003b).  Therefore, understanding weather there is 
a preferential target sequence in the host cellular genome and the mechanism that 
underlies the integration site selection of HIV-1 is important for both basic 
retrovirology and its clinical applications in gene therapy. 
Initial experiments with murine retroviruses revealed that DNA assembled with 
nucleosomes constitutes a better substrate for integration as compared to naked 
DNA. In vivo genomic DNA is complexed with nucleosomes (chromatin). 
Incorporating DNA into nucleosomes in vitro does not reduce integration, as might 
have been expected from a steric hindrance model, but instead creates new hotspots 
for integration. Analysis of these integration hotspots indicates that these are sites at 
which DNA is probably distorted owing to the wrapping of DNA around 
nucleosomes (Bushman et al., 2005). Indeed, in chromatin the preferred integration 
sites are periodically spaced by 10 bp, indicating that HIV-1 integration occurs 
preferentially at positions where the major groove is on the exposed face of the 
nucleosomal DNA helix (Bushman, 1994; Muller and Varmus, 1994; Pruss et al., 
1994; Pryciak et al., 1992). 
 
Figure 1-24. Preferred DNA integration sites into nucleosomal DNA. Favorable sites for retroviral 
integration are located into the major groove on the exposed face of the DNA that bends around 
nucleosomes (schematically represented by cylinders). The arrows indicate the favorable integration sites. 
(Cereseto and Giacca, 2004). 
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Since the nucleosomal complex usually restricts the accessibility of other proteins to 
DNA, the enhancement of retroviral integration into chromatinized DNA was an 
unexpected outcome. Indeed, the presence of DNA-binding proteins on the target 
DNA creates regions refractory to integration due to steric interference (Bor et al., 
1995; Bushman, 1994; Pryciak et al., 
1992). Therefore, other factors, such as 
DNA structure rather than the proteins 
themselves, probably influence the 
efficiency of virus integration. To 
distinguish the different roles played by 
DNA structure (bending around 
nucleosomes) and proteins (histones) 
during integration, the N-terminal tails of 
the histones protruding from the nucleosomes were removed from the target DNA. 
In these experiments, a similar distribution and frequency of integration were 
observed in intact or tailless histone-bound DNA, indicating that the wrapping of 
DNA around nucleosomes, rather than the presence of proteins, is the major 
determinant for integration site selection by the HIV-1 integrase (Pruss et al., 1994). 
The importance of DNA distortion is consistent with the idea that it is involved in 
the integrase mechanism, so that pre-distorting the target DNA favours the 
integration reaction. Indeed, in vitro experiments, using the E. coli IHF protein 
(integration host factor) that binds inside the DNA bend, showed an increased 
efficiency of integration at hotspots within the IHF site itself (Bor et al., 1995). This 
could be explained by the fact that the outside surface of the bend is easily 
accessible for integration. In addition, by modifying DNA structure with a variety of 
methods, it has been clearly demonstrated that the extent of integration enhancement 
upon bending correlates with the extent of the bending (Muller and Varmus, 1994). 
On the other hand, the presence of a DNA-binding protein on target DNA can block 
access of integration complexes, creating regions that are refractory to integration. 
For example, LEF protein (lymphoid enhancer factor) bends DNA but lies outside 
the bend covering the region of the greatest distortion favorable for integration, and 
therefore did not create integration hotspots (Bor et al., 1995). 
Figure 1-25. Schematic diagrams of the IHF-H' 
complex (A) and the LEF-DNA complex (B). 
Each protein is shown stippled. DNA is shown as 
the bent cylinder. Arrows mark approximate 
location of integration hotspots in the IHF site. 
(Bor et al., 1995). 
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Extensive analyses of the sequences flanking the integration sites have revealed 
some weak biases due to different primary sequence (Carteau et al., 1998; Pryciak 
and Varmus, 1992; Stevens and Griffith, 1996). However, a unique consensus DNA 
sequence necessary for retrovirus integration has not been identified (Bor et al., 
1996; Fitzgerald and Grandgenett, 1994; Goodarzi et al., 1997), indicating that the 
primary sequence of the integration target site has a relatively minor influence on 
site selection during infection. In light of the evidence indicating the importance of 
the DNA structure on target site selection, the role of certain sequences influencing 
integration efficiency can be explained by the modifications of the local DNA 
structures induced by these sequences (Muller and Varmus, 1994; Pruss et al., 
1994). This notion has been ultimately demonstrated using a supercoiled DNA 
containing an extensive inverted repeat as the integration target. In this study, 
integration by the HIV-1 and ASV integrase preferentially occurred in only one half 
of the inverted repeat, thus suggesting that this bias was due to the creation of a 
secondary structure favorable for integration rather than to the primary sequence 
(Katz et al., 1998). Indeed, several reports have correlated integration in vivo with 
the presence of nearby repeated sequences, including LINE-1 elements (Stevens and 
Griffith, 1994), clusters of Alu repeats (Alu islands) (Stevens and Griffith, 1996), or 
topoisomerase II cleavage sites (Howard and Griffith, 1993). However, in all these 
studies the number of integration sites analyzed was relatively low. In addition, their 
conclusions are challenged by another report in which no strong bias could be 
detected in favor of, or against, integration near Alu or LINE-1 elements (Carteau et 
al., 1998). Considered together, the overall conclusion of these studies is that DNA 
secondary structure, and not DNA primary sequence, is a major determinant for 
integration site selection. 
It has been observed that centromeres are disfavored integration targets in vivo, 
despite the fact that centromeric alphoid repeats are used similarly to other 
sequences when tested as naked DNA in vitro (Carteau et al., 1998). Inside the cells, 
centromeres assume a heterochromatic conformation, which is known to be wrapped 
tightly by distinctive DNA-binding proteins, and this chromatin environment is 
unfavourable for the expression of most genes. Moreover, alphoid sequences 
become more resistant to digestion with DNase I than most DNA in isolated nuclei. 
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This indicates that the packing of DNA into centromeric heterochromatin renders it 
less accessible, and so it disfavours integration. In keeping with this observation, a 
number of other in vivo surveys of retroviral integration sites have revealed that viral 
gene insertion is statistically biased to regions close to DNase I hypersensitive sites, 
which are characterized by an open chromatin conformation (Goodenow and 
Hayward, 1987; Panet and Cedar, 1977; Robinson and Gagnon, 1986; Rohdewohld 
et al., 1987; Vijaya et al., 1986). Since open chromatin is a hallmark of actively 
transcribed areas, it is not surprising that most of these studies have also found an 
association between retrovirus integration and genomic regions containing 
transcriptionally active genes (Mooslehner et al., 1990; Scherdin et al., 1990). 
However, these early in vivo studies could be the results of a potential bias imposed 
by the relatively small sample size analyzed and the selection of cloned proviruses 
for analysis. In fact, if integration occurred near the genes affecting the growth of 
the infected cells, these cells could be either over or less represented in the analyzed 
population, thus providing a false impression of integration near active genes. 
Recent progress made in the field of genome and transcriptome analysis has allowed 
for genome-wide surveys of HIV-1 integration preferences. Following large-scale 
sequence analysis, the distribution of HIV integration sites in the chromosomes of a 
human lymphoid cell line, SupT1, was investigated (Schroder et al., 2002). This 
study showed that genes were favoured targets for HIV integration, and later studies 
of HIV integration in other cell types reached the same conclusion (Mitchell et al., 
2004; Wu et al., 2003). Further studies investigated whether there were any 
preferences in the location of HIV integration sites along the length of transcription 
units (Mitchell et al., 2004; Schroder et al., 2002; Wu et al., 2003). No biases were 
found. Evidently, the positive influence of transcription units on HIV integration 




Figure 1-26. Analysing retroviral integration sites in the human genome. To analyse retroviral 
integration sites in the human genome, cultured cells are infected with HIV or another retrovirus. DNA 
from infected cells is isolated, cleaved with restriction enzymes and ligated to DNA linkers. Integration 
sites are then amplified using one primer that binds to the viral DNA end and another primer that binds to 
the DNA linker (see the figure). Amplification is carried out a second time with nested primers, and the 
PCR products, which contain host– virus DNA junctions, are cloned and sequenced (Schroder et al., 
2002). Integration sites are mapped on the draft human genome sequence (see Figure 1-27), and local 
features at integration sites are quantified. Various control sites can be used for comparison in these 
experiments. Probably the best type of control takes advantage of integration in vitro. Schroder and 
colleagues purified DNA from uninfected SupT1 cells and used this DNA as a target for preintegration-
complex integration in vitro (Schroder et al., 2002). Reaction products were purified and integration sites 
were cloned, as for the in vivo sites. The analysis then compared the in vivo and in vitro populations. 
Statistical analysis revealed that the distribution of integration sites in the in vitro population was 
indistinguishable from random sampling of the human genome (Schroder et al., 2002), supporting the 
idea that the clonino and analytical methods used did not bias the analysis. Another type of control takes 
advantage of random locations in the human genome that are generated computationally. These are used 
in statistical comparisons with the experimental population. A more sophisticated variation of this 
approach uses random sites that are selected in a way that takes into account the possible influence of the 
distribution of restriction-enzyme recognition sites used in the cloning of experimental integration sites. 
(Bushman et al., 2005). 
Transcriptional profiling analysis has been carried out in some of the cell types 
studied as integration targets, allowing the influence of transcriptional activity on 
integration-site selection to be assessed. Some of these transcriptional profiling 
studies were carried out on retrovirus-infected cells (Lewinski et al., 2005; Mitchell 
et al., 2004; Schroder et al., 2002), so that the data reflected the influence of 
infection on cellular gene activity (Bushman et al., 2005; Corbeil et al., 2001; 
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Mitchell et al., 2003; Schroder et al., 2002; van 't Wout et al., 2003). Analysis of the 
microarray data revealed that the median expression level of genes hosting HIV 
integration events was consistently higher than the median expression level of all the 
genes assayed on the microarray. Transcriptional profiling studies were carried out 
for HIV vector integration in SupT1 cells (Schroder et al., 2002). This study showed 
that the trend towards integration in highly expressed genes increased when data 
from infected cells were used, which indicates that genes that are activated by 
infection are favoured integration targets. 
 
Figure 1-27. Sites of HIV-1 cDNA Integration in the Human Genome. Locations of chromosomal 
sequences matching HIV-1 integration site clones are shown as “lollipops” above the linear 
chromosomes. Purple indicates HIV-1; red, HIV-based vector; and green, PIC (in vitro control). The 
human chromosomes are shown numbered. For each chromosome, the color of the dashes on the upper 
bar indicates integration within genes (gold) or outside genes (gray). The lower bar indicates relative gene 
density, with more-gene-dense regions shown as a more intense red. Centromeres are shown by the gray 
rectangles. Karyotype analysis showed that the Y chromosome is not present in the SupT1 cells studied 
and the representation of chromosomes was roughly equal in the cells analyzed. (Schroder et al., 2002). 
Since the majority of the HIV-1 infected cells die very shortly after infection due to 
cytopathic effects or by immunoclearance, it has been hypothesized that the bias for 
integration into transcriptionally active regions is a strategy to maximize its 
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expression to produce viral progeny. Conversely, a latent infection can be 
established by silencing the basal viral expression by integration into 
heterochromatic regions (Jordan et al., 2001). 
Taken together, these data indicate that the integration is favoured in the 
transcriptionally active genes. These regions are characterized by an open chromatin 
structure, which is more accessible to the integration apparatus. Since histone 
posttranslational modifications are involved in chromatin condensation and gene 
regulation (Allis et al., 2007), a role for acetylation and methylation of histones in 
directing retroviral integration has been investigated (Wang et al., 2007). In this 
study 40,569 unique sites of HIV-1 integration have been sequenced. Analysis of 
integration site positions in the densely annotated ENCODE (Encyclopedia of DNA 
elements) regions revealed that integration was favoured near transcription-
associated histone modifications, including H3 acetylation, H4 acetylation, and H3 
K4 methylation, but was disfavored in regions rich in transcription-inhibiting 
modifications, which include H3 K27 trimethylation and DNA CpG methylation. 
Different hypothesis have been proposed to explain such correlations. One model 
takes in consideration a family of related integrase enzymes encoded by yeast 
retrotransposons that contain chromodomains (Hizi and Levin, 2005), which bind 
methylated histone tails, thus direct binding is a candidate explanation for 
integration targeting. However, retroviral integrases do not contain domains known 
to bind modified histones. Another possibility is that the cellular proteins recruited 
by specific histone posttranslational modifications tether integration complexes near 
sites of modification. Alternatively, epigenetic modifications may be only markers 
of favored integration sites and not directly involved in the targeting mechanism 
(Bushman et al., 2005). Recently, the cellular protein LEDGF/p75 has been 
identified as a HIV-1 IN co-factor (Cherepanov et al., 2003; Maertens et al., 2003; 
Turlure et al., 2004), which is functionally important for targeting the proviral DNA 
(Cherepanov et al., 2003; Ciuffi et al., 2005; Emiliani et al., 2005; Kang et al., 2006; 
Maertens et al., 2003) through a mechanism that is not linked with histone 
modifications (see subsequent sections). 
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INTERACTION OF HIV-1 INTEGRASE WITH HOST CELLULAR 
PROTEINS 
HIV-1 has only a limited genome (Frankel and Young, 1998), nevertheless its 
replication in the human cell Interaction with host cellular proteins requires multiple 
and distinct activities. Consequently, the virus exploits cellular proteins and cellular 
pathways to complete the different steps in its life cycle (Goff, 2007; Van Maele et 
al., 2006). 
As mentioned above, PICs contain linear viral DNA and several viral proteins 
including matrix, reverse transcriptase, integrase and nucleocapsid. Cellular proteins 
have also been identified in functional PICs, suggesting a functional involvement for 
the viral infectious process. Indeed, even though purified recombinant integrase is 
necessary and sufficient to carry out processing and strand transfer in vitro, a variety 
of viral and cellular proteins have been put forward as important partners in 
establishing the integrated provirus in the infected cell. 
Cellular co-factors of integration have been identified in different ways: (I) by in 
vitro reconstitution of enzymatic activity of salt-stripped PICs; (II) by using the 
yeast two- hybrid assay; and (III) by co-immunoprecipitation.  
PICs isolated from cells infected with HIV-1, show a strong preference for 
integration into the target DNA added to the reaction rather than into the viral DNA 
carried within the PIC. Indeed, HIV-1 PICs contain a cellular barrier-to-
autointegration factor (BAF) that prevents suicidal autointegration (Lin and 
Engelman, 2003). BAF binds double-stranded DNA and is, therefore, probably 
recruited by infectious retroviruses during the late stage of reverse transcription 
(Harris and Engelman, 2000; Zheng et al., 2000). It has been suggested that BAF 
acts by bridging DNA molecules in order to condensate DNA, thus rendering the 
viral DNA inaccessible as a target for integration (Lee and Craigie, 1998; Zheng et 
al., 2000). BAF can also promote efficient intermolecular DNA recombination by 
anchoring PICs to target DNA prior to the integration reaction. Hence, the 
prevention to autointegration and the promotion of intermolecular integration by 
BAF may involve a unique mechanism of DNA bridging (Suzuki and Craigie, 
2002). At the cellular level, the role of BAF still remains to be elucidated. However, 
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the ability of BAF to compact DNA suggests a possible role in chromatin 
organization. Findings that lamina-associated polypeptide 2 (LAP2), a protein 
associated with nuclear lamina, interacts with BAF reinforce this hypothesis 
(Furukawa, 1999; Shumaker et al., 2001). 
Fractionation of an uninfected cell extract that restored in vitro PIC activity after 
salt-stripping yielded high mobility group chromosomal protein A1 (HMGA1; 
formerly HMGI(Y)), a non-histone DNA-binding protein that can modulate 
transcriptional regulation and chromatin structure (Farnet and Bushman, 1997). Two 
members of this protein family, HMGA1 and HMGA2, recognize specific sequences 
in the cellular genome and probably function by facilitating the binding of 
transcription factors to the chromatin (Thomas and Travers, 2001). HMGA1 and 
HMGA2 have been identified within the PICs of MLV and HIV-1, where they act 
by stimulating retroviral integration (Farnet and Bushman, 1997; Li et al., 2000). A 
recent attempt to investigate the role of these cellular proteins during the viral 
replication cycle has indicated that they are dispensable for retroviral integration, 
probably due to redundancy with other factors (Beitzel and Bushman, 2003). The 
mechanism by which HMGs stimulate intermolecular integration is still being 
debated, and several models have been proposed: (I) by binding specific DNA 
sequences in the LTR, HMGs may act by bridging distant DNA segments into 
proximity (Farnet and Bushman, 1997; Li et al., 2000); consistently, the cDNA ends 
in PICs are known to be protected from nuclease attack by bound proteins that also 
function as a protein bridge between the viral ends (Miller et al., 1997; Wei et al., 
1997); (II) by binding both viral and target DNA, thus bridging the PIC to the 
cellular genome; this hypothesis, however, appears unlikely since no HMG binding 
sites have been identified close to the integration sites and HMGs act on viral DNA, 
while they have no effect on target DNA during the integration reaction (Aiyar et al., 
1996); (III) by condensing the viral cDNA that, in turn, would stabilize the integrase 
in an active conformation (Farnet and Bushman, 1997; Li et al., 2000). 
EED is a chromatin-remodeling protein that belongs to the widely conserved 
Polycomb group of proteins, and has very recently been found to interact with 
integrase (Violot et al., 2003). Interestingly, BAF, HMGs and EED share the 
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common feature of all being associated to condensed DNA structures. Although the 
data so far acquired indicate a primary effect of these proteins on donor viral DNA 
rather than on the acceptor cellular genome, it still remains an open question weather 
these factors might play a major role at the level of the integration site in vivo. In 
addition, these proteins may also function by bridging the interaction with other 
factors (e.g. transcriptional factors) that ultimately could favor integration as well as 
transcription.  
By using yeast two hybrid approach Kalpana and coworkers (Kalpana et al., 1994) 
found another IN cellular co-factor, the integrase interactor 1 (INI1), also known as 
hSNF5. INI1 is the human homolog of yeast SNF5, a transcriptional activator and 
component of the chromatin remodeling SWI/SNF complex (Carlson and Laurent, 
1994). Likewise, INI1 was shown to be part of the mammalian SWI/SNF complex 
(Wang et al., 1996). INI1 and integrase interact through direct binding and this 
association promotes integrase activity (Kalpana et al., 1994). Although INI1, as a 
component of the SWI/SNF complex, has been hypothesized to play a role in 
integration-site selection, no experimental evidence has been produced to support 
this idea (Van Maele et al., 2006). Interestingly, a possible role for INI1 in the post-
integration steps of HIV-1 replication is stronger (Yung et al., 2001). Indeed, INI1 
probably interacts with integrase within the context of Gag-Pol precursor and 
inhibits viral particle production (Yung et al., 2001). These results indicate that INI1 
is required for late events in the viral life cycle, and that ectopic expression of the 
minimal integrase-interactor domain of INI1 (S6) inhibits HIV-1 replication in a 
transdominant manner via its specific interaction with integrase within the context of 
Gag-Pol (Yung et al., 2001). On the contrary, it has been reported that siRNA 
mediated silencing of SWI/SNF complex expression inhibited the formation of 2-
LTR circles and integrated forms of viral DNA, suggesting a role for SWI/SNF 
complex in the early steps of HIV-1 replication (Maroun et al., 2006). In fact a 
single amino acid change, K71R, in integrase reduced its ability to interact with 
SNF5/ Ini1, leading to an increased viral infectivity (Maroun et al., 2006).  
Ku, a chromatin-associated protein that functions by participating in double-stranded 
DNA break recognition and repair, has also been identified in PICs (Li et al., 2001; 
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Lin and Engelman, 2003). This protein seems to enhance the circularization of a 
portion of the total viral DNA produced by reverse transcription in infected cells. It 
has been hypothesized that free viral DNA ends could induce apoptosis in infected 
cells. By promoting viral DNA circularization, Ku might therefore protect cells from 
cell death, allowing the viral replication cycle to be efficiently completed (Li et al., 
2001). 
Recently, a new binding partner of HIV-1 integrase was identified following a study 
of the HIV-1 integrase complexes present in nuclei of human cells that stably 
overexpress the viral integrase from a synthetic gene (Cherepanov et al., 2003). 
Using co-immunoprecipitation, a novel cellular co-factor interacting with integrase 
was found. The same co-factor, known as lens epithelium derived growth factor 
(LEDGF/p75), has been independently confirmed by at least two other groups, by 
using co-immunoprecipitation (Turlure et al., 2004) or yeast-two-hybrid (Emiliani et 
al., 2005). LEDGF/p75 contains 530 amino acids and several functional domains 
(Van Maele et al., 2006). In the N-terminal region of LEDGF/p75, a PWWP (for 
Pro-Trp-Trp-Pro) domain of 92 residues is present that functions as a protein–
protein interaction domain and/or DNA-binding domain. A functional nuclear 
localization signal (NLS, residues 148–156) is present. In accordance with its ability 
to interact with HIV-1 integrase, an evolutionarily conserved integrase-binding 
domain (IBD) of about 80 amino acids (residues 347–429) was recently mapped to 
the C terminus (Cherepanov et al., 2004). LEDGF/p75 is predominantly localized in 
the nucleus, where it is intimately associated with the chromosomes (Nishizawa et 
al., 2001). The precise stoichiometry of the integrase–LEDGF/p75 complex in the 
infected cell has not been elucidated, but the simplest model suggests a symmetrical 
Figure 1-27. Domain structure of LEDGF/p75. The p75 and p52 splice variants and the different 
domains are highlighted. In the N-terminal region of LEDGF/p75, a PWWP domain of 92 residues is 
present that functions as a protein–protein interaction domain and/or a DNA-binding domain. A 
functional nuclear localization signal (NLS) has been identified. An evolutionarily conserved integrase-
binding domain (IBD) was mapped to the C terminus. A possible AT-hook-like domain is also 




complex containing a pair of integrase tetramers and two subunits of LEDGF/p75 
(Cherepanov et al., 2003).  
The nuclear distribution of HIV-1 integrase perfectly matches that of LEDGF/p75 
(Cherepanov et al., 2003; Maertens et al., 2003). Knock-down of endogenous 
LEDGF/p75 using small interfering RNA (siRNA) completely abolishes the nuclear 
localization of HIV-1 integrase and its association with chromosomes in cells 
transiently transfected with the integrase fused to enhanced GFP (EGFP) (Maertens 
et al., 2003). In pull-down assays using different recombinant integrases, it was 
subsequently demonstrated that LEDGF/p75 interacts with lentiviral but not 
retroviral integrases (Busschots et al., 2005). Direct interaction in cells was 
confirmed using fluorescence-correlation spectroscopy (FCS) (Maertens et al., 
2005). Two approaches were used to validate the role of LEDGF/p75 during HIV 
replication. Transient and stable siRNA-mediated knock-down of LEDGF/p75 
reduced HIV replication significantly, without effect on viability or growth kinetics 
of the target cells (Vandekerckhove et al., 2006). In the second approach, the Q168A 
(Gln/Ala) mutation in integrase, which abolishes interaction with LEDGF/p75 but 
not integrase catalytic activity, was exploited to show a stop in the replication 
process due to a specific block at the integration step, whereas the nuclear import 
was not hampered (Emiliani et al., 2005). Thus, both RNAi- and mutant-based 
experiments point to an important role of LEDGF/p75 in HIV replication. These 
data, however, are at odds with some findings from another group (Llano et al., 
2004); this discrepancy might be owing to the inefficient siRNA-based knockdown 
of LEDGF/p75, leaving a very small amount of LEDGF/p75. In order to overcome 
this problem, Llano et al. (Llano et al., 2006) used intensified RNA interference and 
dominant-negative protein approaches to show that LEDGF/p75 is indeed an 
essential HIV-1 integration co-factor. Recently, the generation of LEDGF/p75 
knockout mouse embryo fibroblasts (MEFs) (Shun et al., 2007b) allowed for the 
first time to analyze HIV-1 integration in the complete absence of LEDGF/p75 
protein. The lack of LEDGF/p75 protein expression showed that HIV-1 replicates 
less efficiently and changes its integration bias from transcriptionally active regions 
to promoter regions and CpG islands (Shun et al., 2007b). Therefore, since 
LEDGF/p75 associates with transcriptionally active genes (Ge et al., 1998; Mitchell 
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et al., 2004; Shinohara et al., 2002), it acts as a tethering factor for IN, by 
specifically targeting viral integration toward LEDGF/p75-associated regions. 
Based on the preferential integration of HIV-1 into transcriptionally active regions 
of chromatin, Cereseto et al. explored the association of IN with cellular proteins 
possessing HAT activity (Cereseto et al., 2005).  Among these proteins, p300 
resulted to interact with HIV-1 integrase both in vitro and in vivo (Cereseto et al., 
2005; Topper et al., 2007). This factor regulates gene expression by bridging the 
transcriptional machinery to several known transcription factors, and by promoting 
histones acetylation. In addition to its HAT activity, p300 also acetylates a number 
of different cellular and viral proteins (Cereseto and Giacca, 2004). The carboxy-
terminus domain (CTD) of IN (amino acids 212-288) binds specifically to p300 and 
gets acetylated on lysines 264, 266, and 273 (Cereseto et al., 2005; Topper et al., 
2007). Acetylation of IN increases its binding to DNA in vitro, according with the 
fact that acetylation of DNA-binding proteins often increases their binding affinity 
to DNA (Cereseto et al., 2005). In addition, acetylation of IN increases its DNA 
strand transfer activity of approximately two-fold in vitro, indicating a potential role 
for p300-dependent acetylation of IN during virus infection (Cereseto et al., 2005). 
Mutational analysis revealed a reduced integration efficiency in vivo (Apolonia et 
al., 2007; Terreni, 2009; Topper et al., 2007).  
PICS NUCLEAR IMPORT 
The pre-integration complexes are formed by the retrotranscribed viral DNA and 
both cellular and viral proteins. Several factors intervene in PICs nuclear 
translocation. The active nuclear transportation is determinant for lentiviruses, 
including HIV, to infect non-dividing cells, such as terminally differentiated 
macrophages (Lewis et al., 1992). However, the mechanism governing the nuclear 
import is still poorly understood. Indeed, unlike other viral proteins such as reverse 
transcriptase or integrase, nuclear import is not accompanied by a measurable 
enzymatic activity (De Rijck et al., 2007). Moreover, HIV-1 proteins have a 
pleiotropic nature; since the genomic capacity of a lentivirus is restricted to about 9 
kb, viral proteins evolved to play various roles in the replication cycle in close 
interaction with each other and with the proteins of the host. Therefore, deletions or 
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mutations in any viral protein are likely to alter many steps in viral replication, 
hindering the interpretation of the results obtained.  
Matrix is one of the viral proteins involved in the nuclear import. It has a basic-type 
nuclear localization signal (NLS) at the N-terminus (Bukrinsky et al., 1993a), 
resembling the NLS of SV40 large T antigen. Later on, it was shown that matrix 
NLS was capable of binding to Rch1, a member of the importin-α family (Gallay et 
al., 1996). However, the matrix 
NLS hypothesis is controversial 
(Fouchier et al., 1997; 
Heinzinger et al., 1994). The 
ultimate proof that matrix is not 
the only factor involved in 
nuclear import was the finding 
that a virus lacking the complete globular head of matrix was still capable of 
replicating in macrophages (Reil et al., 1998). Recently, the replacement of HIV-1 
MA protein with that of MLV, which is not able to infect non-dividing cells, did not 
have any adverse effects on viral infection in interphase cells (Yamashita and 
Emerman, 2004). These data suggest that the importance of MA for nuclear import 
of the PIC is still highly controversial and redundancy exists with other factors.  
Another viral protein that has been investigated for its role in PIC nuclear 
translocation is Vpr. Speculations about its involvement in nuclear import started 
when Vpr was shown to play an important role in facilitating viral replication in 
macrophages (Bukrinsky et al., 1992; Eckstein et al., 2001; Heinzinger et al., 1994; 
Popov et al., 1998; Vodicka et al., 1998). The first indication for a direct role of Vpr 
in nuclear translocation 
came from the observation 
that PICs containing a 
mutated matrix NLS were 
still able to replicate in 
macrophages in presence of 
Figure 1-28. Schematic overview of the matrix protein. 
NLS, nuclear import signal; NES, nuclear export signal; Env, 
envelope. Numbers refer to the amino acid number. (De Rijck 
et al., 2007).  
Figure 1-28. Schematic overview of viral protein R. The three a-
helices are shown in gray. Potential functions of the three a-helices 
and the C-terminal domain are indicated. Numbers refer to the 




functional Vpr, but a severe replication defect was observed when both these 
proteins where mutated (Heinzinger et al., 1994). However, these data were not 
confirmed by Kootstra et al. (Kootstra and Schuitemaker, 1999). It was also shown 
that Vpr associates with the nuclear envelope and even more specifically with 
nucleoporins (Vodicka et al., 1998). Next to this, HIV-1 replication is inhibited by 
addition of a Nup98 inhibitor or RNAi-mediated knockdown of Nup98 (Ebina et al., 
2004). 
These interactions seem to indicate that Vpr is involved in docking of the PIC to the 
NPC. Next to interactions with the NPC, Vpr was shown to interact with importin α 
(Vodicka et al., 1998). Given that importin α also binds other components of the 
PIC such as integrase or matrix, it was suggested that Vpr acts like an importin β-
like protein (Vodicka et al., 1998). In this hypothesis, importin α binds to the 
preintegration complex through interaction with integrase or matrix, while Vpr binds 
to importin α and docks the preintegration complex to the nuclear envelope 
(Vodicka et al., 1998). A second theory suggests that Vpr facilitates nuclear import 
by stabilizing the interactions of matrix or integrase with the nuclear import 
machinery (Popov et al., 1998).  
In the complex mechanism of nuclear import it seems that another viral component 
is involved: the central DNA flap. Mutations in this sequence showed controversial 
results: some groups found replication defect of HIV-1 virus in different cell lines 
(Arhel et al., 2006b; Charneau et al., 1992; Charneau et al., 1994; Zennou et al., 
2000), others reported only a delay in the viral replication and some others showed 
even no effect (Dvorin et al., 2002; Hungnes et al., 1992; Limon et al., 2002b). 
Recently, it was demonstrated unambiguously that the DNA flap stimulates HIV 
replication in a dose-dependent manner (De Rijck and Debyser, 2006). At the lowest 
virus dose used, the absence of the DNA flap resulted in a 100-fold defect in viral 
replication in various cell lines and in PBMC. This dose-dependent effect might 
explain part of the existing controversy. At high doses of virus, the impact of the 
DNA flap is subtler. The replication defect was pinpointed to a step between reverse 
transcription and integration. Apparently, the DNA flap can overcome a rate limiting 
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step that can be bypassed using a high MOI (De Rijck and Debyser, 2006; De Rijck 
et al., 2007).  
Several groups showed, as mentioned before, no replication defect in presence of 
both matrix and Vpr mutants (Gallay et al., 1997). These data were explained by 
postulating a bipartite NLS (NLSP 186–189 and NLSD 211–219) in integrase. This 
bipartite NLS was shown to interact with importin α and NLS mutations inhibited 
this interaction. Moreover, an HIV-1 strain mutated in both NLSs was replication-
defective even in the presence of functional Vpr and matrix. However, the effect of 
NLSP and NLSD on nuclear localization of integrase was confirmed by some 
groups (Ao et al., 2005; Petit et al., 2000), but not by others (Depienne et al., 2001; 
Lu et al., 2004; Tsurutani et al., 2000). A more recent in vitro study showed that 
integrase mediates the import of viral DNA into the nucleus using the Impα/β 
pathway, suggesting the potential for IN to fulfill such a role in vivo (Hearps and 
Jans, 2006).  
HIV-1 viral components, however, are not the only ones that putatively take part in 
the PICs nuclear import. Indeed, there is growing body of evidence for the 
involvement of cellular proteins. The hypothesis that LEDGF/p75 is involved in the 
nuclear import arises from the requirement of this cellular co-factor to relocalize 
transfected viral IN from the cytoplasm to the nucleus (Llano et al., 2004; Maertens 
et al., 2003; Vanegas et al., 2005). However, a direct effect of the nuclear 
translocation on PICs has not been observed (De Rijck et al., 2006; Emiliani et al., 
2005; Vandekerckhove et al., 2006). It has been showed that the interaction between 
IN and LEDGF/p75 already occurs in the cytoplasm within the PICs (Llano et al., 
2004) and might increase the affinity of IN for DNA (Busschots et al., 2005) or 
stabilize the whole pre-integration complex. In this case, LEDGF/p75 could 
indirectly influence the nuclear import of PICs.  
Recently another cellular co-factor has been shown to be one of the key actors of 
HIV-1 PICs nuclear import: transportin-SR (TRN-SR, TNPO3) (Brass et al., 2008; 
Christ et al., 2008). This factor was initially reported to play a role in HIV-1 
replication (Brass et al., 2008) and subsequently to promote PICs nuclear import 
through its interaction with IN (Christ et al., 2008). TNPO3 has been identified 
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independently by two different approaches: (I) a large-scale siRNA screen (Brass et 
al., 2008) and (II) yeast-two-hybrid screen. TNPO3 (Lai et al., 2000) was initially 
described as the human homolog of the yeast nuclear import factor Mtr10. TNOP3 is 
a karyopherin, which import multiple proteins into the nucleus, including histone 
mRNA stem-loop binding protein, serine/arginines-rich proteins that regulate 
splicing of mRNA. The recognition of the SR-proteins by TRN-SR relies on the 
conserved SR-domain and requires phosphorylation (Kataoka et al., 1999; Lai et al., 
2000; Lai et al., 2001). The gene tnpo3 encodes two isoforms via alternative 
splicing: TRN-SR1 and TRN-SR2 (Yun et al., 2003). In most tissues and in all cell 
lines only TRN-SR2 is expressed, whereas the TRN-SR1 isoform is undetectable 
(Yun et al., 2003). Christ et al. showed that TRN-SR2 interacts with IN and the 
relevance in HIV-1 replication has been demonstrated by using iRNA (Christ et al., 
2008). In fact, the depletion of TRN-SR2 severely affects HIV-1 replication in 
HeLaP4 cells and in primary macrophages (Christ et al., 2008). In addition, they 
showed that TNPO3 mediates the translocation of PICs in the nuclear compartment 
(Christ et al., 2008). One of the most used nuclear import assay is an in vitro 
transport system, in which recombinant transport factors and their potential cargos 
are added to digitonin-permeabilized cells (Liu et al., 1999b). However, this import 
assay lacks the use of intact cells and intact nuclei. To overcome this problem, 
nuclear import was studied upon infection of intact living cells with fluorescently 
labeled HIV-1 virions (Albanese et al., 2008). Data obtained with such novel 
approach showed a decreased PIC nuclear import by more than 5-fold in TRN-SR2 
knockdown cells, showing that TNPO3 is indeed the cellular import factor of HIV-1 
(Christ et al., 2008).  
FLUOROPHORES AND THEIR APPLICATION 
In the past years many different aspects of life science have been extensively studied 
using a wide array of molecular biology, genetic, biochemistry, bioinformatic and 
structural biology approaches. However, in order to identify the subcellular 
compartments and the timing in which different molecules are localized and/or 
interact with each other is critical to directly visualize all these components. Two 
things are requested to reach such purpose: (I) to label proteins and cellular 
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structures by fluorescence and (II) to observe the fluorescent signal coming from 
these microscopic structures with the microscope. This approach was made possible 
by the use of fluorescent proteins, such as green fluorescent protein (GFP) (Chalfie 
et al., 1994; Crameri et al., 1996; Pines, 1995; Prasher, 1995), and the introduction 
of confocal microscopy (Minsky, 1988; Wilson and Carlini, 1988). 
Fluorescence microscopy allows the examination of all biological specimens, fixed 
or alive, because it allows the selective and specific detection of molecules at small 
concentrations with good signal-to-background ratio. At the same time, although 
traditional fluorescence microscopy affords excellent detection of fluorophores in 
thin samples, when applied to thick or living samples, it has always been hampered 
by the fact that the entire sample is excited indiscriminately and therefore most of 
the fluorescent photons arise from out-of-focus fluorophores. Confocal scanning 
microscopy, developed in the last several decades, solved this problem by restricting 
photodetection to light originating from the focal point. Thus, optical sectioning 
became possible and afforded three-dimensional microscopic reconstruction of 
biological specimens, as it will be described later (Yuste, 2005). Thanks to 
fluorescent microscopy, and in particular to confocal microscopy, it is possible to 
visualize viral proteins tagged to fluorescent proteins, and observe their behavior in 
the cell, with respect to some specific structures.  
Fluorescent Proteins 
The first fluorescent protein that has been discovered is GFP. It has been discovered 
by Shimomura et al. (Shimomura et al., 1962) as a companion protein to aequorin, 
the famous chemiluminescent protein from Aequorea victoria jellyfish. The 
peculiarity and the potential of GFP is, indeed, its fluorescence. The GFP from A. 
victoria has a major excitation peak at a wavelength of 395 nm and a minor one at 
475 nm, while the emission peak is, as suggested by its name, in the green portion of 
the visible spectrum, at 509 nm. 
Although GFP was first crystallized 
in 1974 and diffraction patterns 
reported in 1988, the structure was 
Figure 1-29. Ribbon representation 
of  the structure of GFP, showing 11 
β-strands forming a hollow cylinder 
through which is threaded a helix 
bearing the chromophore, shown in 




first solved in 1996 by two groups: Ormö et al. (Ormo et al., 1996)  (Protein Data 
Bank accession number 1EMA), and by Yang et al. (Yang et al., 1996) (accession 
number 1GFL). GFP consists of 238 amino acids organized in an 11-stranded β-
barrel threaded by an α-helix running up the axis of the cylinder.  
Fluorescence property of GFP is given 
by a functional group known as 
chromophore. It absorbs energy of a 
specific wavelength (excitation) and 
emits energy at a longer wavelength 
(emission). The chromophore of GFP 
is attached to the α-helix and is buried 
almost perfectly in the center of the 
cylinder, which has been called a β-
can. The chromophore is a p-
hydroxybenzylideneimidazolinone 
(Cody et al., 1993; Prasher et al., 1992) 
formed from residues 65–67, which are 
Ser-Tyr-Gly in the native protein. 
According to the currently accepted mechanism (Cubitt et al., 1995; Heim et al., 
1994; Inouye and Tsuji, 1994) for chromophore formation, first GFP folds into a 
nearly native conformation, then the imidazolinone is formed by nucleophilic attack 
of the amide of Gly 67 on the carbonyl of residue 65, followed by dehydration. 
Finally, molecular oxygen dehydrogenates the α-β bond of residue 66 to put its 
aromatic group into conjugation with the imidazolinone. Only at this stage does the 
chromophore acquire visible absorbance and fluorescence (Tsien, 1998).  
The fluorescent property of GFP has been widely and deeply exploited in biology. 
Indeed, this protein is a fluorescent dye that is gene encoded. Therefore, by using 
standard molecular biology techniques, it is possible to express it in any cell type as 
reporter. In addition, GFP can be fused to another protein of interest and see at the 
fluorescent microscope its localization in the cell, its mobility, and its interaction 
with other proteins (Chalfie et al., 1994; Pines, 1995; Prasher, 1995). However, 
Figure 1-30. Mechanism proposed by Cubitt et al. 
(Cubitt et al., 1995) for the intramolecular 
biosynthesis of the GFP chromophore, with rate 
constants estimated for the Ser65→Thr mutant by 
Reid & Flynn (Reid and Flynn, 1997) and Heim et al. 




while GFP from A. victoria folds fairly efficiently when expressed at or below room 
temperature, its folding efficiency declines steeply at higher temperatures. This is 
not desirable for biology applications, where all enzymatic reactions work well at 
37°C. Therefore a GFP mutant able to fold efficiently at 37°C was widely desired. 
The most extensive attempt to develop such a mutant while preserving the complex 
wild-type spectrum utilized DNA shuffling (Crameri et al., 1996), a technique for 
recombining various mutations while creating new ones. This approach produced a 
triple mutant, F99S, M153T, V163A, which improved 37°C-folding, reduced 
aggregation at high concentrations, and increased the diffusibility of the protein 
inside cells (Tsien, 1998).   
Many other mutations have been 
made, including improvement in 
the spectral characteristics of GFP 
and color mutants. Indeed, to date 
it is possible to choose among 
variants that differ in their 
excitation/emission spectra: BFP, 
ECFP, Cerulean, EGFP, EYFP, 
Venus, mCitrine, mOrange, 
DsRed, mRFP, mCherry, 
tdTomato, mStrawberry, mPlum 
(Shaner et al., 2007; Shaner et al., 
2005). So, the vast range of 
fluorescent protein variants 
developed over the past years feature fluorescence emission profiles spanning 
almost the entire visible light spectrum, giving the opportunity to express in the cell 
more than one fused protein and see how these proteins interact among them or with 
cell structures.  
Confocal microscope 
A confocal microscope creates sharp images of a specimen that would otherwise 
appear blurred when viewed with a fluorescent microscope. This is achieved by 
Figure 1-31. Excitation and emission spectra for new 
RFP variants. Spectra are normalized to the excitation and 
emission peak for each protein. (a,b) Excitation (a) and 
emission (b) curves are shown as solid or dashed lines for 
monomeric variants and as a dotted line for dTomato and 
tdTomato, with colors corresponding to the color of each 
variant. (c,d) Purified proteins (from left to right, 
mHoneydew, mBanana, mOrange, tdTomato, mTangerine, 
mStrawberry, and mCherry) are shown in visible light (c) 
and fluorescence (d). The fluorescence image is a 
composite of several images with excitation ranging from 
480 nm to 560 nm. (Shaner et al., 2004). 
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excluding most of the light from the specimen that is not from the microscope’s 
focal plane. Therefore, the image has less haze and better contrast than that of a 
wide-field fluorescent microscope and represents a thin cross-section of the 
specimen. Thus, apart from allowing better observation of fine details it is possible 
to reconstruct 3D images of the specimen.  
The first example of confocal microscopy as been set up by Marvin Minsky in 1955 
(Minsky, 1988; Semwogerere and Week, 2005). His invention would perform a 
point-by-point image construction by focusing a point of light sequentially across a 
specimen and then collecting some of the returning rays. By illuminating a single 
point at a time Minsky avoided most of the unwanted scatter light that obscures an 
image when the entire specimen is illuminated at the same time. Additionally the 
light returning from the specimen would pass through a second pinhole aperture that 
would reject rays that were not directly from the focal point. The remaining 
“desirable” light rays would then be collected by a photomultiplier and the image 
gradually reconstructed using a long-persistence screen. Modern confocal 
microscopes have kept the key elements of Minsky’s design: the pinhole apertures 
and point-by-point illumination of the specimen. Advances in optics and electronics 
have been incorporated into the current designs and provide improvements in speed, 
image quality, and storage of the generated images.  
In the modern laser scanning confocal microscope, the light exciting the fluorophore 
comes from a laser light source. The advantages to use this light source are: high 
intensity, point-by-point illumination, and a wide range of wavelength available. 
The laser beam passes through a light source aperture and is reflected by a dichroic 
mirror that directs the laser to the objective lens, which, in turn, focuses the light 
source into a small focal volume. However, since the laser beam generates a point-
by-point illumination a scanning of the light source is necessary to excite point-by-
point an area of the specimen to generate an image. Therefore, between the dichroic 
mirror and the objective lens there is an assembly of vertically and horizontally 
scanning mirrors. These motor-driven mirrors scan the laser across the specimen. 
When light is incident on a fluorescent molecule or on the chromophore of a 
fluorescent protein, it absorbs a photon of light that increases its energy causing an 
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electron to jump to a discrete singlet excited state. Typically, the molecule quickly 
(within 10-8 sec) dissipates some of the absorbed energy through collisions with 
surrounding molecules causing the electron to drop to a lower energy level. If the 
surrounding molecules are not able to accept the larger energy difference needed to 
further lower the molecule to its ground state, it may undergo spontaneous emission, 
thereby losing the remaining energy, by emitting light of a longer wavelength (for 
example, green light in the case of GFP). The light emitted by the fluorescent 
molecules of the sample is descanned by the same mirrors that are used to scan the 
exciting light from the laser and then passes through the dichroic mirror without 
being reflected. Thereafter, it is focused onto the pinhole. The light that makes it 
through the pinhole is measured by a detector such a photomultiplier tube.  In 
confocal microscopy, there is never a complete image of the specimen because at 
any instant only one point is observed. Thus, for visualization the detector is 
attached to a computer, which builds up the image one pixel at a time. The image 
created by the confocal microscope is of a thin planar region of the specimen, an 
effect referred to as optical sectioning. Out-of-plane unfocused light has been 
rejected, resulting in a sharper, better-resolved image. The ability of a confocal 
microscope to create sharp optical sections allows the 3D image reconstruction of 
the specimen. Data gathered from a series of optical sections imaged at short and 
regular intervals along the optical axis are used to create the 3D reconstruction 
(Semwogerere and Week, 2005).  
Fluorescent viruses 
In a typical viral replication cycle, virus binds to the cell surface, enters the cell and 
the viral genome is transported to specific sites in the cytoplasm or in the nucleus, 
depending on the viral species. Newly synthesized viral proteins and genetic 
material are subsequently transported to specific sites for assembly into progeny 
viruses. All these viral steps have been extensively investigated with molecular 
biology, bioinformatic, structural biology and biochemical studies, leading to the 
actual knowledge on the viral replication cycles. The recent use of fluorescent 
probes together with the confocal microscope opened new perspectives in studying 
virus-host interaction, complementing previous studies. In fact, such approach 
INTRODUCTION  
 66 
allows to directly visualize single viral particles, enabling researcher to follow 
virions within intact living cells and to probe the dynamic interactions between these 
virions and the cellular machinery. In the last decade there was an increasing and 
exponential interest in this field, therefore many authors exploited this approach 
with different viruses to answer many unsolved issues (Arhel et al., 2006a; 
Brandenburg and Zhuang, 2007; Campbell et al., 2007b; Damm et al., 2005; del Rio 
et al., 2005b; Jouvenet et al., 2008; Lakadamyali et al., 2003; Lampe et al., 2007; 
Lehmann et al., 2005; McDonald et al., 2002; McDonald et al., 2003; Muller et al., 
2004; Nicola and Straus, 2004; Rudner et al., 2005; Rust et al., 2004). 
The first step towards single-virus tracking is labeling the viral components and 
relevant cellular structures. A crucial requirement is that both viruses and cellular 
structures need to be labeled with a sufficient number of fluorophores for detection 
at the single particle level without inhibiting viral infectivity and cell functions. The 
external components of a virus, such as the capsid of a non-enveloped virus or the 
membrane of an enveloped virus, can be readily labeled with chemical fluorescent 
dyes, such as cynine or Alexa dyes (Lakadamyali et al., 2003; Pelkmans et al., 2001; 
Seisenberger et al., 2001; Suomalainen et al., 1999). Tracking virions labeled in this 
manner can provide important insights into the uncoating or cellular trafficking 
mechanisms of viruses. On the contrary, internal components of assembled viral 
particles are typically inaccessible to chemical dyes. Therefore, viral proteins within 
the virions are labeled with fluorescent proteins, so as that the resulting fusion 
protein is incorporated in the viral particle during the assembly in the producer cells 
(Campbell et al., 2007b; Lampe et al., 2007; McDonald et al., 2002; Muller et al., 
2004). These can be even used to label endogenous cellular proteins, facilitating the 
study of virus-cell interactions.  
Labeled viruses are then visualized in the cells using one of the following 
fluorescence microscopy set-up: (I) epifluorescence microscopy, that is often the 
method of choice for studies on long-range viral trafficking or transport, (II) 
confocal microscopy, and (III) total internal reflection fluorescence (TIRF) 
microscopy, whose excitation depth is of 100-200 nm. Therefore, this technique is 
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used to monitor events occurring near the cell surface, such as entry or budding of 
viral particles. 
 
Figure 1-32. A typical single-virus tracking setup includes an inverted microscope with a 
temperature controlled stage, several lasers, optics and a sensitive detector. The figure shows the 
microscope setup. Various laser lines, such as Argon ion (Arg; 457 nm, 488 nm and 514 nm), Krypton 
ion (647 nm; not shown), helium-neon (HeNe; 543 nm, 594 nm and 633 nm) and Nd:YAG (532 nm) 
lasers, can function as light sources to excite different fluorophores. Multicolour imaging is enabled by a 
combination of several different laser lines with specific excitation and detection optics that allow 
different coloured excitation to be combined at the sample, and different coloured fluorescence emissions 
to be separately detected. The lower part of the figure shows imaging geometries. In the epi-fluorescence 
geometry (left panel), a collimated light beam illuminates a large sample area (~ 100 µm in linear 
dimension) (Stephens and Allan, 2003). Fluorescence emission from the sample is collected by a high 
numerical aperture objective and detected by a CCD camera. The advantages of this scheme are the low 
signal loss, rapid wide-field detection and large excitation depth, which allow single particles to be 
tracked in a large sample volume. The disadvantage is its poor rejection of the fluorescence background 
signal from the cell. Confocal microscopy (middle panel) uses a focused light beam and spatial filtering 
techniques (pinholes in excitation and detection paths) to eliminate out-of-focus background fluorescence, 
but at the cost of signal reduction (Amos and White, 2003). For the observation of fast dynamics in live 
cells, a spinning disk confocal setup is often preferred over the relatively slow scanning confocal 
microscope, which relies on rotating mirrors to scan a focused laser beam in the imaging plane and a 
point detector, such as avalanche photodiode or photomultiplier tubes, for signal acquisition (Stephens 
and Allan, 2003). The spinning disk confocal microscope relies on a pair of rapidly rotating discs, one 
with an array of pinholes and the other with correspondingly aligned micro-lenses. Thereby the excitation 
light is subdivided into thousands of beams, which simultaneously scan the entire field at a rate of >1000 
frames per second. This scheme effectively creates a wide-field image detected by a CCD camera. When 
combined with Z-direction scanning of the sample stage, both confocal schemes allow the construction of 
3-dimensional images. In a TIRF microscope (right panel), the incident light strikes the interface between 
two optical media of different refractive indices (for example, a glass substrate and a cell) at a sufficiently 
large angle to induce total reflection (Axelrod, 2001). As a result, an evanescent excitation field is 
generated, extending only a few hundred nanometers into the second medium. This wide-field imaging 
geometry offers the best rejection of background signal, but can only be used to detect events occurring 
close to the adhering surface of the cell. In order to simultaneously track a large number viruses, a camera 
chip with a high number of pixels is needed, which allows a large field of view. BS, beam splitter; CCD, 
charge-coupled device; DM, dichroic mirrors; F, filter; M, mirrors; SL, optical slits to control image size; 
S, shutters; TIRF, total internal reflection fluorescence. (Brandenburg and Zhuang, 2007). 
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Due to the limiting size of the virus (the smallest virus has a diameter of only 20-30 
nm), restricted number of fluorescent probes that can be attached to each single viral 
particle, in order to avoid impairment of viral infectivity. For example, whereas 
hundreds to thousands of dye molecules can be attached to a relatively large 
influenza virion without affecting its infectivity (Lakadamyali et al., 2003), only 30-
50 dye molecules can be attached to a polio capsid owing to its small size 
(Brandenburg and Zhuang, 2007) and attaching more than a few dye molecules to 
the capsid of adeno-associated virus, renders the virus non-infectious (Seisenberger 
et al., 2001). 
Imaging viral entry 
Viruses exploit specific receptors on the cell surface to identify and infect target 
cells. However, these receptors are often rare or distributed in regions that are not 
readily accessible to incoming virions. Therefore, many viruses first bind to 
relatively non-specific attachment factors, such as carbohydrates, and migrate along 
the cell surface to locate specific receptors (Marsh and Helenius, 2006). Specific 
virus–receptor interactions activate signaling cascades, guide the virus into 
endocytic pathways and/or trigger conformational changes in the virus envelope or 
capsid proteins for genome release (Marsh and Helenius, 2006). Single-virus 
tracking offers an ideal method for the visualization of virus movement. Multicolor 
live-cell imaging that allows tracking of single-virus particles together with 
fluorescent-protein labeled cellular structures provides a powerful tool for studying 
viral entry mechanisms. Using this approach, even transient interactions between 
viruses and cellular proteins can be detected. Multicolour labelling of distinct virus 
components also allows viral disassembly during entry to be monitored. Such 
dynamic information is crucial for a more complete understanding of viral entry 
mechanisms. 
Several viruses, such as murine leukaemia virus, Avian leukosis virus and vesicular 
stomatitis virus (VSV) use the cortical actin cytoskeleton, together with myosin II, 
for directed movement along microvilli or filopodia, surfing towards the cell body 
before entry (Lehmann et al., 2005). Differently, murine polyoma virus-like particles 
have distinct modes of movement on the cell surface: an initial phase of free 
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diffusion is followed by actin-dependent confined movement in small domains 
(Ewers et al., 2005). Together, these imaging experiments show that viral 
attachment is followed by organized transport on the cell surface, probably to locate 
specific receptors or special active zones that are efficient in virus uptake. These 
data reveal a crucial role for fluorescent viruses in the study of viral entry. 
Multicolor live-cell imaging provides additional information on the interactions 
between virus and cellular structures, further elucidating viral-entry mechanisms. 
Using this approach, single Simian virus 40 (SV40) particles were simultaneously 
tracked with GFP-tagged caveolae. These experiments revealed the dynamic SV40 
entry process and a new endocytic organelle, the caveosome (Pelkmans et al., 2004; 
Pelkmans et al., 2001; Tagawa et al., 2005). The majority of SV40 viral particles 
colocalize with caveolae, activating tyrosin kinases and inducing rearrangement of 
actin stress fibers to form actin tails on virus-loaded caveolae (Pelkmans et al., 
2002). After a dynamin-dependent pinching process, the SV40-loaded caveolae 
leaves the plasma membrane and enters the caveosome before finally reaching the 
ER through microtubule-dependent transport. Polyoma virus and echovirus 1 also 
enter cells through a similar pathway to SV40 (Elphick et al., 2004; Pietiainen et al., 
2004; Upla et al., 2004). 
Fluorescently labeled influenza virus showed to use a distinct entry mechanism 
(Matlin et al., 1981; Rust et al., 2004; Sieczkarski and Whittaker, 2002). As directly 
visualized in a viral tracking experiment, influenza viruses can simultaneously use 
two pathways to enter cells (Rust et al., 2004): most viral particles are internalized 
through clathrin-mediated endocytosis by promoting the de novo formation of 
clathrin-coated pits (CCPs) at the viral binding site; the remaining virions enter cells 
through a clathrin- and caveolin-independent pathway. After entry by these 
pathways the virus particles have similar post-endocytic trafficking behaviour, 
which leads to viral fusion with similar efficiencies. Live imaging of cells infected 
with fluorescently labeled influenza virus revealed that viral particles are 
preferentially delivered, by microtubule-dependent transport, to the dynamic early 




Figure 1-33. Time-lapse images of influenza viruses in live cells. (a) Stacked, time-lapse images of 
influenza viruses in living cells, revealing actin and microtubule-dependent transport. The virus is 
labelled with the lipophilic dye, DiD. The sudden colour change from blue/pink to yellow/white indicates 
a dramatic increase in the fluorescence signal of DiD, indicating the fusion of the virus with an endosome. 
(b) Simultaneous images of a DiD-labelled virus (upper panels and red in lower panels) and fluorescent 
protein-labelled clathrin (middle panels and green in lower panels) in a cell show the internalization of the 
virus by a clathrin-coated vesicle. The centres of dotted circles in the middle panels indicate the virus 
positions. Overlay of green and red signals appears yellow. The time (in seconds) after viral attachment 
and different stages of viral entry are shown below the images.  
Other fluorescent viruses have also been observed to colocalize with CCPs in live 
cells, including reovirus and adenovirus (Ehrlich et al., 2004; Meier et al., 2002). In 
common with influenza, reovirus enters by the de novo formation of CCPs (Ehrlich 
et al., 2004). Experiments tracking reoviruses, transferrin, LDL and labelled CCPs 
revealed a random initiation behaviour of coated pits, which are only stabilized after 
cargo binding (Ehrlich et al., 2004).  
Besides clathrin- or caveolin-mediated endocytosis, various viruses, including 
polyoma virus and herpes simplex virus (HSV) (Damm et al., 2005; Liebl et al., 
2006; Nicola and Straus, 2004), exploit other clathrin- and caveolin-independent 
entry pathways. 
As shown by these examples, the ability to monitor time-dependent behaviour of 
individual viral particles and to probe dynamic interactions between viral and 
cellular structures has revealed its relevance in understanding the mechanisms of 
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viral entry. These studies have showed to be helpul in unravelling previously 
unknown virus–cell interactions that are crucial for infection. 
Following viral cytoplasmic trafficking 
After uncoating, the viral contents need to be transported to proper sites for 
replication. Objects larger than 20 nm (or significantly heavier than 500 kDa), such 
as viruses, cannot freely diffuse through the crowded cytoplasm (Luby-Phelps, 
2000). Therefore, to reach the site of replication viruses have successfully hijacked 
cellular transport systems, such as microtubule and actin filaments. 
As shown with different single-virus trajectories, many viruses are transported by 
minus and plus end-directed motor proteins along microtubules towards the 
microtubule organizing centre (MTOC), either by directly interacting with molecular 
motors or through inclusion in a motor-interacting vesicle. This was observed for 
reovirus, adenovirus, HSV and influenza virus (Dohner et al., 2002; Georgi et al., 
1990; Lakadamyali et al., 2003; Suomalainen et al., 1999). Cytoplasmic trafficking 
of viral particles is often highly regulated as with, for example, HSV in neurons. 
After fusion of incoming virions with the plasma membrane, HSV capsids are 
transported towards the minus end of microtubules by dynein and its cofactor 
dynactin (Dohner et al., 2002). In the axons of sensory neurons, incoming HSV 
Figure 1-34. Microtubule-dependent transport of Ad2 
to the MTOC/nuclear envelope. (A) TR-labeled Ad2 
was bound to HeLa cells in the cold and internalized for 
15 (panel a) or 60 min (panel b). Cells were labeled for γ-
tubulin and analyzed by confocal laser scanning 
microscopy (shown are the sections that contained the 
perinuclear punctate g-tubulin signal only). Virus particles 
(red) and g-tubulin (green) are pseudocolored. (B) TR-
labeled Ad2 was bound to HeLa cells in the cold in the 
absence (panels a and b) or presence of either 20 mM 
nocodazole (panels c-f) or 25 nM taxol (panels g and h). 
Drug treatment included a 30-min preincubation with 
drugs before virus binding. Cells were warmed to 378C in 
the presence or absence of drugs for 75 min (panels a-d, 
and h) or treated with nocodazole for the same time 
followed by an incubation without drug for 75 min (panels 
e and f). Cells were fixed in PFA and stained for lamins A, 
-B, and –C using anti-rabbit FITC and analyzed by 
confocal microscopy for TR and FITC fluorescence. 
Complete stacks of optical sections are shown. 




capsids are moved by retrograde transport, whereas newly assembled capsids 
undergo bidirectional and saltatory motions, indicating a modulation of the plus-end 
directed motility (Smith et al., 2004).  
The mechanisms by which capsids are transported to the nuclear pore complex for 
the import of viral genomes are less well known. Capsids might be transported by 
kinesin from the MTOC towards the nuclear pore complex and nuclear import 
factors might be involved in the unloading of capsids from microtubules that are 
proximal to the nucleus (Strunze et al., 2005). The direct tracking of an incoming 
viral genome in live cells has been challenging due to difficulties encountered in 
generating infectious virions harbouring labelled viral DNA or RNA. Tracking 
microinjected viral ribonucleoprotein (vRNP) particles from influenza showed 
diffusion as the predominant mechanism for the transport of vRNPs both towards 
the nuclear pore complexes and inside the nucleus (Babcock et al., 2004). 
Visualizing viral assembly 
A successful viral infection is ultimately marked by the assembly and release of 
progeny virus particles. After genome replication and protein synthesis, the subviral 
components are transported to the assembly site and progeny virions leave the cell 
by directly budding from the plasma membrane, controlled exocytosis or lysis of the 
cell. Labelling viral structural components with fluorescent proteins allows the 
assembly of individual virions to be monitored, and shows the location and kinetics 
of assembly as well as the exit mechanisms of matured viruses. 
A series of imaging experiments by time-lapse microscopy revealed the exit mode of 
vaccinia virus (Greber and Way, 2006). Intracellular enveloped vaccinia virus 
particles move from their perinuclear assembly site to the plasma membrane along 
microtubules (Herrero-Martinez et al., 2005; Hollinshead et al., 2001; Rietdorf et al., 
2001; Ward, 2005; Ward and Moss, 2001a; Ward and Moss, 2001b) These particles 
fuse with the plasma membrane, but remain attached as cell-associated enveloped 
virus (CEV) (Smith et al., 2003). It was recently discovered that African swine fever 
virus also shows a microtubule-dependent movement towards the plasma membrane, 
followed by actin polymerization that propels the virus away from the cell (Jouvenet 
et al., 2004; Jouvenet et al., 2006).  
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Compared with imaging the entry and transport of single virions, which typically 
involves labelling incoming viruses and therefore does not suffer from strong 
background cell fluorescence, it is more challenging to probe the assembly and 
egress of viruses at the single particle level. The background fluorescence from 
newly synthesized viral components makes it extremely difficult to monitor early 
assembly steps, while determining the distribution of viral proteins in living cells is 
currently more tractable. For example, the bluetongue virus core protein VP3 has 
highly distinct cellular distributions in the presence and absence of other viral 
proteins (VP7 and NS2) that are related to assembly (Kar et al., 2005). After initial 
stages of assembly, which accumulate sufficient proteins to form a virion, the signal 
might become sufficiently large to allow viral egress to be tracked at the single-
virion level. Experiments with labelled pseudorabies virus tegument and capsid 
proteins demonstrate viral assembly in the cell body before entering the axon of 
cultured neurons (del Rio et al., 2005a), while the association of human 
cytomegalovirus tegument and capsid proteins occurs inside nuclear inclusions 
(Sampaio et al., 2005). 
Fluorescent HIV-1 viruses 
In the last 25 years since the discovery of HIV-1, the development of new 
techniques and technologies based on fluorescent probes and microscopy also 
allowed to visualize the trafficking of HIV-1 viral particles and proteins in their 
natural context of living cells, greatly increasing our knowledge throughout the 
different stages of viral life cycle.  
Imaging HIV-1 entry 
The ability to fluorescently label membranes of individual virions has offered the 
opportunity to monitor the process of fusion occurring between individual virions 
and target cells in real time. This method relies on the possibility to observe the 
mixing of target cell and fluorescently labeled viral membranes. This technique has 
been used by Markosyan and colleagues to analyze the events occurring during 
fusion mediated by HIV-1 envelope (Markosyan et al., 2005). They used both a 
fluorescent lipid dye (DiD) to label the viral membrane and a fluorescent 
nucleocapsid-GFP protein that freely diffuses away from virions after the 
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permeabilization of virions or effective mixing of viral and cytoplasmic 
compartments (Markosyan et al., 2005). This experimental set up allowed to 
quantitatively analyze lipid mixing of membrane components from the formation of 
a fusion pore large enough to allow mixing of cytoplasm and viral contents. They 
showed that hemifusion (the mixing of membrane contents) occurred more rapidly 
and before the nucleocapsid-GFP protein entered the target cell, demonstrating that 
fusion pore formation is a multistep process occurring during HIV-1 envelope fusion 
(Markosyan et al., 2005).  
 
Figure 1-35. Imaging and analysis of individual virus-cell fusion events. Top panel, virions colabeled 
with NC-GFP and DiD are colored yellow, and those that do not contain DiD are green; DiD-only labeled 
vesicles are red. The first image (time  0) shows a U87 cell adhered to virions immobilized on a coverslip. 
Fusion was triggered immediately after the first frame by a temperature-jump to 37°C. The virus marked 
by arrowhead transferred its lipid and content into the target cell (third and fourth frames, respectively). 
Two viral particles that exhibited only DiD mixing activity are marked by arrow and an asterisk. Bottom 
panel, the DiD (red circles) and NC-GFP (green circles) fluorescence signals of the fusing virus (top 
panel, arrowhead) as a function of time at 37°C. The fluorescence traces for the virus marked by arrow 




The development of a dually labeled HIV-1 allowed discriminating virions that have 
productively entered the target cell via fusion from those virions that have been 
nonspecifically endocytosed and remain within the endosomal compartment 
(Campbell et al., 2007b). Campbell et al. labeled the HIV-1 viral core by 
incorporating EGFP fused to Vpr within the virions (Campbell et al., 2007b). In 
addition, they labeled the envelope of the viral particles with mCherry fluorescent 
protein fused to the N-terminal 15 aminoacid sequence of c-Src (S15) (Campbell et 
al., 2007b). This short tag specifically targets the fluorescent protein to the plasma 
membrane, generating a cell with a labeled membrane. Therefore, exploiting these 
cells to produce EGFP-Vpr labeled virions, they generated HIV-1 particles dually 
labeled. Following infection, S-15 mCherry fluorescent signal is lost as a 
consequence of membrane fusion, and EGFP-Vpr viral particles are visualized in the 
cytoplasm (Campbell et al., 2007b). The ability to separate these two viral 
populations allows a more careful analysis and quantification of those virions that 
have actively undergone postentry steps during infection (Campbell et al., 2008; 
Campbell et al., 2007b; Yamashita et al., 2007). 
Following HIV-1 cytoplasmic trafficking 
The observation of individual virions in target cells has provided critical insight into 
the biology of HIV-1 infection. The EGFP-Vpr labeled virus (McDonald et al., 
2002) was monitored in the cytoplasm of infected cells. The authors proved that the 
fluorescent signals indeed derive from HIV-1 complexes by (1) sedimentation of 
EGFP-Vpr with viral proteins, (2) co-immunostaining with p24CA and with p17MA, 
(3) colocalization with virion membranes and (4) association with newly synthesized 
cDNA in infected cells (McDonald et al., 2002). Therefore, labeling individual 
virions with this protein allowed to visualize with fluorescence microscopy the 
cytoplasmic behavior of individual viral complexes in both live and fixed cells 
(McDonald et al., 2002). These studies have been performed by pseudotyping 
virions with the glycoprotein of vesicular stomatitis virus (VSV-g), in order to 
increase viral tropism.  Live cell observation of viral trafficking demonstrated that 
virions can move in the cell at speeds consistent with microtubule-mediated 
movement in cells, resulting in the perinuclear accumulation of viral complexes 
(McDonald et al., 2002). This was confirmed by the microinjection of target cells 
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with fluorescently labeled tubulin, which allowed the trafficking of individual viral 
cores along microtubules to be visualized in living cells (McDonald et al., 2002). 
This trafficking required the minus-end microtubule motor dynein, as microinjection 
of target cells with antidynein antibodies prevented the perinuclear accumulation of 
viral complexes. 
 
Recently, Arhel et al. developed an alternative method to visualize the trafficking of 
individual virions (Arhel et al., 2006a). They inserted a tetracystein motif into HIV-
1 IN. This small tag, consisting in two pairs of cysteines held in a hairpin 
configuration (Cys-Cys-Pro-Gly-Cys-Cys), can specifically be bound and labeled by 
fluorescent biarsenical derivatives (Adams et al., 2002; Griffin et al., 1998). The 
advantage of this tag is to be relatively small with respect to EGFP, overcoming 
problems related to the steric hindrance of the fluorescent proteins which might lead 
to disruption of viral functions or marked loss of infectivity (Engelman et al., 1995; 
Figure 1-36 Microtubule-dependent and -independent movement 
of HIV particles in living cells. Hos/CD4 cells were microinjected 
with rhodamine-tubulin (Cytoskeleton) and incubated for 1 h at 37 C 
to label microtubules (blue), spinfected with GFP–Vpr (green), and 
DiD (red)-labeled HIV Bru3 for 1 h at 1,200 g, 23 C. The cells were 
washed and placed in medium supplemented with 50 mM Hepes and 
0.1 µM taxol to maintain microtubule structure. Images were 
collected every minute in the three color spectra at 37 C. (A) Cell at 
the beginning time point. Nucleus is to the lower left, out of frame. 
(B) Two time segments depicting microtubuledependent (white 
arrow) and -independent (colored arrow) movement of DiD-negative 
particles. The particle on microtubules appears to be the same in both 
time segments, although assignment is ambiguous in one intermediate 
frame so that this could represent two independent particles moving 
on microtubules. Bars: (A) 10 µm; (B) 5 µm. (McDonald et al., 2002). 
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Muller et al., 2004). Labeling is achieved with membrane-permeable biarsenical 
compounds that fluoresce in either green (FlAsH) or red (ReAsH) wavelenghts. The 
primary disadvantage of this labeling technique is a relatively high degree of 
background signal detectable even in the absence of proteins carrying tetracystein 
motifs (Rudner et al., 2005). Arhel et al. overcome this obstacle by labeling the virus 
in the supernatant, prior infection, instead of at the intracellular level (Arhel et al., 
2006a).  
Using these integrase-labeled virions, they measured the trajectories obtained by 
these virions using live cell microscopy. They observed that virions exhibited rapid, 
Figure 1-37. FlAsH labeling of HIV-1 integrase allows detection and characterization of HIV-1 
complexes docked at the nuclear membrane and within the nuclear compartment. P4 cells were 
observed between 20 and 24 h after infection with FlAsHlabeled HIVLAI(vsv)IN-C4 virus. Image 
stacks (z 1/4 0.8 mm) were acquired at 5-s intervals for a and b (bottom) and at 90-s intervals for b 
(top) and c for 21–32 min. All scale bars indicate 5 mm. (a) 4D tracking of an individual HIV-1 
complex reveals passage from movement I (with peaks up to 1 mm/s) to II and finally to association 
with the nuclear membrane (movement III). MSD plots contrast initial directed movement 
(movement I; t 1/4 0–408 s) with restricted movement upon docking (movement III; t 1/4 800–1121 
s). (b) Characterization of the movement of HIV-1 complexes at the nuclear membrane. Images 
show confocal slices and 3D surface reconstructions with individual docked HIV-1 complexes 
(arrows). As the nucleus moves over time, the relative movement of the docked complex was 
accurately calculated by subtracting the movement of the nucleus from that of the complex (top right 
panels). The MSD plot (bottom right) indicates confined movement within a volume of 0.7 mm 
average diameter. (c) Characterization of movement of HIV-1 complexes within the nucleoplasm of 
infected cells. Images show a confocal slice and 3D reconstruction with individual HIV-1 complexes 
within the nuclear compartment (arrows). Each line color refers to an individual intranuclear 




curvilinear, saltatory trafficking, indicative of microtubule-based movement, which 
resulted in the perinuclear accumulation of viral complexes (Arhel et al., 2006a). 
Arhel et al. could also visualize a decrease in the motility of viral complexes after 
their perinuclear deposition, which the authors suggest represent a docking 
interaction between the nuclear membrane and reverse transcription complex (Arhel 
et al., 2006a). In addition, they could detect the accumulation of these complexes 
within the nuclear compartment. They observed that, inside the nucleus, movement 
of the viral nucleoprotein complex becomes severely restricted, and they could 
occasionally observe the disappearance of their integrase-labeled signal, which 
could represent the occurrence of individual integration events during infection 
(Arhel et al., 2006a). 
Another study labeled retrotranscribed viral DNA in order to visualize pre-
integration complexes (Turelli et al., 2001). Turelli and co-workers took advantage 
of the fact that reverse transcription is initiated at the time of viral particle formation 
and can be promoted within purified virions by the addition of deoxynucleotides, 
divalent cations, and polyamines (Zhang et al., 1996). This reaction, commonly 
called natural endogenous reverse transcription (NERT), was performed with a 
mixture of nucleotides that included rhodamine-conjugated dUTPs (Turelli et al., 
2001). To ascertain first that this technique allowed the visualization of the viral 
genome once delivered in the target cells, another marker of pre-integration 
complexes was created by producing virions from cells expressing an EGFP 
derivative called EGFP-WXXF (Turelli et al., 2001). In this protein, EGFP is linked 
to a short peptide that allows the incorporation of heterologous proteins into HIV-1 
virions in a Vpr dependent manner (BouHamdan et al., 1998). Dually labeled virions 
were used to infect HeLa cells, revealing the presence of intracytoplasmatic dots 
positive for both EGFP and rhodamine (Turelli et al., 2001). At early time points, 
the signal was first observed at the plasma membrane and then more dispersed in the 
cytoplasm, while at 2.5 hours post-infection it concentrated around the nuclear 
envelope, confirming that the rhodamine label is effectively incorporated into 
nascent reverse transcripts, and therefore provide an adequate tool for detecting 
incoming viral genomes (Turelli et al., 2001). This fluorescently labeled virus has 
been exploited to study the role of cytoplasmic recruitment of INI1 and PML in the 
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early steps of viral replication (Turelli et al., 2001). They infected HeLa cells with 
this fluorescent virus, showing that incoming retroviral pre-integration complexes 
trigger the exportin-mediated cytoplasmic export of the SWI/SNF component of 
INI1 and of the nuclear body constituent PML through (Turelli et al., 2001). These 
two nuclear proteins are relocalized in the cytoplasm within 30 minutes from 
infection, presumably long before any viral protein reaches the nucleus. This event 
is therefore most likely signal mediated. In addition, when rhodamine-labeled 
virions were used to infect HeLa cells transfected with EGFP-INI1, they observed 
cytoplasmic colocalization between incoming viral genomes and INI1 (Turelli et al., 
2001). They hypotesized that, once loaded on the PIC, INI1 and PML could recruit 
the other components of the SWI/SNF complex as well as PML binding histone 
acetyltransferases such as CBP/p300 (Turelli et al., 2001). This could result in both 
facilitating integration and promoting transcription of the provirus by inducing 
remodelling of chromatin at the integration site through a combination of ATP-
dependent DNA translocation and histone acetylation. This would temporarily 
maintain the proviral DNA in an open state favourable for the loading of 
transcription factors on the viral promoter, thereby allowing for the priming of viral 
gene expression (Turelli et al., 2001). 
Monitoring interactions with cellular restriction factors 
Live and fixed cell microscopy techniques have also proven particularly valuable in 
understanding the cell biology of the retroviral restriction factor TRIM5α (Bieniasz, 
2004; Stremlau et al., 2004). Members of the TRIM family localize to various 
regions of the cytoplasm and nucleus (Reymond et al., 2001), and TRIM5α is 
known to multimerize into discrete regions in the cytoplasm known as cytoplasmic 
bodies (Stremlau et al., 2004). It was originally suggested that these structures 
represented nonfunctional, static accumulations of protein, but live cell microscopy 
has revealed that these bodies are dynamic structures that appear relevant to the 
ability of TRIM5α to restrict HIV-1 virions during infection. Using TRIM5α 
proteins fused to EGFP and EYFP proteins, TRIM5α cytoplasmic bodies were 
shown to utilize the microtubule cytoskeleton to traffic throughout the cell 
(Campbell et al., 2007a). Although it is unclear if it is cytoplasmic bodies 
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themselves or instead properties inherent to the TRIM5α protein that allow it to 
dynamically multimerize into such structures that are critical to mediate restriction, 
the ability to visualize the interactions occurring between virions and restriction 
factors in situ has provided a better understanding of this process. 
Live and fixed cell imaging techniques have also been used to directly observe the 
interactions that occur between TRIM5α and HIV-1 virions. A stable accumulation 
of individual viral complexes associating with TRIM5α cytoplasmic bodies after 
proteasome inhibition was observed using fixed cell microscopy (Campbell et al., 
2008), providing a mechanistic explanation for previous biochemical studies which 
inferred that proteasome function was required for a step in the restriction process. 
Live cell microscopy was used to observe the interactions between viral complexes 
and restriction factors in real time. These experiments revealed that restriction-
sensitive HIV-1 viral complexes could both interact with preexisting TRIM5α 
cytoplasmic bodies and induce the de novo formation of cytoplasmic bodies around 
individual virions (Campbell et al., 2008). 
Visualizing HIV-1 assembly and budding 
The complex interactions occurring between viral and host cell proteins that affect 
the formation and release of individual virions has also been successfully 
investigated through cell imaging. The labeling of HIV-1 Gag protein precursor with 
EGFP has been useful for studying its localization in the cell and the mechanism that 
governs it. In fact, Hermida-Matsumoto and Resh showed that Gag-EGFP associates 
with cellular membranes in transfected cells, displaying a punctate pattern 
(Hermida-Matsumoto and Resh, 2000). In addition, they observed that Gag-EGFP 
relocalizes in cytosolic complexes in the presence of the myristoylation inhibitor 2-
OH-Myr, revealing myristoylation as a necessary event for plasma membrane 
targeting of HIV-1 Gag (Hermida-Matsumoto and Resh, 2000).   
Visualization and quantification allowed detailed analyses of Gag multimerization 
and its subsequent involvement in viral assembly. These studies have been 
performed by studying the virus-like particles (VLPs) formation following Gag 
multimerization. However, expressing Gag-EGFP by itself resulted in a variety of 
INTRODUCTION  
 81 
aberrant viral particle structures (Larson et al., 2005; Muller et al., 2004) and in a 
reduction of infectivity of about 2 orders of magnitude (Muller et al., 2004). In order 
to overcome this problem, equimolar amount of Gag and Gag-EGFP were expressed 
(Larson et al., 2005). Fixed cell studies using correlative light and electron 
microscopy, which allows individual fluorescent punctum to be examined by 
electron microscopy, clearly demonstrate that fluorescent puncta observable by light 
microscopy are indeed budding virions (Larson et al., 2005). However, one of the 
difficulties in the field has been determining if a given punctum is a developing VLP 
or one that has formed, been released from the cell and has become reassociated 
with the cell after release. This could partly explain number of conflicting reports in 
this area of study, and requires an accurate interpretation of these results.   
Aspects of cell biology that govern VLP behavior in cells have been examined with 
microscopy. An examination of the intracellular mobility of Gag-EGFP signals in 
cells demonstrated that the Gag-EGFP protein is extremely mobile in cells, and that 
mobility is increased when the determinants that mediate the later stages of 
assembly are removed, suggesting that as the assembly process proceeds, Gag 
mobility is reduced (Gomez and Hope, 2006). In addition, fluorescence recovery 
after photobleaching (FRAP) and photoactivatable-GFP (PA-GFP) analysis revealed 
that the mobility of membrane-associated forms of Gag-GFP requires cholesterol 
(Gomez and Hope, 2006). FRAP involves the photobleaching of fluorescent fusion 
proteins, such as Gag-EGFP, in a discrete region of the cell and the measurement of 
the rate at which fluorescence returns (or does not) to that region. PA-GFP is a GFP 
variant that is only weakly fluorescent before its activation by 413 nm light 
(Patterson and Lippincott-Schwartz, 2002). Activation of this protein in a discrete 
region of the cell allows the trafficking of the protein originally present in this 
region to be followed over time. Depletion of cholesterol reduced Gag-GFP or Gag-
PA-GFP motility in live cell experiments, which could be rapidly restored by 
cholesterol replenishment. This work, consistent with the observation that 
cholesterol depletion reduces viral production (Ono and Freed, 2001), cumulatively 
suggests that VLP formation can be mediated by interactions that occur as a result of 




The Resh laboratory has used FlAsH labeling to observe Gag protein trafficking 
after its ribosomal translation (Perlman and Resh, 2006). One of the advantages of 
FlAsH labeling is that labeling can be achieved concurrently with translation, 
without the requirement for protein maturation that can be a factor in the observation 
of fluorescent fusion proteins. Moreover, a combinatorial use of FlAsH and ReAsH 
reagents allows tracking newly synthesized protein populations. This is 
accomplished by labeling existing proteins in a cell with one reagent, followed by 
exposure of cells to the second reagent. Under these circumstances, the second 
reagent used will occupy the binding sites present on newly synthesized protein. The 
Resh group has used this technique to follow newly synthesized Gag proteins from 
an initial, perinuclear localization to localization in a multivesicular body-like 
compartment before its accumulation at the plasma membrane in COS-1 cells 
(Perlman and Resh, 2006). However, Rudner et al. used a similar technique to 
visualize the same phenomenon in HeLa cells, but observed that the perinuclear loci 
in which newly synthesized protein appeared to be located did not contain 
appreciable levels of the p6Gag epitope by immunostaining, leading the authors to 
conclude that these intracellular FlAsH-positive loci represent background staining 
rather than authentic Gag protein (Rudner et al., 2005).  
One of the most elegant and efficient approaches used to study the interaction of 
Gag proteins during VLP formation took advantage of fluorescence resonance 
energy transfer (FRET) to measure the interaction between Gag molecules fused to 
fluorescent FRET partners. FRET exploits the fact that excitation of some 
fluorophores can transfer energy to an acceptor fluorophore in very close proximity, 
such that the wavelength-specific excitation of one fluorescent protein can result in 
the excitation of a separate, neighboring fluorescent protein. FRET signals can 
therefore be used to monitor the close association (5 nm) between proteins in cells 
by exciting one protein (called the donor) and measuring emission occurring from a 
separate protein (called the acceptor) (Piston and Kremers, 2007).  Derdowski et al. 
used FRET to measure the multimerization occurring between YFP-labeled and 
CFP-labeled HIV-1 Gag constructs in cells during VLP formation (Derdowski et al., 
2004). Protein–protein interactions between the individual Gag proteins required for 
FRET occurred predominantly at the plasma membrane and required Gag 
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myristoylation. Gag mutants with the G2A mutation, which prevents myristoylation, 
did not exhibit similar FRET activity. Furthermore, plasma membrane localization 
was required for Gag-Gag multimerization and measurement of FRET signal, but by 
itself plasma membrane localization was not sufficient to induce FRET between 
individual Gag proteins. Regions within the I domain of Gag, which is known to 
mediate the ability of Gag to multimerize (Sandefur et al., 1998), were required to 
allow plasma membrane localized Gag proteins to generate FRET signal (Derdowski 
et al., 2004). A similar finding was made by Hubner and colleagues, who performed 
FRET analysis of Gag protein assembly (Hubner et al., 2007). These authors 
inserted a fluorescent protein between the matrix and capsid regions of the Gag 
precursor protein, flanked by protease cleavage sites (Gag internal GFP, Gag-iGFP) 
(Hubner et al., 2007). Unlike traditional Gag-GFP constructs, this approach allows 
the observation during the formation of infectious virions rather than VLP 
formation. They could also observe FRET between Gag donor and acceptor 
proteins. In this case they exploited Venus and cerulean fluorescent proteins, which 
are recently developed variants of YFP and CFP exhibiting improved brightness and 
FRET characteristics (Kremers et al., 2006). Consistently with Derdowski et al. 
(Derdowski et al., 2004), FRET measurements between Gag-iCerulean and Gag-
iVenus were greatly impaired when the functional assembly domain within the 
nucleocapsid region of Gag was mutated. 
FRET analysis has also been used to quantify interactions occurring in the final 
stages of viral assembly. During virus release, components of the host cell endocytic 
sorting machinery are required to facilitate the release of infectious virions from the 
target cell (Morita and Sundquist, 2004). Tsg101 is a component of this machinery 
and was identified as a Gag binding protein that is required for the release of virions 
from cells (Garrus et al., 2001). A CFP-Gag and YFP-Tsg101 construct interacts in 
living cells during virus assembly. Gag expression induced Tsg101 to localize to the 
plasma membrane from a cytoplasmic and vesicular localization that was assumed 
in the absence of Gag, and this interaction was sufficient to induce FRET between 
these two fluorescent proteins (Derdowski et al., 2004). 
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A recent study has also used live cell imaging to examine virus production. This 
study used total internal reflection fluorescent microscopy (TIR-FM) to monitor the 
formation of VLPs at the plasma membrane (Jouvenet et al., 2008). By using TIR-
FM, these authors were able to concentrate their analysis on assembling virions or 
 
Figure 1-38. Variation in HIV-1 assembly kinetics. (a) Distribution of the time to complete assembly 
for 370 individual VLPs in 11 HeLa cells expressing Gag/Gag–GFP. Time to complete assembly was 
defined as the interval between the points of inflection on plots of fluorescence intensity against time, for 
each VLP. (b) Time to complete assembly is plotted against the time at which assembly commenced in 
three cells imaged for 40 min. Zero time is defined as the time at which observation began; that is, when 
more than 1 but fewer than 20 VLPs were visible in the TIR field for each cell. R=-0.71; R2=0.5. (c, d) 
Assembly of HIV-1 particles from fulllength proviral plasmids. c, Images of an individual HIV-1 virion 
assembly event. Fields are 5.5 mm35.5 mm. Numbers above the fields are minutes:seconds. (d) Plots of 
the fluorescence intensity over time for three assembly events, including that shown in c. (Jouvenet et al., 
2008). 
puncta in specific regions of the plasma membrane. TIR-FM signals decay 
exponentially with increasing distance from the region of the plasma membrane 
being analyzed, allowing for high sensitivity in the analyzed region (Toomre and 
Manstein, 2001). The formation of individual Gag-GFP puncta could be measured, 
and events were divided into slow-forming and fast-forming populations. The 
slowly forming puncta were largely immobile compared with those that rapidly 
INTRODUCTION  
 85 
appeared. Moreover, the colocalization of puncta with fluorescently labeled 
endocytic proteins, such as clathrin and CD63, predominated in the rapidly 
appearing population, whereas the slowly developing puncta did not associate with 
these markers. This allowed subsequent analysis to concentrate on these slowly 
appearing puncta, which were concluded to represent genuine VLP assembly events. 
Moreover, these slowly appearing puncta shared a similar fluorescent threshold at 
which no additional fluorescence appeared in these puncta, a point that indicates that 
a complete VLP has assembled. Careful analysis of these slow appearing puncta 
allowed the kinetics of VLP assembly to be quantified, with an average of 8.5 min 
passing between the time a punctum is first visible and when its maximal 
fluorescence is achieved. Lastly, Jouvenet et al. monitored the final event in viral 
particle formation (Jouvenet et al., 2008) using a pH-dependent GFP variant called 
pHlourin (Miesenbock et al., 1998), whose property is to lose fluorescence at low 
pH. When HIV-1 particles accomplished the fission of virion and cell membranes, 
they are not able to exchange any molecules –even protons– with the cell cytoplasm. 
Lowering the pH of the cytoplasm by raising the pCO2 lowered cytosolic pH, 
resulted in a dramatic quenching in the fluorescence of Gag-pHlourin in the 
cytoplasm more than in cell-free VLPs (Jouvenet et al., 2008). This experiment 
allowed to clearly visualize budded VLPs, distinguishing them from those that are 
nascent VLPs, whose interiors are continuous with the cytosol. 
Visualization of viral synapses 
Contact between cells of the immune system results in the accumulation of 
numerous cell surface proteins, cytoplasmic proteins and other components at the 
point of cell-to-cell contact. The ability to visualize the dynamic redistribution of 
cellular proteins and compartments that is induced by contact between cells of the 
immune system has been critical in facilitating our understanding of these events. 
Jolly and coworkers have demonstrated that cell-to-cell transmission of HIV-1 
virions is facilitated by exactly the same types of interactions between cells that 
mediate the immunological synapse (Jolly et al., 2004; Kupfer and Kupfer, 2003). 
Using immunofluorescence microscopy, they observed that the interactions between 
infected T cells and uninfected T cell targets induced the accumulation of HIV-1 
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Env and Gag at the point of cell-to-cell contact, which they defined as the 
virological synapse (VS). This interaction also induced the accumulation of target 
cell CD4 and CXCR4 coreceptor at the virological synapse. Using imaging-based 
assay systems, they demonstrated that the accumulation of these molecules at the 
virological synapse required the actin cytoskeleton and microtubule network, and 
the transfer of virus to target cells and their subsequent infection was reduced when 
this accumulation was prevented using pharmacological inhibitors (Jolly et al., 2004; 
Jolly et al., 2007). Chen and colleagues have subsequently demonstrated that this 
way of transmission could be the predominant mechanism by which viral infection 
occurs, estimating that VS-mediated infection is 18,000 times more efficient than 
infection by cell-free virus (Chen et al., 2007).  
 
Figure 1-39. Visualizing the cell-to-cell contacts that mediate viral transfer. (a) The virological 
synapse visualized by Jolly and coworkers (Jolly et al., 2004). Cell-to-cell contact mediates the 
recruitment of CD4 receptor (red) on the target cell and viral envelope in the infected cell (green) to the 
VS. Scale bar, 1 µm. (b) The recruitment of individual HIV-1 virions (green) in the dendritic cell 
(bottom) to regions of the cell in contact with a T cell (top cell), as described by McDonald et al. 
(McDonald et al., 2003). Cells are visible by nuclear (blue) and actin (red) staining. (c) The recruitment of 
FlAsH labeled Gag protein (green) expressed in primary macrophages (M) to the point of cell-to-cell 
contact. Scale bar, 15 µm (Yu et al., 2008). The left panel shows the Gag fluorescence, the middle panel 
shows the macrophages, and the right panel combines these images and the point of cell-to-cell contact is 
highlighted the boxed region. (Kupfer, 2003; Jolly et al., 2007; Chen et al., 2007). 
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A similar phenomenon has also been observed between T cells and dendritic cells 
that had been exposed to HIV-1 virions (McDonald et al., 2003). Fixed and live cell 
imaging were used to demonstrate that HIV-1 virions enter the endosomal 
compartment of dendritic cells and accumulate in regions of the cell that come in 
contact with neighboring T cells (McDonald et al., 2003). Imaging-based assays 
were also used to detect the spatial redistribution of internalized virions in dendritic 
cells (McDonald et al., 2003). Yu et al. have recently demonstrated that these 
internalized virions reside in a compartmentalized invagination of the plasma 
membrane of the dendritic cell, where they remain susceptible to membrane 
impermeable gp120 inhibitors (Yu et al., 2008). They have also demonstrated the 
cell-to-cell transfer of these compartmentalized virions from dendritic cell to target 
T cells (Yu et al., 2008). This accumulation of virions at the point of cell-to-cell 
contact, termed the infectious synapse (Jolly et al., 2004), provided a mechanistic 
understanding of how dendritic cells can enhance HIV-1 infection of T cells without 
becoming infected themselves, a process known as trans-infection.  
Cell-to-cell transfer of virus from antigen-presenting cells has also been observed in 
macrophages (Gousset et al., 2008). In this case, Goussett et al. introduced a 
tetracysteine motif inside gag, without interfering with Gag trafficking, virus 
assembly or release, particle infectivity, or the kinetic of virus replication (Gousset 
et al., 2008). They exploited this construct to follow viral Gag protein produced after 
infection of macrophages (Gousset et al., 2008). Gag accumulated in multivesicular 
bodies during virus production, and these particles contained structures recruited to 
the point of cell-to-cell contact in a fashion precisely resembling the synapse 
structures described above (Jolly et al., 2004; McDonald et al., 2003).  
In addition to accumulating at points of cell-to-cell contact, recent reports have also 
demonstrated that extensions termed membrane nanotubes might also be exploited 
by viruses during cell-to-cell transmission of virus. These structures were first 
identified with live cell imaging as structures capable of facilitating the spread of 
murine leukemia virus (Sherer et al., 2007). More recently, these structures were 
shown to mediate the transport of HIV-1 Gag and Env proteins during cell-to-cell 
transmission (Sowinski et al., 2008).  
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These works cumulatively demonstrate the power of imaging techniques to observe 
and quantify critical aspects of cell biology that are simply not apparent when using 
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CELLS AND ANTIBODIES 
HeLa, 293T and HeLa-H2B-EYFP cells (generously supplied by Jörg Langowski) 
were maintained in DMEM supplemented with 10% FCS. HeLa-H2B-EYFP cells 
were cultured in medium containing 500 µg/ml of G418 (Gibco BRL, Milan, Italy). 
Primary antibodies used for immunofluorescence were: mouse mAb AG3.0 anti-
HIV p24CA and rabbit anti-HIV p17MA (AIDS Research and Reference Reagent 
Program), goat anti-Lamin A/C (Santa Cruz Biotechnology, Inc., Santa Cruz, CA), 
rabbit anti-trimethyl-Histone H3 Lysine 9 (Upstate Biotechnology, NY, USA). 
Primary antibodies used for western blot analysis were: mouse anti-IN 8G4 obtained 
from the AIDS Research and Reference Reagent Program and anti-HIV-1 human 
sera generously supplied by Maurizio Federico. Secondary antibodies used for 
immunofluorescence were: anti-rabbit or anti mouse conjugated with Alexa-594, 
Alexa-633 and Alexa-647 (Molecular Probes, Eugene, OR) and anti-goat conjugated 
with Alexa-680 (Molecular Probes, Eugene, OR). Secondary antibodies used for 
western blot analysis were: anti-mouse and anti-human conjugated with HRP (Santa 
Cruz Biotechnology, Inc., Santa Cruz, CA). 
EXPRESSION PLASMIDS 
pVpr-IN-ECFP was constructed by cloning Vpr (PCR amplified from pNL4.3) in 
frame with the codon optimized IN (Limon et al., 2002a) into the pECFP-N1 vector 
(Clontech Laboratories, Inc., Saint-Germain-en-Laye, France). In addition an HIV-1 
protease cleavage site (IRKVL), flanked at both C- and N- terminus by a flexible 
linker (KLRILQST and RDPPVAT, respectively), was introduced between Vpr and 
IN. pVpr-IN-EGFP was constructed by substituting the ECFP cDNA with EGFP.  
p6xHis-tagged IN and IN-EGFP were constructed by cloning wild-type IN or IN-
EGFP in frame with the plasmid pASK-IBA37plus. 
The pD64E and pNL4-3.Luc.R-E- were obtained from the AIDS Reference and 
Reagent Program.  
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RECOMBINANT PROTEINS 
N-terminal 6xHis-tagged IN and IN-EGFP proteins were expressed in Escherichia 
Coli BL21 and purified by metal ion affinity (BD TALON Metal Affinity Resin, BD 
Biosciences, Palo Alto, CA) according to the protocol reported in Bushman et al. 
(Bushman et al., 1993).  
IN ACTIVITY ASSAY 
Oligonucleotide substrates for IN reaction assays were as follows: 71 (5′-
GTGTGGAAAATCTCTAGCA-3′) and 72 (5′-ACTGCTAGAGATTTTCCACAC-
3′) (Parissi et al., 2001). 71 oligonucleotide was labeled with 32P using 
polynucleotide kinase and annealed to the complementary 72 oligonucleotide. 
Strand transfer reaction was carried out in 20 mM Hepes, pH 7.2, 7.5 mM MnCl2, 
0.05% NP-40 and 10 mM DTT, in the presence of the 71/72 substrate. [32P]-labeled 
duplex DNA (1 pmol) was incubated in a final volume of 20 µl with 50 or 200 ng of 
6xHis-IN or 6x-His-IN-EGFP proteins at 37 °C for 1h. The reaction products were 
separated by electrophoresis on a 15% polyacrylamide gel with 7M urea in Tris-
Borate-EDTA buffer, pH 7.6, and then visualized by phosphoimaging (Cyclone). 
VIRUS PRODUCTION AND INFECTION 
HIV-IN-EGFP (-ECFP) virions were produced by transfecting 3x106 293T cells by 
calcium phosphate with 6 µg of pVpr-IN-EGFP (-ECFP), 6 µg of pD64E and 1 µg 
of pVSV-G. The control viruses were produced by transfecting 3X106 293T cells by 
calcium phosphate with 6 µg pNL4-3.Luc.R-E- or pD64E together with 1 µg pVSV-
G. Supernatants were collected after 48 hrs, filtered through a 0.45 µm pore size 
filter and then concentrated by ultracentrifugation. For visualization experiments, 
luciferase assay and Alu-PCR ultracentrifugation was performed at 110.000 x g for 
2 hrs at 4°C; for western blot analysis at 35,000 x g for 1.5 hrs at 4°C on a 20% 
sucrose cushion. Viral titers were quantified by RT assay or p24 ELISA 
(Innogenetics, Gent, Belgium).  Infections for Alu-PCR and luciferase assays were 
performed using viral loads equivalent to 157.000 RT cpm on 400.000 cells. For 
immunofluorescence analysis viral loads equivalent to 1,5 µg or 3 µg of HIV-1-p24 
were used to infect 40.000 cells; 2 hrs following infection cells were washed and 
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incubated for 1 min with 1x Trypsin (Sigma, Milan, Itlay) to eliminate un-entered 
virions absorbed onto cellular membrane. 
Alu-PCR was performed as described in Cereseto et al. (Cereseto et al., 2005), 
treating the viral supernatants with 160U/ml Turbo DNase (Ambion, Austin, Texas) 
before infecting.  
The synthesis of viral cDNA was analyzed in 293 T cells infected with viral loads 
equivalent to 157.000 RT cpm of NL4.3R-E-, D64E or HIV-IN-EGFP. Viral stocks 
used for the infections were treated with 160U/ml Turbo DNase (Ambion, Austin, 
Texas).  In order to analyze viral cDNA from the moment of production up to the 
approximate time when the synthesis peaks, total genomic DNA was extracted at 2 
h, 8 h, 24 and 36 h post-infection. The use of a specific set of primers allows the 
detection of viral cDNA at different stages of the synthesis. The early viral cDNA 
was monitored using the M667-AA55 (R/U5 specific) primer pair and the full 
length, or nearly complete viral cDNA (late), with M667-M661 (R/gag specific) set 
of primers (Zack et al., 1990).  
IMMUNOFLUORESCENCE AND NERT FLUORESCENCE 
LABELING 
Viral particles immunostaining was performed by adsorbing viral supernatants on 
chamber slides (BD Biosciences, Bedford, MA, USA) for 4hrs at 37°C with 10 
µg/ml of polybrene, followed by rinsing with phosphate-buffered saline (PBS) and 
fixation with 2% paraformaldehyde in PBS for 15 minutes at room temperature. 
Intracellular immunostaining was performed in cells grown on chamber slides. 
Coverslips were then fixed with 2% paraformaldehyde in PBS for 15 minutes at 
room temperature followed by incubation for 5 minutes with glycine 100 mM in 
PBS and permeabilization with 0,1% Triton X-100 in PBS for 5 minutes. After 
treatment in blocking buffer (0,1% Tween and 1% BSA in PBS) for 30 minutes, 
primary antibodies were incubated for 1 hour at 37°C in blocking buffer followed by 
incubation for 1 hr at 37°C with secondary antibodies.  Chamber slides were 
mounted with Vectashield  before microscopy analysis (Vector Laboratories Inc., 
Burlingame, CA).  
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Virions containing fluorescently labeled cDNA by NERT activity were prepared by 
incubating 400 ng of p24 viral supernatants for 4 hrs at 37°C with an endogenous 
reverse transcription reaction buffer, as previously described (Zhang et al., 1996) 
and modified as follows: 10 mM Tris-HCl (pH7.4), 150 mM NaCl, 1mM MgCl2, 
100 µM dATP, 100 µM dCTP, 100 µM dGTP,  25 µM dUTP, 10µM Alexa-594-
dUTP (Molecular Probes, Eugene, OR). 
IMAGE ACQUISITION AND ANALYSIS 
Three-dimensional stacks of fixed cells were acquired with the TCS SL laser-
scanning confocal microscope (Leica Microsystems, Milan, Italy) equipped with 
galvanometric stage using a 63×/1.4 NA HCX PL APO oil immersion objective. Z-
step and y-step size was 0.3 µm. An Ar laser was used for ECFP (λ=458 nm), EGFP 
(λ=488 nm), EYFP (λ=514 nm) and Alexa-680 (λ=633 nm) excitation. Fluorescence 
emission was collected in the ranges 468-494, 495-525, 527-585 and 587-722 nm 
for ECFP, EGFP, EYFP and Alexa-680, respectively. For the two- and three-color 
analysis a sequential image acquisition was used to reduce crosstalk between 
different signals below 5%. Multi-channel images were contrast stretched (linearly) 
and assembled in ImageJ (NIH). H2B-EYFP fluorescence intensity among different 
cell images were normalized using the following procedure: for the acquisition the 
laser power was adjusted to maximize dynamic range and to avoid image saturation 
with the brightest value ranging between 220 and 250; the contrast range was then 
linearly expanded assigning the brightest value to 255. For cross analysis with 
3MeK9H3 staining the H2B-EYFP fluorescence intensity was quantified in the 
3MeK9H3 positive regions after rescaling with the above-described procedure. 
Raw data (i.e. confocal z stacks) were deconvolved using the experimental PSF 
measured for each channel and imposing the optical parameters adopted during 
image acquisition. For each fluorescent channel the point spread function (PSF) of 
the microscope was calculated using PSF distilled function in Huygens Essential 
software (Scientific Volume Imaging BV. Hilversum, The Netherlands). There the 
lamin A/C Alexa-680 signal (blue) was linearly expanded between 30 and 250, 
while the PICs signal (green) between 2 and 50. The applied lookup table defines a 




























MOLECULAR ENGINEERING OF FLUORESCENT HIV-1 
PARTICLES 
Construction of fluorescently labeled IN proteins 
Even though viral genome is restricted to 9 Kb, it has all the information for the 
transcription control elements and for coding 15 different proteins (Frankel and 
Young, 1998). Nonetheless, some viral proteins are the result of viral mRNA 
splicing, some other are translated as polyprotein, which, subsequently, are cleaved 
in specific regions by the HIV-1 protease. Therefore, altering the sequence of the 
provirus, by introducing or deleting sequences, can, in principle, impair the genome 
processing and the synthesis of viral proteins, leading to a block in the viral 
assembly and/or the viral replication cycle. Since our aim was to visualize the 
localization of HIV-1 IN in the nucleus of infected cells, we wanted to fuse IN viral 
protein to a fluorescent protein without disrupting the viral genome. Therefore, we 
exploited a technique known as trans-incorporation, which consists in the property 
of Vpr to interact with p6 region of Gag (Bachand et al., 1999; Paxton et al., 1993). 
As previously described (McDonald et al., 2002; Wu et al., 1995), exogenous 
proteins are shuttled in the viral particle by fusion with Vpr. In addition, it has been 
shown that trans-incorporated IN complements catalytically inactive IN of IN-
mutant-HIV-1 molecular clones (trans-complementation), even though is less 
efficient (Fletcher et al., 1997). The introduction of a HIV-1 protease sensitive 
proteolytic cleavage site between Vpr and IN (Vpr-PC-IN) allows the separation of 
the two proteins, completely restoring the enzymatic activity of IN (Fletcher et al., 
1997). Importantly, previous reports showed that the fusion of a protein at the C-
terminus of Vpr-PC-IN does not affect viral assembly and infectivity (Holmes-Son 
and Chow, 2000; Tan et al., 2006).  
Considering the above findings, we generated a plasmid construct carrying a HIV-1 
sensitive proteolytic site (PC) in between Vpr and fluorescently labeled IN (IN-
ECFP, IN-EGFP or IN-mCherry), as shown in Figure 3-1. The resulting sequence of 






Figure 3-1. Vpr-IN-EGFP DNA construct. HIV-1 IN protein is fused at the N-terminus to Vpr and at 
the C-terminus to the fluorescent protein EGFP. Between Vpr and IN there is a proteolytic cleavage site 
(PC). HIV-1 protease recognize this site and cleave it, leaving the N-terminus of IN free from Vpr.  
Initially, we analyzed the catalytic properties of IN following fusion with EGFP at 
the C-terminus. To this aim, recombinant wild-type IN or IN-EGFP proteins were 
expressed in E. coli with a 6xHis tag at the N-terminus, purified using nickel-chelate 
affinity chromatography and used in a strand transfer reaction. This experiment 
evaluates the capacity of IN to produce DNA fragments of different sizes (P), as a 
result of multiple integration events, when a short oligonucleotide is used as a 
substrate (S) (Marchand et al., 2001). The lengths of the 3’-end-joining products are 
heterogeneous because the site of joining is non-specific. As shown in Figure 1Bis, 
fusion of EGFP at the C terminus of IN did not change significantly the strand 
transfer activity with respect to the wild-type IN (Figure 3-2, lane 3 and 5, 
respectively). These results are in line with previous reports, proving that IN 3’-end-
joining activity is not affected by the fusion of DNA binding protein at the C-





Figure 3-2. Catalytic activity of HIV-1 IN-EGFP fusione protein. The reaction was carried out with 50 
or 200 ng of 6xHis-IN (Lanes 2 and 3) or 6xHis-IN-EGFP (Lanes 4 and 5). Lane 1 represents a reaction 
done in the absence of protein. The filled arrowhead denotes the position of the substrate (21-mer), while 
the bands that migrates above the substrate are the products of the strand transfer reaction. 
IN-EGFP is trans-incorporated into the viral particles 
In order to produce pseudotyped HIV-1 viral stock containing labeled IN (HIV-IN-
EGFP), 293T cells were co-transfected with pVIN-EGFP, pVSV-G and the proviral 
construct pD64E. This HIV-1 molecular clone is derived from an env-deleted 
pNL4.3 provirus, expressing luciferase reporter gene and an IN mutated in the 
residue 64 (Svarovskaia et al., 2004). Since the substitution from Asp 64 to Glu 
results solely in a defect in integration and does not affect other critical stages of the 
virus life cycle, suppressed IN catalytic activity, the IN-EGFP fusion protein 
provided in trans exclusively mediates the integration of the recombinant HIV-1 
fluorescent virus (hereafter, HIV-IN-EGFP). 
To assess the incorporation in the viral particles and the protease cleavage of VIN-
EGFP protein, supernatants containing wild-type, mutated or HIV-IN-EGFP virions 
were concentrated by ultracentrifugation (see Material and Methods) and analyzed 
by Western blot (WB). Wild-type and mutated viruses were produced by transfecting 
293 T cells with pVSV-g and pNL4.3.Luc.R-E- (Connor et al., 1995; He et al., 
1995) or with pD64E, respectively. Both wild-type and mutated viruses contain a 
luciferase reporter gene, but the former expresses a functional IN, while the latter 
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encodes a catalytically inactive IN. Using an anti-IN antibody, a band at the same 
size as IN (32 KDa) is detected in HIV-IN-EGFP virus, as well as in control 
NL4.3.Luc.R-E-, and D64E viruses (Figure 3-3A, lane 4, 2 and 3, respectively). In 
addition, two more bands, corresponding to Vpr-IN-EGFP and its proteolytic 
product IN-EGFP, are exclusively visible in the fluorescently labeled virions (Figure 
3-3A, lane 4), proving that IN-EGFP is efficiently incorporated and subsequently 
digested by the viral protease. Notably, reproducible results showed that the amount 
of IN in both NL4.3.Luc.R-E- and D64E virions is comparable, while it decreases in 
HIV-IN-EGFP virions. Further investigations are needed to explain the different 
composition of the trans-incorporated viral particles.  
 
Figure 3-3. IN-EGFP is trans-incorporated into intact HIV-1 virions. Supernatant from un-transfected 
control cells (lane 1) or cells transfected with pVSV-G and pNL4-3.Luc.R-E- (lane 2), pD64E (lane 3) or 
pD64E together with pVpr-IN-EGFP (lane 4) were pelleted by ultra-centrifugation through a 20% sucrose 
cushion and analyzed by western blot using antibodies anti-IN (A) or with an anti-HIV-1 human serum 
(B).  
In order to verify that the trans-incorporation of VIN-EGFP protein does not affect 
the regular assembly of HIV-IN-EGFP virions, we evaluated the correct synthesis of 
viral proteins and processing of Gag-Pol polyprotein by WB, using human anti-HIV 
serum. As shown in Figure 3-3B, HIV-IN-EGFP virions (lane 4) have same pattern 
and amounts of viral proteins and polyproteins as the two control viruses (lane 2 and 
3), indicating that synthesis and maturation processes are not affected by trans-
incorporation of VIN-EGFP. As expected, HIV-IN-EGFP virions (Figure 3-3B, lane 
4) display two more bands, proving that Vpr-IN-EGFP is efficiently incorporated 
and is subsequently digested by the viral protease.  
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Visualized IN-EGFP particles are virions 
Once assessed the regular HIV-IN-EGFP viral assembly and maturation, the 
fluorescence of these viral particles was observed with the confocal microscope, by 
directly spotting concentrated viral supernatant on a glass coverslip. As shown in 
Figure 3-4A, a high number of green fluorescent dots is visible. These dots appear 
heterogeneous in size, with a broad distribution of fluorescence intensity. 
Indirect immunofluorescent staining of HIV-IN-EGFP virions bound to glass 
coverslip confirmed that virtually all the observed EGFP fluorescent dots were 
associated with matrix (p17MA) (Figure 3-4C) or capsid viral proteins (p24CA) 
(Figure 3-4D). These data prove that IN-EGFP fluorescent dots are indeed viral 
particles. The extensive colocalization between the EGFP spots and the two viral 
proteins (Figure 3-4E) is consistent with the findings of McDonald et al. (McDonald 
et al., 2002). 
 
Figure 3-4. IN-EGFP colocalizes with HIV-1 viral proteins. (A) Supernatants from 293 T cells 
transfected with the pD64E, pVpr-IN-EGFP and pVSV-G plasmids were ultra-centrifuged through a 20% 
sucrose cushion, adhered to glass coverslips and visualized for EGFP fluorescente (green). (B-E) 
Harvested supernatant was fixed, immunostained with specific antibodies against viral proteins p17MA and 
p24CA and then visualized for EGFP fluorescence (B and E), p17MA (C and E) and p24CA (D and E). (F-I) 
sSme as in B-E with NL4.3-Luc.R-E-. (L-O) Same as in B-E with D64E. (E, I, O) Merged image, where 
white spots result from overlapping green, blue and red signals. Bars, 5 µm. 
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To ascertain that the green signal was exclusively due to the IN-EGFP protein the 
same immunostaining experiment was performed on both NL4.3.Luc.R-E- (Figure 
3-4F, G, H and I) and D64E (Figure 3-4J, K, L and M) viral supernatants. The 
presence of p17MA and p24CA immunofluorescence signals in both wild-type and 
mutated viruses (Figure 3-4G and H, and Figure 3-4K and L, respectively) and the 
lack of green dots (Figure 3-4F and J) indicate that green fluorescence signals 
specifically originate from labeled IN of HIV-IN-EGFP virions. These results are a 
final demonstration that IN-EGFP is successfully and specifically trans-incorporated 
in the fluorescent virus.  
Next, the amount of HIV-IN-EGFP viral particles colocalizing with p17MA, p24CA or 
both was quantified. On average, 68% of the particles identified by α-p17MA 
antibody costain for IN-EGFP (see Table 3-1) and 63% of the virions detected by α-
p24CA antibody colocalize with IN-EGFP. This indicates that a high percentage of 
virions identified by HIV-1 Gag protein is strongly labeled with IN-EGFP. 
Interestingly, 80% of the viral particles labeled with both α-p17MA and α-p24CA 
antibodies colocalize with IN-EGFP (see Table 3-1). These results indicate that IN-
EGFP fusion protein allows the detection of all but a few virions by confocal 
microscopy.  
Colocalize with 
Particles staining for 
p17MA p24CA VIN-EGFP 
p17MA - 76% ± 7% 68% ± 2% 
p24CA 69% ± 3% - 63% ± 11% 
p17MA p24CA - - 80% ± 9% 
Table 3-1. Quantification of the colocalization between viral proteins and IN-EGFP particles. 
VISUALIZATION OF HIV-IN-EGFP VIRIONS IN THE 
CYTOPLASM 
IN-EGFP dots in the cell are viral particles 
Previous structural and functional experiments revealed that HIV-IN-EGFP is a 
complete virion and behaves like a wild-type virus, showing that trans-incorporation 
of IN-EGFP does not affect any component or functionality of the viral particles. 
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Following, we focused on the visualization of fluorescently labeled virion in 
infected cells. To this aim, HIV-IN-EGFP virions were used to infect HeLa cells. 
In order to visualize weather IN-EGFP interacts with the other viral proteins to form 
PICs in infected cells, we performed an immunostaining 6 hours post-infection, 
using antibody recognizing p17MA or p24CA. It has been previously demonstrated 
that HIV-p17MA is detectable in PICs but p24CA is not (Miller et al., 1997). 
Conversely, McDonald et al. (McDonald et al., 2002) showed with visualization 
experiments that capsid structure remains intact during the initiation of reverse 
transcription in the cytoplasm. Our results, shown in Figure 3-5 are consistent with 
McDonaltd et al. (McDonald et al., 2002). Indeed, the majority of EGFP spots were 
positive for p17MA (Figure 3-5A) and p24CA (Figure 3-5B), indicating that IN-EGFP 
proteins form a complex with both the other two viral proteins in the cytoplasm of 
infected cells. 
 
Figure 3-5. HIV-IN-EGFP virions can be visualized in infected cells. (A) Confocal visualization of 
HeLa cells infected with concentrated supernatants derived from cells transfected with the pD64E, pVpr-
IN-EGFP and pVSV-G plasmids. Six hours post-infection cells were immunostained with antibodies 
against p17MA and visualized for EGFP fluorescence (green) or p17MA staining (red). In the merged 
image, where cell and nuclear shapes are outlined in white, yellow spots indicate full overlapping of 
green and red signals. Bar, 5 µm. Enlargements of the boxed region show individual color and merged 
images. Bar, 2 µm. (B) Same as in (A) using antibodies against p24CA. 
Visualization of IN-EGFP retrotranscription complexes: IN-
EGFP PICs 
PICs are defined as integration-competent complexes (Lehmann-Che and Saib, 
2004), since they complete the reverse transcription of the viral genome, translocate 
into the nucleus of the infected cell and integrate viral cDNA. Therefore, the 
colocalization of IN-EGFP with p17MA or p24CA is not enough to show that 
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cytoplasmic fluorescent spots are indeed PICs. In order to visualize that IN-EGFP 
particles are able to reverse transcribe the viral genome, natural endogenous reverse 
transcription (NERT) activity was exploited. It has been shown that reverse 
transcription starts during viral particle formation and can be promoted by adding 
deoxynucleotides, divalent cations, and polyamines to extracellular viral supernatant 
(Zhang et al., 1996). This approach has been previously used for visualization 
purposes (Turelli et al., 2001) by incubating viral supernatant in presence of 
fluorescent dUTPs (Alexa-594 dUTPs). Similarly, this labeling was performed on 
supernatant containing NL4.3.LucR-E- virions, HIV-IN-EGFP virions, or 293 T 
cells not producing viruses (mock) for 4 hours at 37°C. Following, each supernatant 
was used to infect HeLa cells. Four hours post-infection cells were fixed and imaged 
at the confocal microscope. As shown by the presence of red dots in Figure 3-6B, 
wild-type virions incorporate fluorescent dUTPs in the retrotranscribed viral DNA 
during NERT, allowing the visualization of NL4.3.Luc.R-E- PICs in the infected 
HeLa cells. Similarly, red fluorescent dots (Figure 3-6E) are visualized in HeLa cells 
infected with HIV-IN-EGFP virions labeled with fluorescent dUTPs. Moreover, no 
fluorescence has been detected in the cells treated with mock supernatant, indicating 
that the fluorescent signal is specific for the labeling of retrotranscribed viral cDNA 
and does not gives unspecific signal. Notably, this experiment also shows that 
reverse transcription is not impaired. 
Next, colocalization between HIV-IN-EGFP viral particles and fluorescent dUTPs 
was evaluated. As shown in Figure 3-6D, IN-EGFP viral particles are visualized in 
infected HeLa cells and two of them colocalize with the fluorescently labeled 
retrotranscribed viral cDNA (Figure 3-6F and Figure 3-6F insets). This result 
demonstrates that IN-EGFP particles are indeed PICs. However, Figure 3-6F shows 
only a minority of IN-EGFP spots overlapping with fluorescently labeled cDNA. 
The reduced number of positive PICs can be explained by the rather low efficiency 
of the NERT assay and to the reported observation that only a limited number of 




Figure 3-6. HIV-IN-EGFP virions containing neo-synthesized viral cDNA can be visualized in 
infected cells. (A-C)) Confocal visualization of a HeLa cell at 6 hours after infection with NL4.3.Luc.R-
E- viral supernatant (A) incubated with deoxynucleotides Alexa-594-dUTP (B). Merged image is 
represented in (C). (D-F) Same as in A-C. (1 and 2) Enlargements of two IN-EGFP viral particles 
colocalizing with neo-synthesized viral cDNA. (G-I) Same as in A-C with supernatant costaining no 
virus. Cell and nuclear shapes are outlined in white. Bar, 5 µm.  
FUNCTIONAL IN-EGFP PICS TRANSLOCATE IN THE 
NUCLEUS 
Are IN-EGFP viral particles really visualized in the nucleus? 
As demonstrated, IN-EGFP particles in infected cells are functionally active PICs 
and integrate like wild-type viruses in the host cell genome. Therefore, next step was 
to visualize the nuclear level of IN-EGFP PICs in target cells. To this aim, HeLa 
cells, constitutively expressing histone H2B fused to EYFP (HeLa H2B-EYFP) 
(Weidemann et al., 2003), were infected with HIV-IN-ECFP virions. ECFP labeled 
virions were used in place of HIV-IN-EGFP to allow better spectral separation. 
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H2B-EYFP has been used to visualize the nuclear compartment in order to 
distinguish cytoplasmatic PICs (cPICs) from nuclear PICs (nPICs). Initial analysis 
revealed that several PICs located in the close proximity or juxtaposed to the nuclear 
membrane. To circumvent the misleading signals deriving from these outer PICs a 
bi-directional scanning was employed.  
Usually, the laser beam of confocal microscope scans the specimen along the XY 
plane (see Figure 8A), giving an image as result (Minsky, 1988). Acquisition of 
adjacent images of the sample along the z-axis allows the 3D reconstruction of the 
specimen. In addition, specimen can be acquired also along the XZ axes (see Figure 
3-7B), giving as result an image that is orthogonal to the previous one. Taking 
advantage from these 2 different acquisition modes, we were able to clearly 
distinguish PICs located into the nuclear compartment from those that were not.  
 
Figure 3-7. Confocal scan modes. 3-dimensional illustration showing the XY scan mode (A) or the XZ 
scan mode (B) of the confocal microscope.  
Figure 3-8 shows the result of three XY-XZ double scans of putative nuclear PICs. 
For each cell, the three upper panels correspond to images acquired with XY scan in 
the IN-ECFP channel, H2B-EYFP channel or the merge of the two channels, 
respectively. Subsequently, on these cells an XZ scan was performed (vertical scan) 
in correspondence of a putative nuclear PIC. The position where we performed this 
vertical scan is reported for each cell as a white line at both sides of the XY merge 
image. The XZ scans in the IN-ECFP channel, H2B-EYFP channel or the merge of 
the two channels are in the lower panels. A white line at both sides of XZ merge 
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images indicates the height at which the XY image has been acquired. As 
demonstrated from these images nuclear localization might be interpreted in all cells 
here reported (cell 1, 2 and 3) (see Figure 3-8 C, I, P). However, due to the irregular 
shape of the nucleus, the comparison of the XZ scans reveals that exclusively cell 3 
(Figure 3-8S) contains a nuclear PIC, while cells 1 (Figure 3-8F and 2 (Figure 3-8L) 
show PICs trapped in nuclear invagination, outside the envelope.  
 
Figure 3-8. Cytoplasmic or nuclear localization of PICs. (A-C) XY scan of HeLa H2B-EYFP nucleus 
(B, red) infected with HIV-IN-EGFP virions (A, green). Merged image is shown in C. (D-E) XZ scan of 
the nucleus in B. White lines in C and F represent where XZ and XY images were acquired, respectively. 
(G-L) same as in A-F. (M-S) same as in A-F. Cell 1 (A-F) and cell 2 (G-L) show PICs in the close 
proximity or juxtaposed to the nucleus, while cell 3 (M-S) displays a nuclear PIC. 
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The XZ scan of an infected cell showed in Figure 3-9 further demonstrates that the 
irregularity of the nuclear membranes in which PICs are trapped might induce the 
misinterpretation of the results.  
Therefore these experiments clearly demonstrate that the H2B-EYFP used to label 
the nucleus cannot allow to detect nuclear invagination or whole nuclear 3D 
structure, thus misleading to wrong PICs intranuclear localization.  
 
Figure 3-9. PIC trapped in the irregularity of the nuclea membrane. The nucleus of HeLa H2B-
EYFP (mid panel) infected with HIV-IN-EGFP virions (left panel) shows an IN-EGFP PIC trapped in the 
irregularity of the nuclear membrane (right panel). 
To better define the nuclear border, we decided to stain the internal boundary of the 
nucleus, occupied by the nuclear lamin. To this aim, we performed an 
immunofluorescence staining of nuclear lamin with antibody α-Lamin A/C. 
Subsequently we acquired a series of XY stacks every 0.3 µm, starting from the top 
of the nucleus towards the bottom. This approach leads to the acquisition of a 
sufficient number of z-stack images of the nuclear lamina, covering the whole 
nuclear compartment, which allowed us to make a 3D reconstruction of the nuclear 
boundaries. The antibody α-Lamin A/C specifically stains the nuclear periphery, so 
that the final 3D reconstruction gives a hollow sphere as result (see Figure 3-10A). 
This approach allowed a clear definition of the nuclear lamina, which in turn enables 




Figure 3-10. Nuclear lamin A/C staining. (A and B) two different visualization modes of a 3-
dimensional reconstraction of a HeLa cell nucleus immunostained with antibody anti-Lamin A/C. 
The staining with nuclear lamin antibody was then performed on HeLa cells infected 
with HIV-IN-EGFP. XY images of nuclear PICs were acquired in the channel of IN-
EGFP and in that of the Lamin A/C (Figure 3-11A). Following, XZ scan in both 
channels (represented by the red lines at both sides of Figure 3-11A) was performed 
exactly in correspondence of the identified nPIC (Figure 3-11B). A 3D 
reconstruction of Figure 3-11A and B was carried out (Figure 3-11C-H) to better 
visualize PICs localization with respect to the nuclear volume.  
 
Figure 3-11. Nuclear visualization of the HIV-IN-EGFP virus. Nucleus of a HeLa cell infected with 
the HIV-IN-ECFP virus (green) and immunostained with lamin A/C (blue). (A) XY section of the nucleus 
of the infected cell. (B) XZ section of the nucleus in A performed in correspondence of the red lines 
represented in A. (C-H) 3-dimensional reconstructions of the nucleus in A. 
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Next, the infected cell shown in Figure 3-11 was sectioned every 0.3 µm along the z-
axis or the y-axis by acquiring confocal images of IN-EGFP and LaminA/C signals 
with the XY  (Figure 3-12B) or XZ  (Figure 3-12C) scan mode, respectively.  in the 
spectral channels corresponding to IN-EGFP and lamin A/C staining (Figure 3-12).  
 
Figure 3-12. Visualization of HIV-IN-EGFP in the nucleus of infected cell. Nucleus of a HeLa cell 
infected with the HIV-IN-ECFP virus (green) and immunostained with lamin A/C (blue). Acquisition of 
confocal images was performed as z-stack (B) with a z step size of 0.3 µm and was followed by 
deconvolution based on experimentally determined PSF (see Experimental Procedure) and 3-
dimensional reconstruction (A and D). (C) Adjacent xz section of the nucleus in B acquired every 
0.301 µm. Bars, 5 µm. (E) HeLa cells were infected with HIV-IN-EGFP virions, fixed 6 hours after 
infection and immunostained with antibody anti-lamin A/C. The image shows an IN-EGFP PIC trapped 




This approach allowed the detection of all the PICs present in the different focal 
planes of the whole cell. Notably, since images are acquired every 0.3 µm along z-
axis and PICs are not planar but occupy a 3D volume, fluorescence coming from IN-
EGFP PICs is detectable in more than one stack, typically in three stacks.  
Comparing Figure 3-12B with Figure 3-12C the number of nuclear PICs is the same, 
proving that combining the staining of nuclear lamin A/C with the acquisition of 
confocal images along the z-axis of the nucleus is the best system to accurately 
define nuclear PICs. The 3D reconstruction of these z-stack images allowed a better 
visualization of these data (Figure 3-12D). In addition, this approach identifies 
nuclear invaginations, avoiding misinterpretation of PICs localization, as shown in 
Figure 3-12E. 
Summarizing, our approach consists in plating HeLa cells on a chamber slide, 
infecting with HIV-IN-EGFP virions and fixing typically 6 hours post-infection to 
perform an immunofluorescence using Ab α-Lamin A/C. Following, XY scan mode 
of the confocal microscope is used to acquire images of infected cells every 0.3 µm 
along the z-axis, starting from the top to the bottom of the nucleus. The combination 
of lamin staining together with the acquisition of 3D images are the necessary 
criteria to establish the nuclear localization of PICs. 
Translocation of HIV-IN-EGFP in the nucleus follows CA 
disassembly 
It is known that CA shells disassemble is a necessary event before viral DNA 
translocation through the nuclear pore (Arhel et al., 2007; Forshey et al., 2002; 
Miller et al., 1997). Therefore, as a better indication that PICs identified in the 
nucleus are functionally active virions, an immunofluorescence was performed on 
HeLa cells infected with HIV-IN-EGFP using antibody α-Lamin A/C and α-p24CA. 
This experimental set up allows to visualize at the same time the position of IN-
EGFP PICs with respect to nuclear lamin and the capsid protein. To discriminate 
cPICs from nPICs, images were acquired with the confocal microscope every 0.3 
µm with the XY scan mode. Figure 3-13A shows IN-EGFP virions colocalizing 
heterogeneously with p24. Figure 3-13B displays two cPICs costaining with p24CA: 
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one is few microns far from the nuclear envelope, while the other is very close to it. 
In Figure 3-13C a nPIC is observed and it does not costain with p24CA. 
This analysis has been performed on 10 different cells, obtaining a colocalization 
between IN-EGFP signal and p24CA signal of 50% in the cytoplasm and of 0% in the 
nucleus, where we found a total of 12 nPICs. The analysis with Student’s t-test 
revealed that these results are statistically significant different, with P<0.01. 
Therefore, these data further prove the functional integrity of the nuclear HIV-IN-
EGFP virions.  
 
Figure 3-13. Nuclear translocation of HIV-IN-EGFP virions follows capsid disassembly. (A) Merged 
image of a confocal section obtained from HeLa cells infected with HIV-IN-EGFP supernatants (green) 
and immunostained with antibodies anti-p24CA (red) and lamin A/C (blue). Yellow indicates full 
overlapping of EGFP and anti-p24CA signals. Cell and nuclear shapes are outlined in white. 
Enlargements of frames B and C are shown in the right panels along with the individual color images. 
Bars, 5 µm and 1 µm in the whole frame and enlarged boxes, respectively. 
Nuclear IN-EGFP particles bind viral cDNA 
As shown previously, cytoplasmic IN-EGFP PICs are functionally active, since they 
bind retrotranscribed viral cDNA. In order to verify that their functional integrity is 
preserved at the nuclear level, we wondered weather nuclear IN-EGFP PICs still 
bind viral cDNA. To this aim, NERT approach was exploited to incorporate 
fluorescent dUTPs in retrotranscribed viral cDNA of HIV-IN-ECFP virions. The 
dUTPs labeled supernatant was used to infect HeLa expressing H2B-EYFP histones 
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and after 6h cells were fixed and imaged at the confocal microscope. A z-scan of the 
nucleus was performed, by recording separately the three spectral channels 
corresponding to IN-ECFP PICs (Figure 3-14A, green), H2B-EYFP (Figure 3-14A, 
blue) and Alexa-594-dUTPs (Figure 3-14A, red). Figure 3-14A shows a nuclear IN-
ECFP PIC colocalizing with fluorescent dUTPs, indicating that nPIC is indeed 
bound to retrotranscribed viral cDNA and suggesting its integrity and functionality.  
To further prove the intranuclear localization of PICs associated with 
neosynthesized cDNA, the same experiment was also performed in HeLa cells that 
have been subsequently immunostained with Lamin A/C antibody (Figure 3-14B). 
Cells were imaged at the confocal microscope, acquiring pictures with the XY-scan 
mode and sectioning the whole nucleus every 0.3 µm. Figure 3-14B (white arrow) 
shows a cytoplasmic IN-EGFP PIC (green) colocalizing with Alexa-dUTPs (red) 
very close to the nucleus (blue). More interesting, a PIC colocalizing with 
retrotranscribed viral DNA is observed within the nuclear boundaries. 
 
Figure 3-14. Nuclear IN-EGFP virions colocalize with viral cDNA. (A) Merged image of a confocal 
section obtained from H2B-EYFP HeLa cell infected with HIV-IN-EGFP supernatant incubated with 
deoxynucleotides Alexa-594-dUTP. Cell and nuclear shapes are outlined in white. (B) Merged image of a 
confocal section obtained from HeLa cell infected with HIV-IN-EGFP supernatant incubated with 
deoxynucleotides Alexa-594-dUTP and immunostained with antibody anti-LaminA/C. Cell shape is 
outlined in white. Yellow indicates full overlapping of EGFP and Alexa-594-dUTP signals. Bars, 5 µm 
and 1 µm in the whole frame and inset box, respectively. 
Taken together, these results show the functional integrity of nuclear IN-EGFP 
PICs, validating HIV-IN-EGFP virus as a tool in visualization experiments. 
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HIV-IN-EGFP nuclear translocation kinetic  
The visualization of functionally active HIV-IN-EGFP virions in the nuclear 
compartment allowed to investigate the kinetic of nuclear translocation. It has been 
estimated that proviral DNA is detectable almost 8 hours after HIV-1 entry (Kim et 
al., 1989).  We have thus quantified the number of viral PICs at different time points 
from 3 to 24 hours after infection. HeLa cells were plated on six different chamber 
slides and infected with HIV-IN-EGFP virions. Next, cells were fixed at different 
time points (3h, 6h, 9h, 12h, 16h and 24h) and immunostained with antibody α-
Lamin A/C.  
 
Figure 3-15. Nuclear translocation kinetic of HIV-IN-EGFP virions. HeLa cells infected with HIV-
IN-EGFP virions were fixed and the mean number of intranuclear viral particles per cell was quantified at 
3 hrs, 6 hrs, 9 hrs, 12 hrs, 16 hrs and 24 hrs. At each time point an average of 30 cells was analyzed and 
SD represented as error bars.  
Images were acquired with the XY scan mode along the z-axis of the whole nucleus, 
as previously described. The amount of IN-EGFP PICs in infected cells was 
quantified automatically using the function “Analyze particles” of the software 
ImageJ (NIH). Automated quantification could not be used for nuclear PICs due to 
multiple parameters required for the analysis. Therefore, nPICs were counted one by 
one, screening each cell stack by stack. Thirty cells per each time point were 
analyzed, finding the highest number of nPICs at 6 hours post-infection (Figure 
3-14), with a mean of 3.5±1.1 (mean±SD, Standard Deviation). From 6 hours to 9 
hours post infection the number of nPICs decreases steeply while after this time 
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point the number of nuclear PICs decreases gradually up to 24 hours when no PICs 
are detectable anymore. 
Finally, 6 hours post-infection the ratio of nuclear-to-cytoplasmic PICs was 
evaluated. Compared to the total average amount of PICs per cell (167.5±33.4; 
mean±SD, 30 cells), only a small fraction (2.0±0.8%; mean±SD) was found in the 
nucleus.  
DISTRIBUTION OF IN-EGFP PARTICLES IN THE NUCLEUS 
Peripheral distribution of HIV-IN-EGFP 
Analyzing HeLa cells infected with HIV-IN-EGFP we noticed that PICs were 
preferentially detected at the nuclear periphery. In order to quantify this preliminary 
observation at 6 hours post-infection, cells were immunostained with α-Lamin A/C 
antibody and the distance of nPICs from the nuclear boundaries was evaluated. 
Interestingly, our results, showed in Figure 3-16, reveal a preferential distribution of 
nuclear pre-integration complexes in the nuclear periphery. In fact, HIV-IN-EGFP 
nPICs localize at distances ranging from 0.4 to 2.0 µm from the nuclear border, with 
a mean of 0.9±0.4 nPICs, while the frequency of nPICs decreases dramatically 
toward the centre of the nuclei.  
 
Figure 3-16. HIV-IN-EGFP virions preferentially localize in the periphery of the nucleus.  
Distribution of intranuclear PICs distances from the lamin A/C staining. 
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Characterization of heterochromatin in HeLa H2B-EYFP cells 
The peculiar distribution of IN-EGFP PICs at the periphery of the nucleus arises the 
question weather chromatin organization may influence their localization. Indeed, 
recent studies revealed that chromatin has different levels of accessibility, depending 
on histone acetylation (Gorisch et al., 2005). This allowed the description of the 
dynamic accessibility of different chromatin states in response to histone acetylation 
with an apparent pore diameter, which defines the maximal size of complexes 
capable to penetrate these regions.  
In order to verify weather different chromatin condensation states may affect PICs 
accessibility, HeLa cells expressing histone H2B fused to EYFP fluorescent protein 
were used. Since H2B is part of the nucleosomes, the fluorescent signal coming 
form EYFP correlates with chromatin condensation, with brighter and darker areas 
indicating heterochromatin and euchromatin, respectively (Bhattacharya et al., 2006; 
Kanda et al., 1998; Kimura and Cook, 2001). However, the correspondence between 
fluorescence intensity and chromatin condensation state is merely arbitrary. In fact, 
we wondered weather it was possible to associate euchromatin and heterochromatin 
to the H2B-EYFP fluorescence intensity, so as to correctly identify those areas 
within the regions occupied by nPICs. Therefore, we needed to verify the correlation 
of these two forms of chromatin with H2B-EYFP fluorescence intensity. It has been 
shown that different histone posttranslational modifications are related to highly 
condensed, transcriptionally inactive and late replicating heterochromatin (Allis et 
al., 2007; Dimitrova and Gilbert, 1999; Wu et al., 2005). Therefore, HeLa H2B-
EYFP cells (Figure 3-17A) were immunostained with an antibody specific for the 
tri-methylated lysine 9 of histone 3 (3MeK9H3) (Figure 3-17B and C). We acquired 
images at the confocal microscope, by recording separately the channels 
corresponding to H2B-EYFP (Figure 3-17A, red) and 3MeK9H3 staining (Alexa-
647) (Figure 3-17B, green). The cross analysis of fluorescence related to H2B-EYFP 
and the 3MeK9H3 immunostaining (Figure 3-17B, green bars) allowed us to 
precisely and rigorously correlate heterochromatin with a range of fluorescence 
intensity of H2B-EYFP. This analysis revealed that the average H2B fluorescence 
intensity of the overlapping regions is equal to 195 arbitrary units (a.u.) and its 
distribution width at half-height ranges from 140 to 230 a.u. as indicated by the 
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arrow in Figure 3-17D. Therefore, these data not only demonstrate that the high 
intensity H2B-EYFP fluorescence regions are indeed occupied by silenced 
heterochromatin but, more important, we can assign them precise values. 
 
Figure 3-17. Correlation between H2B-EYFP fluorescence intensity and heterochromatin. HeLa 
cells constitutively expressing H2B-EYFP histones (A) were immunostained with the antibody anti-tri-
methylated lysine 9of histone 3 (B), which is a heterochromatin marker. Merged image (C) shows that 
only high intensity H2B-EYFP fluorescent regions costain (shown in yellow) with silenced 
heterochromatin. (D) Fluorescence intensity distribution frequency for H2B-EYFP (red bars) and for 
H2B-EYFP in the 3MeK9H3 positive regions (green bars) of the nucleus represented in A. The arrow 
represents the width at half-height of the H2B-EYFP fluorescence intensity distribution derived by cross 
analyzing with the 3MeK9H3 heterochromatin marker.  
IN-EGFP viral particles localize in less condensed chromatin 
In order to identify weather heterochromatin or euchromatin could influence the 
localization of PICs within intact nuclei, HeLa-EYFP cells were infected with HIV-
IN-EFCP virions and fixed 6 hours post-infection. ECFP labeled virions were used 
in place of HIV-IN-EGFP to allow better spectral separation. Cells were acquired at 
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the confocal microscope, by recording separately the spectral channels of IN-ECFP 
and H2B-EYFP. The presence of a chromatin condensation marker, such as H2B-
EYFP, allowed to identify the fluorescence intensity signal precisely in the regions 
of nuclear IN-ECFP PICs. In order to quantify this signal, a linescan was performed 
in the channel of H2B-EYFP (see Figure 3-18). For each image containing a nPIC 
three lines were drawn. Two were in the highest (blue line) and lowest (green line) 
intensity regions, respectively. A third line was drawn in correspondences of IN-
ECFP PICs, allowing to detect both the H2B-EYFP (white line) and the IN-ECFP 
signals (cyan line). As shown in Figure 3-18, in correspondence of peak of the IN-
ECFP nPIC fluorescence signal the linescan of H2B-EYFP display values 
comparable to those relative to the linescan drawn in the lower fluorescence 
intensity areas, reflecting a decondensed and highly accessible chromatin.  
 
Figure 3-18. IN-EGFP virions localize in less condensed chromatin. (A) H2B-EYFP (red) HeLa cells 
were infected with HIV-IN-EGFP virions (green). (B and C) Linescans of the H2B-EYFP fluorescent 
signal were drawn in correspondence of condensed and decondensed chromatin (blue and green, 
respecitvely), and IN-ECFP PIC (white). (C) Cyan line identifies HIV-PIC. It represents how IN-ECFP 
fluorescence signal change along the white linescan. In correspondence of IN-ECFP peak the H2B-EYFP 
fluorescent signal is comparable to that of decondensed chromatin regions.  
Next, an automated approach was required for a broad screening. Since the 
expression of histone H2B fused to EYFP is not equal among different cells, 
comparable normalized values were required. To this aim the H2B-EYFP 
fluorescence intensity was linearly rescaled over the 8-bit range (0-255 arbitrary 
units, a.u.), as described in Material and Methods. Then, a region of interest (ROI) 
was drawn around each IN-ECFP nPIC and the mean fluorescence intensity in the 
EYFP channel has been measured (see white circles in Figure 3-19A, and Table 
3-2). In parallel, in the same picture, the mean fluorescence intensity was recorded in 
three ROIs drawn in the brightest regions (Figure 3-19B, blue circles) and three 
more ROIs drawn in the darkest regions (excluding nucleolar regions) (Figure 
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3-19B, green circles). Then, the mean value and the standard deviation relative to 
the highest and lowest fluorescence intensity were calculated (see Table 3-2) and 
displayed in the graph of Figure 3-19C. Since acquired images have 8-bit, each 
channel has a depth of 256 colors. This means that darkest regions have a value of 
zero, while brightest regions correspond to 255. Figure 3-19C shows in red the 
counts of fluorescence intensity relative to H2B-EYFP, starting from the lowest 
value (zero) to 255. The resulting graph is a Gaussian curve, where the counts 
represent the number of pixels that have the same intensity value. The averages and 
standard deviations of the less condensed and more condensed regions are 
represented with a green bar and a blue bar, respectively. The two green bars in the 
Gaussian curve of Figure 3-19C represent the mean value of the fluorescence 
intensity of the regions occupied by the two IN-ECFP nPICs visualized in Figure 
3-19A. Therefore, both nPICs are located in the less condensed regions. Following 
this procedure, 48 different cells were analyzed (see Figure 3-19D and Table 3-3): 60 
PICs were in the less condensed regions, 8 in the more condensed regions and 11 in 
the region in between these two, that we called intermediate region. Therefore, this 
analysis revealed that the vast majority of nuclear PICs are in more accessible and 
less condensed regions, while only the 3% of them are in the tightly condensed 
chromatin (see Figure 3-19E and Table 3-3). These results show thus a bias of 













PICs in less 
condensed regions 
PICs in an 
intermediate status 
PICs in tightly 
condensed regions 






Figure 3-19. IN-EGFP PICs localize in less condensed chromatin regions. (A) H2B-EYFP (red) HeLa 
cells were infected with HIV-IN-EGFP virions (green). A circular ROI was drawn around each nuclear 
PIC and the mean fluorescence intensity in the EYFP channel has been measured and reported as green 
bar in the graph represented in C. (B) The mean fluorescence intensity was recorded in three ROIs 
drawn in the brightest regions (blue circles) and three more ROIs drawn in the darkest regions (green 
circles). Mean values and the standard deviations were calculated and plotted in C as light blue area 
and light green area, respectively. (C) Graph representing the counts of fluorescence intensity relative 
to H2B-EYFP, starting from the lowest value (zero) to 255. The resulting graph is a Gaussian curve, 
where the counts represent the number of pixels that have the same intensity value. The two green bars 
represent the mean value of the fluorescence intensity of the regions occupied by the two IN-ECFP 
nPICs visualized in A. (D) Histogram representing the number of PICs in the different regions of 
chromatin. (E) Pie graph showing the percentage of PICs in the less condensed regions, in the more 
condensed regione or in region in betweeen these two.   
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IN-EGFP viral particles selectively target euchromatin 
The establishment of values of H2B-EYFP fluorescence intensity corresponding to 
heterochromatin allowed to set up a new and more rigorous method to analyze the 
condensation of the chromatin in the regions occupied by nPICs and to correlate it 
with either euchromatin or heterochromatin. However, this analysis method needed 
still an improvement. In fact, drawing a ROI around each nPICs includes also pixels 
that are not really occupied by them. Therefore, it was analyzed the condensation of 
the chromatin only in the pixels of H2B-EYFP images overlapping with IN-ECFP 
nPICs fluorescence signal. To this aim, 70 randomly chosen HeLa H2B-EYFP cells 
infected with HIV-IN-ECFP virions were analyzed, fixed 6 hours post-infection and 
immunostained with antibody α-Lamin A/C. As explained above, a z-stack of the 
whole nucleus of each cell was acquired by recording separately the three spectral 
channels corresponding to IN-ECFP, H2B-EYFP and Lamin A/C staining (Alexa-
680). Figure 3-20A shows four representative HeLa H2B-EYFP nuclei (red) 
delimited by the nuclear lamin immunostaining (blue) and containing individual IN-
ECFP viral PICs (green). A total of 103 IN-ECFP nPICs was identified in the nuclei 
of the 70 randomly chosen cells and a ROI was defined exactly in the pixels 
occupied by each nPIC (PIC ROIs). In addition, the same number of ROIs was 
randomly chosen within the same nuclear planes (Random ROIs). Subsequently, in 
order to see if there was a preferential distribution of IN-ECFP nPICs, H2B-EYFP 
fluorescence intensity was measured in the PIC ROIs (Figure 3-20B, red bars) and 
compared to the H2B-EYFP fluorescence intensity in the Random ROIs (Figure 
3-20B, grey bars). As explained above and in Material and Methods, in order to 
obtain comparable values among different cells, the H2B-EYFP fluorescence 
intensity was rescaled over the entire 8-bit range (0-255 a.u.). As a result of this 
analysis the average H2B-EYFP fluorescence intensity was equal to 104.5±11 
(mean±SD) and 132.6±15 (mean±SD) for PIC ROIs and Random ROIs, 
respectively. In order to understand weather the two distributions were similar, we 
compared them by using the non-parametric two-tailed Kolmogorov-Smirnov test, 
which yielded a statistically significant difference among them (P<0.001) (Figure 
3-20B, inset). These results clearly demonstrate that IN-ECFP nPICs are non-
randomly distributed in the nuclei, showing a preferential localization in low H2B-
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EYFP fluorescence intensity areas. Moreover, since our previous experiments 
showed that H2B-EYFP fluorescence intensity ranging from 140 a.u. to 230 a.u. 
correlate with heterochromatin (indicated with an arrow in Figure 3-20B), and since 
nPICs occupy areas with a fluorescence intensity equal to 104.5±11, we can 




Figure 3-20. HIV-IN-ECFP virions preferentially localize in the periphery of the nucleus and 
outside heterochromatin regions. (A) Confocal images of HIV-IN-ECFP virions (green) in nuclei of 
HeLa cells expressing H2B-EYFP (red) and immunostained with antibody against lamin A/C (blue). Bar, 
5 mm. (B) H2B-EYFP fluorescence intensità distribution frequency for PIC ROIs (defined by the HIV-
IN-ECFP virions, red bars) and for Random ROIs (selected randomly in the same planes, grey bars) (n = 
103). Solid lines are obtained by Gaussian fitting. The 3MeK9H3 labeled arrow represents the width at 
half-height of the H2BEYFP fluorescence intensity distribution derived by cross analyzing with this 
heterochromatin marker (see Experimental Procedures). In the inset the distribution cumulative 




HIV-IN-EGFP AS NUCLEAR IMPORT ASSAY 
Influences of drugs in nuclear import 
In the past few years, many drugs have been developed to block different steps of 
HIV-1 replication cycle. For example, 3’azido-3’deoxythymidine (AZT) specifically 
blocks reverse transcription process, while MK-518 (Vandegraaff and Engelman, 
2007) inhibits strand transfer activity of IN. Treatment of infected cells with these 
drugs differently affects the fate of PICs.  
In order to investigate which step of the viral infectivity process is hampered, these 
drugs were tested in combination with HIV-IN-EGFP virus. First of all, different 
concentrations of AZT or MK-518 (1x, 10x, 100x, with respect to their IC50) were 
tested in order to completely impair viral replication cycle. Treated and untreated 
HeLa cells were infected with wild-type virus and luciferase activity was monitored 
2 days post-infection. As shown in Figure 3-21A (green histogram), an IC50 of AZT 
results in a moderate decrease of luciferase activity. Increasing the concentration of 
two orders of magnitude almost no luciferase activity is detected, indicating that 
retrotranscription process is completely blocked. To exclude that luciferase activity 
was related to transcription of non-integrated viral DNA, the IN catalytically 
inactive viral clone D64E was used instead of NL4.3.Luc.R-E- (Figure 3-21A, red 
histogram). Similar results are observed in Figure 3-21B, indicating MK-518 
completely blocks integration at a dosage of 100x with respect to its IC50. To 
monitor cells viability with the increasing concentration of AZT or MK-518, similar 
experiments were performed in uninfected cells, showing no cytopathic effects  
(Figure 3-21A and Figure 3-21B blue histogram, respectively).  
Next, the effect of AZT and MK-518 on PICs nuclear import was monitored. To this 
aim, HeLa cells were treated with either AZT 100x or MK-518 100x and infected 
with HIV-IN-EGFP virions. As control, similar experiments were preformed on 
untreated HeLa cells. Since the amount of IN-EGFP PICs in the nucleus reaches its 
peak 6 hours post-infection, cells were fixed at this time point and immunostained 
with antibody α-Lamin A/C. Following, z-stacks of these cells were acquired and 
the amount of total and nuclear PICs was evaluated. Representative images of mock, 
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MK-518, and AZT treated cell are showed in Figure 3-22A, B and C, respectively. 
 
Figure 3-21. AZT and MK-518 impair HIV-1 viral replication. (A) HeLa cells non-treated (blue bar) 
or treated with different concentration (1x, 10x or 100x) of AZT were infected with wild-type (green bar) 
or D64E (red bar) viruses and luciferase activity was monitored 2 days post-infection. (B) Same as in A 
with MK-518 intstead of AZT. 
In these experiments no major effects of the drugs on the fluorescence signal or cell 
morphology could be revealed, as shown in Figure 3-22D and E. The treatment with 
AZT or MK-518 does not alter the total amount of PICs in the cell (Figure 3-22D). 
Indeed, the average of PICs in mock cells is 176±7 (mean±SD), which is 
comparable with that of AZT or MK-518 treated cells, 182±3 and 173±12, 
respectively. However, the treatment with AZT 100x showed a drastic decrease of 
nuclear PICs (Figure 3-22E). In particular, no nPICs could be detected in 30 cells 
analyzed in two different experiments. These results suggest that the presence of 
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AZT influences the nuclear translocation of PICs. Previous data, based on molecular 
biology assays, indicate that AZT blocks retrotranscription of viral genome. The 
visualization of HIV-IN-EGFP trafficking in the infected cells treated with AZT 
showed that viral particles do not reach the nuclear compartment. Therefore, the 
accomplishment of the retrotranscription is required for the nuclear translocation. 
The number of nuclear PICs in MK-518 treated cells is slightly lower than mock, 
2.4±0.2 compared to 3.2±0.3 (Figure 3-22B). This led us to hypothesize a putative 
role for MK-518 in destabilizing nPICs.  
 
Figure 3-22. AZT blocks PICs nuclear import. HeLa cells non-treated (green bar), treated with DKA 
(MK-518, blue bar) or with AZT (red bar) were infected with HIV-IN-EGFP virions, fixed 6 hours post-
infection and immunostained with antibody anti-Lamin A/C. Confocal z-stacks of these cells were 
acquired and representative images of mock, MK-518, and AZT treated cell are shown in A, B and C, 
respectively. The total and nuclear amount of PICs was evaluated and plotted in the graphs D and E, 
respectively. An average of 30 cells in two independent experiments was analyzed for each treatment and 
SD is represented as error bar. 
In order to investigate on such hypothesis a time laps experiment was performed on 
HeLa cells treated with MK-518 and infected with HIV-IN-EGFP. Infected cells 
were fixed at different time points (3, 6, 9, 12, 16 and 24 hours post infection), 
immunostained with antibody α-Lamin A/C and then z-stack images were acquired 
at the confocal microscope. The results of total PICs and nuclear PICs at each time 
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point are shown in Figure 3-23A and B, respectively. The total amount of PICs in 
treated and not treated cells starts decreasing 9 hours post-infection and no 
significant differences are observed in the presence of MK-518. As shown in Figure 
3-23B, the number of nuclear PICs in treated cells is lower at 6 hours post infection, 
at 3, 9 and 12 hours post infection the reduction is slightly lower with respect to the 
mock and at 16 and 24 hours post infection there are no differences. However, if 
any, the reductions are not significant and the histograms of mock and MK-518 
treated cells are quite similar, suggesting that the drug does not influence either 
nuclear translocation, or nPICs stability.  
 
Figure 3-23. DKA does not affect the kinetic of nuclear import either the PIC stability in the 
nucleus. HeLa cells untreated or treated with DKA (MK-518) were infected with HIV-IN-EGFP virions, 
fixed and the mean number of total and intranuclear viral particles per cell was quantified at 3h, 6h, 9h, 
12h, 16h and 24h. At each time point an average of 30 cells in two independent experiments was analyzed 
and the SD is represented as error bar.  
Transportin SR2 imports PICs into the nucleus 
Recently, it has been shown that the depletion of the cellular protein transportin SR2 
(TRN-SR2) produces a lentiviral specific pre-integration block (Brass et al., 2008). 
Simultaneously, Debyser group revealed by two hybrid screening the interaction 
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between the same factor, transportin SR2, and integrase (Christ et al., 2008). Since 
transportin SR2 is involved in nuclear transportation, it was necessary to design 
experiments to address the role of this factor in HIV-1 nuclear entry. One of the 
most used nuclear import assay is an in vitro transport system, in which recombinant 
transport factors and their potential cargos are added to digitonin-premeabilized cells 
(Liu et al., 1999b). However, this import assay lacks the use of intact cells and intact 
nuclei. The use of a HIV-IN-EGFP virus allows to overcome this problem. In fact, 
as shown in the previous sections, visualization experiments with this fluorescently 
labeled virion revealed to be an accurate system to monitor the nuclear import of 
PICs.  
The expression of transportin SR2 on HeLaP4 cells by selectively targeting its 
mRNA with a siRNA. In order to analyze at the confocal microscope only silenced 
cells, TR-siRNA was conjugated to the fluorescent probe Alexa-568 (siTRN-SR_2 
Alexa-568). In parallel as a control, mismatch siRNA (siTRN-SR_2MM Alexa-568) 
was transfected in HeLaP4 cells. The day after these cells were infected with HIV-
IN-EGFP virions, fixed six hours post-infection and immunostained with antibody 
anti-Lamin A/C, so as to clearly identify nuclear boundaries. As explained in detail 
above, a z-stack of the whole nucleus of each cell was acquired, by recording 
separately the three spectral channels corresponding to IN-EGFP, siTRN-SR_2MM 
Alexa-568 (Figure 3-24A and B) or siTRN-SR_2 Alexa-568 (Figure 3-24C and D), 
and Lamin A/C staining (Alexa-680). HeLaP4 cells positive for the fluorescently 
labeled siRNA-Alexa568 were analyzed with the confocal microscope in order to 
evaluate the ratio of nuclear over cytoplasmatic PICs. The number of nuclear and 
cytoplasmatic PICs was evaluated for each cell, and the derived ratio distribution 
plotted in Figure 3-24E. The average nuclear/cytoplasmatic ratio results equal to 
0.4±0.1% and 2.1±0.1 (mean±SD; n=55) for the TRN-SR2 knocked down and 
control cells, respectively. The two distributions were then compared using the non-
parametric two-tailed Kolmogorov-Smirnov test yielding a statistically significant 
difference (P<0.001) between the two cell populations. This analysis clearly 
demonstrates a decrease in the number of viral PICs in the nucleus upon TRN-SR2 
depletion and demonstrates a primary role of this import factor in PIC nuclear 
translocation. This results in a strong defect in the integration with a consequent 
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block of viral replication. Therefore, the identification of small molecules that 
inhibit the interaction between IN and TRN-SR2 could open new strategies in the 
fight against HIV-1/AIDS. 
 
Figure 3-24. Nuclear Translocation of PICs in HeLaP4 TRN-SR2 Knockdown Cells (A-D) 
Representative images of cells treated with Alexa-568 (red)-labeled siTRN-SR_2MM (A and B) and 
siTRN-SR_2 (C and D). Cells were infected with HIV-IN-EGFP (green) and immunostained with lamin 
A/C (blue). Six hours after infection, cells were fixed and analyzed by laser-scanning confocal 
microscopy. Images are derived from confocal z-stacks with the maximum projection of 3-µm-thick slices 
centered in the middle of the nucleus. Cell shapes are outlined in white. (E) Percentage of PICs in the 
nucleus versus cytoplasmic PICs in cells treated with siTRN-SR_2 (red bars, n = 100) and siTRN-
SR_2MM (green bars, n = 100). Nearly half of the cells treated with siTRN-SR_2 did not contain any PIC 
in the nucleus, whereas in the mismatched control cells, on average 2.2% of the PICs had been imported 
into the nucleus. In the inset, the distribution of cumulative probabilities is plotted for TRN-SR2 siRNA-






























Technology developed in the past 10 years has dramatically increased the ability of 
researchers to directly visualize and measure various stages of the HIV-1 life cycle. 
In many cases, the generation of a great variety of fluorescent viruses together with 
the use of imaging based approaches allowed to answer many previously unsolved 
issues, and to investigate new aspects of the viral replication cycle (Arhel et al., 
2006a; Brandenburg and Zhuang, 2007; Campbell et al., 2007b; Damm et al., 2005; 
del Rio et al., 2005b; Jouvenet et al., 2008; Lakadamyali et al., 2003; Lampe et al., 
2007; Lehmann et al., 2005; McDonald et al., 2002; McDonald et al., 2003; Muller 
et al., 2004; Nicola and Straus, 2004; Rudner et al., 2005; Rust et al., 2004). In 
addition, live cell imaging has allowed a better understanding of dynamic, transient 
events that occur during HIV-1 during HIV-1 replication, including the steps 
involved in viral fusion, trafficking of the viral nucleoprotein complex in the 
cytoplasm and the formation of new virions from an infected cell.  
In this study we have engineered viral particles containing IN fused to EGFP. We 
have obtained this by the trans-incorporation system (Bachand et al., 1999; Paxton 
et al., 1993), allowing the preservation of viral activity. The resulting recombinant 
fluorescent virus enabled the visualization of pre-integration complexes in the 
nucleus of infected cells. We, thus, exploited HIV-IN-EGFP virions to study the 
infection process at the nuclear level. Our results show a prevalence of PICs in the 
nucleus 6 hours post-infection, which localize close to the nuclear periphery, 
specifically in euchromatin regions. Moreover, visualization experiments with IN-
EGFP virions allowed to identify that PICs cannot reach the nuclear compartment in 
AZT treated cells, while MK-518 has no effect in the nuclear import or nuclear PIC 
stability. In addition, IN-EGFP virions revealed that the cellular protein TNPO3 is 
essential for the nuclear import of PICs. This last result arises the possibility to use 
such fluorescent virus as a tool in nuclear import assays.  
MOLECULAR ENGINEERING OF FLUORESCENT HIV-1 
PARTICLES 
The work described in this thesis shows the development, the characterization and 
the exploitation of fluorescently labeled HIV-1 virus.  
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We produced a fluorescent HIV-1 virus by labeling with either EGFP or ECFP the 
viral protein IN. However, we could not insert the sequence of the fluorescent 
protein at the C-terminus of IN in the context of infectious molecular clones of HIV-
1. In fact, previous attempts to produce retroviruses that contained integrase fusion 
proteins were unsuccessful due to loss of virus infectivity after transfection 
(Bushman and Miller, 1997) or loss of fusion protein expression during viral 
replication owing to reversion (Katz et al., 1996). Each of these attempts encoded 
the integrase fusion protein as part of the viral genome, inserting the DNA sequence 
of the sequence-specific DNA-binding protein at the 3’ end of the integrase gene. 
The difficulty in encoding the fusion protein in the viral genome is probably due to 
the overlapping coding region of 3’ IN with vif and to the splice acceptor site 
(Purcell and Martin, 1993). To avoid interfering with crucial elements in the 
integrase gene, we decided to incorporate IN-EGFP fusion protein into HIV-1 viral 
particles in trans. This approach, exploits the Vpr property to interact with p6 region 
of gag (Bachand et al., 1999; Paxton et al., 1993) to shuttle fused exogenous proteins 
inside the viral particles (Fletcher et al., 1997; Liu et al., 1997; Liu et al., 1999a; Wu 
et al., 1999; Wu et al., 1997; Wu et al., 1995). For example, the trans-incorporation 
system has been successfully used to incorporate IN-LexA (Holmes-Son and Chow, 
2000) or IN-E2C (Tan et al., 2006). Importantly, the presence of Vpr at the N 
terminus of trans-incorporated IN does not complement efficiently the proviral 
D64E catalytically inactive IN unless it is cleaved from its fusion partner by the viral 
protease (Fletcher et al., 1997). Therefore, in order to restore its catalytic activity, 
we introduced a proteolytic cleavage site to remove Vpr from the IN-EGFP protein 
after packaging. The successful cleavage of the trans-incorporated construct Vpr-
IN-EGFP by the HIV-1 protease shown in Figure 3-1 was verified by western blot in 
Figure 3-3A and B. 
We evaluated the capacity of IN to perform the 3’-end-joining with the strand 
transfer assay (Figure 3-2), revealing that the introduction of EGFP protein at the C-
terminus of IN does not affect its catalytic activity in vitro. Our data are in 
agreement with previous reports (Holmes-Son and Chow, 2000; Tan et al., 2006), 
showing that the fusion of different proteins at the C terminus of IN does not 
decrease strand transfer activity.  
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The HIV-IN-EGFP virions we produced are structurally intact. In fact, we 
confirmed by different criteria that EGFP signal marks genuine HIV-1 trans-
incorporated complexes: WB (Figure 3-3), colocalization with p17MA and p24CA in 
extracellular (Figure 3-4) and intracellular complexes (Figure 3-5), and association 
with retrotranscribed viral DNA in the cytoplasm (Figure 3-6) and in the nucleus 
(Figure 3-14). WB analyses revealed that the trans-incorporation of Vpr-IN-EGFP 
protein does not alter the structural composition of the virions. Indeed, the 
composition of fluorescently labeled virions is consistent with that of bona fide viral 
particles. As observed in Figure 3-3, it is noteworthy that HIV-IN-EGFP virions 
have a greater amount of IN-EGFP compared to the amount of IN in wild type and 
mutated virions. This can be explained by the fact that IN-EGFP is trans-
incorporated. Notably, visualization experiments on viral particles confirms WB 
analysis on complete viral assembly. In fact, colocalization with HIV-1 viral 
proteins in extracellular viral particles revealed that p17MA and p24CA are virtually 
always associated with the extracellular HIV-IN-EGFP virions as is expected for 
wild type and mutated viruses. An important consideration is that 80% of the viral 
particles double labeled with both α-p17MA and α-p24CA antibodies colocalize with 
IN-EGFP, indicating that our labeling system allows the detection of almost all 
virions by confocal microscopy.   
Another interesting observation is that viral particles appear heterogeneous in size in 
the immunofluorescence with a broad distribution of fluorescence intensity (Figure 
3-4). This is in accordance with previous data (Lampe et al., 2007) and is not 
surprising since HIV-1 particles display a flexible architecture with a broad rage of 
diameters and are composed of variable amounts of Gag polyproteins (Briggs et al., 
2004; Briggs et al., 2003; Wilk et al., 2001).  
VISUALIZATION OF HIV-IN-EGFP VIRIONS IN THE 
CYTOPLASM 
The direct observation of individual virions in target cells increased our 
understanding of HIV-1 infection process (Arhel et al., 2006a; Campbell et al., 
2007b; Jouvenet et al., 2008; Lampe et al., 2007; McDonald et al., 2002; Muller et 
al., 2004; Rudner et al., 2005), which had been difficult to study using classical 
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molecular and cellular biology techniques. This is because many of the virions that 
enter a target cell are non-specifically endocytosed and never enter the cytoplasm by 
envelope-mediated fusion, making the activity of the small population of relevant 
viral cores difficult to assay. Moreover, biologically important events might only 
occur in the context of intact viral cores, which are unstable and difficult to purify 
biochemically. The ability to fluorescently label HIV-1 viral particles with Vpr-IN-
EGFP fusion protein allowed us to overcome this obstacle. In fact, IN remains 
associated with the viral genome until the viral complex enters the nucleus and 
integrates. Therefore, the labeling of IN allows the direct observation of both 
cytoplasmic and nuclear behaviour of individual PICs, as we showed in this thesis. 
The first step for the virus during infection process is the binding to the plasma 
membrane. HIV-1 is considered to be relatively inefficient at infecting cells 
(Andreadis et al., 2000; Kimpton and Emerman, 1992; Piatak et al., 1993). Our 
studies have benefited from the ability to pseudotype HIV-1 virions with the pH-
dependent envelope glycoprotein of vesicular stomatitis virus (VSV-g), which 
allows a majority of virions to productively enter the host cell, compared with the 
small percentage of virions that achieve productive entry using the HIV-1 envelope 
protein. In addition, we were interested in studying virions within the cell. 
Therefore, in order to distinguish between productive and non-productive entry, 
infected cells were treated with trypsin 1x. Recently, Campbell et al. (Campbell et 
al., 2007b) developed an elegant system based on a dual-fluorescent virus to clearly 
identify virions that have productively entered the target cells in a more elegant way. 
However, since our aim was to visualize IN-EGFP PICs within the nuclear 
compartment we did not implement the HIV-IN-EGFP virions with the double 
labeling system.   
Following the entry, HIV-1 releases the capsid in the cytoplasm. There has been 
much speculation about the cytoplasmic fate of the capsid that contains the HIV 
genome inside virions. In some models, it dissolves immediately after membrane 
fusion (Bukrinsky et al., 1993b; Fassati and Goff, 2001; Miller et al., 1997). Others 
propose that it remains intact until the genome reaches a nuclear pore (Arhel et al., 
2007; Forshey et al., 2002). Capsid is a relatively unstable complex that is sensitive 
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to all but the mildest detergent treatment. Therefore the way in which it is isolated 
and purified from infected cells could explain this discrepancy. Our results showed 
that the majority of IN-EGFP spots within the cell are positive for both p17MA and 
p24CA (Figure 3-5), and those within the nuclear compartment does not colocalize 
with p24CA (Figure 3-13), confirming that capsid shells disassemble before entering 
the nucleus. These data are in accordance with Foreshey et al. (Forshey et al., 2002), 
where they show that the stability of the viral core in the cytoplasm of infected cells 
is a prerequisite for efficient HIV-1 retrotranscription and infection. Moreover, our 
data are consistent with McDonald et al. (McDonald et al., 2002), where they 
demonstrate that capsid structure remains intact during the initiation of reverse 
transcription in the cytoplasm. The combination of fluorescent probes and confocal 
microscopy enabled to circumvent the problems related to the isolation and 
purification of cores, allowing us to investigate the real structure of the PICs within 
intact target cells without altering their structure and composition. This confirms the 
great powerful of the fluorescence approach in addressing issues without the 
artefacts related to other techniques. 
Even though IN-EGFP particles in the cytoplasm colocalize with the viral proteins 
p17MA and p24CA, it does not indicate they are pre-integration complexes. Indeed, 
PICs are usually defined as integration competent complexes, whereas complexes 
where reverse transcription process is incomplete are named reverse transcription 
complexes (RTCs) (Lehmann-Che and Saib, 2004; McDonald et al., 2002). The 
presence of EGFP fused to IN within the context of intracellular viral complexes 
might interfere with reverse transcription process, leading to the formation of RTCs 
and not of PICs. In order to visualize reverse transcription associated with the 
internalized viral particle, Hope’s lab (McDonald et al., 2002) injected a 
fluorescently labeled deoxynucleotide into the cells before infection. This is an 
elegant approach to show the retrotranscribed viral DNA in the cytoplasm, although 
fluorescently labeled dUTPs are also incorporated in the nucleus of the target cells as 
a consequence of the microinjection during cellular DNA replication. Therefore the 
high background signal prevents the visualization of retrotranscribed viral cDNA 
within the nuclear compartment. To circumvent the problem we took advantage of 
the natural endogenous reverse transcription activity of the HIV-1 viral particles. 
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Following this procedure neo-synthesized viral cDNA was visualized both in the 
cytoplasm (Figure 3-6) and in the nuclear compartment (Figure 3-14)., associated to 
the IN-EGFP particles. It has been shown that virions subjected to NERT are about 
twice infectious as untreated controls (Naldini et al., 1996). However, we detected 
only a minority of IN-EGFP particles colocalizing with the fluorescently labeled 
viral DNA. This reduced number of positive PICs can be explained by the reported 
observation that only a limited number of entered viral particles is actually infective 
(Thomas et al., 2007). Alternatively, this discrepancy could be explained with the 
lack of poliamines in our reaction mixture during natural endogenous reverse 
transcription, which have been shown to remarkably enhance HIV-1 reverse 
transcription (Zhang et al., 1996). Another important consideration to take into 
account is the steric hindrance of the fluorescently moiety of Alexa-dUTPs, which 
could lead to abortive or non-infectious viral particles. However, the observation of 
HIV-IN-EGFP reverse transcribed viral particles within the nuclear compartment 
(Figure 3-14) shows that the fluorescent label of dUTPs does not impair neither the 
accomplishment of the retrotranscription process nor the nuclear import. Finally, our 
results prove that IN-EGFP complexes are indeed functional PICs. 
FUNCTIONAL IN-EGFP PICS TRANSLOCATE IN THE 
NUCLEUS 
The main scope of this study was the nuclear visualization of HIV-1 PICs. Our great 
effort was to clearly identify the nuclear boundaries, so as to precisely distinguish 
nuclear PICs from cytoplasmic PICs. To this aim we labeled nuclear lamin, which 
stains the inner membrane of the nucleus. This approach resulted to be the best 
solution in order to avoid misinterpretations (see Figure 3-8, Figure 3-9, Figure 3-11 
and Figure 3-12). The combination of multidirectional imaging and accurate image 
processing allowed us to unambiguously identify the viral particles located inside 
the nuclear envelope and distinguish them from those located in its outer proximity. 
In fact, we infected cells with HIV-IN-EGFP and we immunostained them with 
antibody anti-Lamin A/C. Our results (Figure 3-11 and Figure 3-12) show a high 
number of fluorescent PICs very close or juxtaposed to the nuclear membrane, thus 
an accurate analysis is necessary to establish the nuclear nature of viral PICs. The 
acquisition of a cell with both the XYZ and XZY scan modes (Figure 3-12) revealed 
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the same amount of PICs in the nucleus, validating therefore our experimental set up 
and acquisition system.  
Notably, we observed a high frequency of PICs adherent to the borders of the nuclei 
(Figure 3-12). Our results are in agreement with previous reports, where they 
showed that a significant proportion of the signal accumulated in the perinuclear 
region (McDonald et al., 2002). These data suggests that the transition through the 
nuclear membrane is a strong limiting factor during viral replication. This 
observation is also supported by the disproportionate number of nuclear versus 
cytoplasmic viral particles (1/50 ratio). Similarly, Thomas et al. (Thomas et al., 
2007) showed a predominance of virions that do not accomplish reverse 
transcription with respect to those that successfully integrate. In addition, our data 
are consistent with Iordanskiy et al. (Iordanskiy et al., 2006); in fact, they exploited 
quantitative real time PCR to reveal a ratio of nuclear to cytoplasmic complexes of 
1:60. Therefore, results obtained with the multidirectional confocal microscopy we 
set up are in agreement with data coming from a molecular biology approach, 
further confirming the powerful of the HIV-IN-EGFP fluorescent virus as a reliable 
tool to study HIV-1 biology. 
It has been estimated that proviral DNA is detectable almost 8 hours after HIV-1 
entry (Kim et al., 1989). We have thus quantified the number of viral PICs at 
different time points from 3 to 24 hours after infection. We found that the maximum 
nuber of intranuclear HIV-IN-EGFP PICs was observed at 6 hours post-infection 
(Figure 15). The observation of PICs in the nuclear compartment few hours post-
infection (3 and 6 hours) is confirmed by previous studies, where they revealed PICs 
containing retrotranscribed viral DNA in nuclear extracts four hours after infection 
(Fassati and Goff, 2001). At subsequent time points we detected that the number of 
PICs rapidly declined and virtually none was detected 24 hours post-infection 
(Figure 15). Our kinetic data are at odds with previous studies (Arhel et al., 2006a). 
In fact, very recently Arhel et al. developed a fluorescent virus based on Flash 
labeling of IN, allowing HIV-1 nuclear visualization. This system has the enormous 
advantage of exploiting a very little tag, and thus it does not lead to disruption of 
viral functions and loss of infectivity (Engelman et al., 1995; Muller et al., 2004). 
DISCUSSION  
 135 
However, they reported to detect only occasionally Flash-labeled HIV-1 complexes 
within nuclear compartment 24 hours after infection. This discrepancy could be 
explained by a lower sensitivity of the tetracystein labeling approach coupled to an 
analyses performed 24 hours post-infection instead of 6 hours (Figure 3-15).  
HIV-1 is able to replicate in interphasic cells (Weinberg et al., 1991), indicating that 
PICs are able to actively cross the nuclear membrane (Bukrinsky et al., 1992). In 
contrast, it has been shown that PICs from most retroviruses are unable to enter 
intact nuclei and are believed to wait until nuclear membrane breakdown during 
mitosis (Lehmann-Che and Saib, 2004; Lewis and Emerman, 1994; Roe et al., 
1993). Completion of the reverse transcription correlates with changes in protein 
composition of the PICs, which may contribute to the ability of complexes to 
translocate through the nuclear pore complexes. Recently, it has been shown that 
disassembly of nuclear membrane during mitosis allows cytoplasmic viral 
complexes to get access to the nuclear compartment (Iordanskiy et al., 2006). 
Among these, there are two populations: complexes containing incomplete reverse 
transcription products (RTCs) and integration-competent complexes (PICs). 
Iordanskiy et al. showed that these nuclear immature RTCs, contain RT and 
incomplete DNA, can accomplish reverse transcription, but are defective for 
integration (Iordanskiy et al., 2006). Therefore, one could infer that IN-EGFP PICs 
we visualized in the nucleus belong to this population, getting access to the nuclear 
compartment during mitosis. However, we showed that the nuclear IN-EGFP PICs 
we observed did not translocate in the nucleus as a consequence of nuclear 
membrane breakdown. As a matter of fact, we did not detect any IN-EGFP PICS in 
the nucleus of cells treated with AZT (Figure 3-22). In fact, blocking reverse 
transcription process, AZT impedes the intracytoplasmic maturation of RTCs in 
functional PICs. We showed that incomplete reverse transcription results in a block 
of PICs nuclear import (Figure 3-22). Consequently, IN-EGFP particles in cells 
treated with AZT can get access to the nucleus only during mitosis. However, the 
complete absence of nuclear PICs in 60 different treated cells suggests that this 
phenomenon is negligible with our experimental set up.  
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DISTRIBUTION OF IN-EGFP PARTICLES IN THE NUCLEUS 
Integration of the viral cDNA into the host cellular genome is a necessary and 
deeply investigated event in retroviral replication, particularly as concerns the 
identification of the preferred integration sites. To date, however, no specific 
genomic sequences have been associated to such sites. Yet, unraveling the 
mechanisms of integration-site selection for HIV-1 is important not only to better 
understand the biology of retroviruses but also because of its impact on other fields 
as retrovirus-based technology. For instance, retroviral vectors have been 
extensively developed for gene therapy applications, however their use is limited by 
the uncontrollable integration site, a situation that may eventually cause disruption 
of normal cellular proliferation (Cereseto and Giacca, 2004; Hacein-Bey-Abina et 
al., 2003b). In fact, it is now clear that integration of therapeutic retroviral vectors 
can activate proto-oncogenes in patients (Bushman, 2002; Hacein-Bey-Abina et al., 
2003a; Hacein-Bey-Abina et al., 2003b; Williams and Baum, 2003). In recent 
years, wide genome and transcriptome surveys revealed that retroviral integration is 
favoured near transcriptionally active genes (Crise et al., 2005; Kang et al., 2006; 
Lewinski et al., 2006; Mitchell et al., 2004; Schroder et al., 2002; Wu et al., 2003). 
Mounting evidence suggest that the cellular lens epithelium-derived growth factor 
(LEDGF/p75), a IN-interacting factor (Cherepanov et al., 2003; Emiliani et al., 
2005; Turlure et al., 2004), may direct viral integration into transcription units 
(Ciuffi et al., 2005; Shun et al., 2007b). It has been speculated that LEDGF/p75 may 
tether PICs at specific sites by interacting through its PWWP domain with specific 
histone modifications associated with transcriptional elongation. Indeed, the role of 
the chromatin structure and of higher order nuclear organization in retroviral 
integration has not been yet investigated. 
In order to visualize the distribution of PICs with respect to the chromatin 
organization,we exploited the fluorescently labeled histone H2B (H2B-EYFP). In 
fact, it is part of the nucleosomes, which are localized in the nucleus. Many different 
groups have already used this nuclear marker, since it allows the identification of the 
nucleus both in fixed and in living cells (Kanda et al., 1998; Kimura and Cook, 
2001; Weidemann et al., 2003). Therefore, we reasoned that the visualization with 
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confocal microscopy of the fluorescent signal coming from the labeled H2B could 
precisely identify the nuclear structure and organization. In fact, the ability of the 
confocal microscope to create sharp optical sections allows the 3D image 
reconstruction of nucleus. Thus, we infected HeLa cells constitutively expressing 
H2B-EYFP with HIV-IN-ECFP virions and we immunostained them with antibody 
anti-Lamin A/C, in order to accurately distinguish cytoplasmic PICs from nuclear 
PICs. By using HeLa H2B-EYFP cells as an experimental system to distinguish 
different chromatin structure regions (Bhattacharya et al., 2006; Kanda et al., 1998; 
Kimura and Cook, 2001), this study demonstrates that the vast majority of PICs 
localize in decondensed regions of the chromatin, as compared to more condensed 
areas (Figure 3-20). To better correlate chromatin condensation forms observed in 
these cells with functionally distinct regions of euchromatin or heterochromatin, we 
exploited antibodies against post-translational modification of histone H3 (K9 tri-
methylated) specific for transcriptionally silenced regions of heterochromatin 
(Kouzarides, 2007) (Figure 22 and Figure 23). Localization in euchromatin regions 
is in accordance with a recent report showing that proviral integration sites are 
characterized by specific epigenetic codes (Wang et al., 2007). The association with 
definite regions of the chromatin marked by specific post-translational modifications 
might also suggest that chromatin modification factor/s might tether HIV-1 to 
specific sites. We have recently demonstrated that cellular histone-acetyltransferase, 
p300, acetylates IN and enhances viral integration (Cereseto et al., 2005). This 
cellular enzyme, which determines chromatin decondensation through histones 
acetylation, may favour integration by both acetylating IN and by tethering the virus 
to acetylated/decondensed regions of the chromatin. Further study must be carried 
out to address these hypotheses (Cereseto and Giacca, 2004). In addition, another 
factor has been shown to be involved in tethering HIV-1 PICs to the cellular 
genomic transcription units: LEDGF/p75 (Ciuffi et al., 2005; Shun et al., 2007a). 
LEDGF/p75 is predominantly localized in the nucleus, where it is intimately 
associated with the chromosomes (Nishizawa et al., 2001), and it is implicated in 
gene expression (Fatma et al., 2001; Ge et al., 1998; Singh et al., 2001). The 
PWWP domain of LEDGF/p75 interacts specifically with histone modifications 
associated with transcriptional elongation. Therefore, it has been suggested that 
LEDGF might tether PICs at specific sites in the nucleus (De Rijck et al., 2007; 
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Van Maele et al., 2006). Taking into account all these data, what does really address 
PICs in transcriptionally active regions? Is it the histone-acetyltransferase p300, 
which binds IN and tethers PICs to acetylated regions of the chromatin? Is it the 
binding of LEDGF at the cytoplasmic level, which tether PICs to transcriptionally 
active units and increase the affinity of IN for DNA? Is it the structure of the 
chromatin, which allows PICs to easily move in euchromatin, while it blocks their 
entry in the tightly condensed heterochromatin? It is not easy to answer these 
questions, however we can speculate on it taking into account our current knowledge 
in this field. Interestingly, it has been shown that heterochromatin is characterized 
by an apparent pore size of 16–20 nm (Gorisch et al., 2005). This means that 
molecules or complexes higher than this value are excluded from heterochromatin. 
Notably, PICs are characterized by the presence of many proteins and the 
retrotranscribed viral genome. Therefore, they are enormous complexes, with a size 
estimated around 28 nm (Miller et al., 1997). This means that they can easily enter 
into the nucleus through the nuclear pore complexes, which are able to transport 
macromolecules up to 39 nm (Pante and Kann, 2002). On the contrary, they are 
excluded by the tightly packed chromatin, since they find a physical barrier of 16-20 
nm.  
Interestingly, we found that IN-EGFP PICs displays a clear preferential position at 
the nuclear periphery (Figure 3-16). This result, together with the observation that 
PICs distribute in euchromatic regions, suggests a role for chromatin structure in 
addressing the viral complexes towards preferential genome domains. This 
perspective arises by the fact that DNA-related metabolic processes including 
transcription, recombination, DNA repair and replication, are coordinated by 
functionally distinct chromatin domains spatially arranged within a precisely defined 
nuclear architecture (Misteli, 2007). It is known that chromosomes, genome regions 
and single genes are nonrandomly arranged within the nucleus (Casolari et al., 2004; 
Taddei et al., 2006; van Steensel et al., 2001). Interestingly, recent advances 
highlight the role of nuclear envelope components in the control of gene expression 
(Akhtar and Gasser, 2007). Indeed, it has been showed that the peripheral 
localization of genome regions might occur directly via interactions between lamin 
A and core histones (Gruenbaum et al., 2005). In addition, the position of single 
genes relative to the nuclear periphery is non random, but rather linked to their 
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functional status (Chambeyron and Bickmore, 2004; Kim et al., 2004). Moreover, 
very recently Taddei et al. (Taddei et al., 2006) demonstrated that genes 
repositioned to the nuclear periphery interact with the nuclear pore components when 
they are activated. As a consequence, there is a specific chromatin architecture very 
close to the nuclear periphery, which may dictate or influence the position of pre-
integration complexes within the nuclear compartment. Therefore, once nPICs 
translocate into the nucleus, they get in contact with less condensed and more 
accessible euchromatin, which favours the integration process (Bushman et al., 
2005). Bushman lab (Schroder et al., 2002) showed that genes activated by infection 
are favoured integration targets. Consequently, activation process itself may promote 
formation of regional hotspots. Therefore, one could speculate that following 
infection some genes are activated and repositioned towards the nuclear periphery. 
As a consequence of activation these genes are in a more open chromatin structure, 
thus favouring integration process (Bushman et al., 2005). 
Taking into account the above observations and our results, we can hypothesize that 
once accomplished reverse transcription process, PICs loose p24CA and translocate in 
the nucleus through the nuclear pores. As soon as they pass the nuclear pores and 
arrive in the nuclear compartment they are already in euchromatin regions, since 
transcriptionally active genes are associated with nuclear pore complexes 
(Gruenbaum et al., 2005; Taddei et al., 2006). At this stage, PICs can move only in 
the less condensed chromatin regions, since they are physically excluded from the 
heterochromatin (Gorisch et al., 2005). Therefore chromatin would act as a 
determinant element for PICs distribution. Subsequently, other proteins such as 
p300 and/or LEDGF/p75 might act by bridging PICs to specific regions of the 
cellular euchromatin. 
HIV-IN-EGFP AS NUCLEAR IMPORT ASSAY 
Lentiviruses are capable of infecting non-dividing cells, such as terminally 
differentiated macrophages (Lewis et al., 1992), due to their capacity to translocate 
in the nuclear compartment through the nuclear pore complexes. Once reached the 
nucleus the integration process takes place. Therefore, one very interesting target of 
anti-retroviral therapy is blocking the nuclear entry, which, in turn, abolishes the 
integration and the subsequent viral replication and spreading.  
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As described in the introduction, it has to be considered that nuclear import is not 
accompanied by a measurable enzymatic activity (De Rijck et al., 2007). To date, 
different techniques have been used such as fractionation assays (Mannioui et al., 
2005), southern blot (Petit et al., 2000), digitonin-permeabilized cells (Adam et al., 
1990). PICs nuclear import can be also indirectly measured quantifying the 
integrated proviruses. However, it can happen that retrotranscribed viral genome can 
translocate in the nuclear compartment without being integrated. To circumvent this 
problem, 2-LTR circles have been used as an indirect measure for the nuclear import 
of PICs. In fact, once in the nucleus, viral DNA can be integrated or forms 1-LTR 
and 2-LTR circles, which are dead-end by-products of viral replication (Coffin et al., 
1997). For example, a reduction in the 2-LTR formation and a subsequent block of 
integration suggest that the block of HIV-1 replication is at the nuclear entry step.  
Since the fluorescent virus we developed can be detected at the nuclear level, we 
reasoned that it could be used as direct assay to measure nuclear import. To assess 
such role we exploited two different drugs: 3’azido-3’deoxythymidine (AZT) and 
MK-518. While the former specifically blocks reverse transcription process, the 
latter inhibits strand transfer activity of IN. We reasoned to test the fluorescently 
labeled virus with these drugs because they differently affect the fate of PICs. In 
fact, while the block of retrotranscription hampers nuclear import, inhibition of IN 
activity does not prevent PICs from reaching the nucleus. As we showed (Figure 16 
and Figure 17) AZT completely inhibit the nuclear translocation. In fact, as recently 
reported, the block in reverse transcription is determinant for the nuclear import 
(Iordanskiy et al., 2006). On the contrary, MK-518 did not hamper PICs to reach the 
nucleus, even if it blocked retroviral integration. In addition, our results revealed 
only a slightly decrease of PICs nuclear import, which is not statistically 
significative, suggesting that this drug acts exclusively through its two strand-
transfer-specific IN inhibition activity and does not affect PICs stability of kinetic of 
nuclear translocation. These results confirmed the specificity of HIV-IN-EGFP in 




To date many viral and cellular nuclear import factors have been investigated: MA 
(Bukrinsky et al., 1993a), Vpr (Heinzinger et al., 1994), the DNA Flap (De Rijck 
and Debyser, 2006), IN (Depienne et al., 2000; Limon et al., 2002b; Pluymers et al., 
1999; Tsurutani et al., 2000), LEDGF/p75 (Llano et al., 2004; Maertens et al., 
2004). Despite the great efforts in finding a putative factor involved, no one of the 
proposed can be put forward as the dominant nuclear import factor. Moreover, some 
factors are actually involved in steps before or after nuclear import; therefore 
mutations on these proteins can lead to only an apparent nuclear import defect. In 
addition, it might be that HIV-1 has adopted several redundant pathways to ensure 
that the PICs can pass the critical step of nuclear import. Very recently, Debyser lab 
discovered a cellular co-factor, known as transportin TRN-SR2 (Christ et al., 2008). 
This factor has been identified as HIV-1 IN co-factor with yeast two-hybrid screen 
system. They showed that its depletion interferes with HIV-1 replication. The 
reduction in the 2-LTR circles formation together with the block of integration 
suggested that nuclear import of PICs was hampered. However, a direct assay to 
reveal such block was missing. Therefore, we exploited HIV-IN-EGFP virus as an in 
vivo nuclear import assay to demonstrate the defect in PICs nuclear translocation 
after depletion of TRN-SR2 (Figure 3-24). This method allowed to conclude that the 
great majority of siRNA-treated cells did not contain any PIC in the nucleus as 
opposed to control cell lines. Very recently, Brass et al. (Brass et al., 2008) 
published an extensive siRNA screen to identify host factors of HIV-1 IIIb 
replication. Two hundred and seventy three siRNAs that decreased HIV replication 
at least 2-fold were identified. Interestingly, the tnpo3 gene, encoding for TRN-SR2 
was identified as a hit. However, they did not pinpoint IN as the viral partner of 
interaction, nor could they validate TRN-SR2 as the nuclear import factor of HIV. 
Therefore, this is the first time that a HIV-1 cellular co-factor has been put forward 
as dominant nuclear import factor.  
To productively infect host cells, HIV needs to perform two entry steps. First the 
virus has to attach cellular membrane receptors and co-receptors in order to enter the 
cytoplasm. Once the pre-integration complex is formed, it needs to dock onto 
nuclear-import receptors to cross the second physical barrier against infection: the 
nuclear membrane. Cell fusion inhibitors like maraviroc and enfuvirtide have 
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successfully entered the clinic (Flexner, 2007). Because nuclear import is still poorly 
understood in comparison, it has remained a yet unexplored target in anti-HIV 
therapy. The strong replication defect provoked by silencing of TRN-SR2 provides a 
rationale for the identification of small-molecule protein-protein interaction 
inhibitors to obstruct loading of the PIC onto its nuclear import factor. Subsequently, 
the use of HIV-IN-EGFP together with lamin staining could be exploited as a tool to 
identify or validate such inhibitors. This shows great promise for HIV-IN-EGFP as s 
novel tool to study anti-HIV drugs. 
FUTURE PERSPECTIVES 
In the absence of an effective vaccine against human immunodeficiency virus type 1 
(HIV-1), small molecule inhibitors that target essential steps in the viral life cycle 
represent the best strategy for suppressing HIV-1 replication and controlling the 
spread of AIDS. There are currently four classes of drugs approved for use with 
AIDS patients: fusion inhibitors that block virus entry; nucleoside reverse 
transcriptase inhibitors (NRTIs) that mimic natural nucleotide substrates; non-
nucleoside reverse transcriptase inhibitors (NNRTIs) that allosterically inhibit 
reverse transcriptase; and protease inhibitors (PIs). Highly active antiretroviral 
therapy (HAART), typically consisting of a PI or NNRTI and two NRTIs, is in most 
cases sufficient to reduce and/or maintain HIV-1 RNA levels within patient blood to 
below levels of detection. However, the relatively low fidelity of the reverse 
transcriptase enzyme in combination with the enormous population of circulating 
virus particles at steady-state replication leads to resistance to single as well as 
multiple drug classes (Brenner et al., 2002; Wensing and Boucher, 2003). 
Furthermore, cessation of HAART in patients with undetectable viral RNA loads for 
periods up to 2 years invariably results in viral rebound, indicating the presence of 
ongoing residual replication in the presence of therapy and/or the persistence of 
latent virus capable of reactivation in response to environmental triggers (Chun et 
al., 1997; Finzi et al., 1999; Wong et al., 1997). Considering the toxicity associated 
with many of the available treatments (Carr et al., 1998; Lewis et al., 2003) and 
difficulties in adhering to complex treatment regimens, there is an urgent need to 
identify and develop new drug targets. As we showed in the last part of this thesis, 
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hampering nuclear import of PICs is perhaps one of the most interesting 
perspectives, since it impede the PIC to enter in the nuclear compartment and, in 
turn, it would block viral integration.  
Therefore, the ability of HIV-1 labeled virus as nuclear import tool could be 
exploited in the development of such new compounds. However, usually a great 
number of drugs need to be tested. To this aim, the combination of HIV-IN-EGFP 
virions with the lamina labeling might be improved and implemented in an 
automated high throughput system, so as to screen a huge number of putative drugs 
that block the PICs nuclear import. The resulting system could lead to the 
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